DATE ADDED TO CATALOG;PUBMEDID;FIRST AUTHOR;DATE;JOURNAL;LINK;STUDY;DISEASE/TRAIT;INITIAL SAMPLE SIZE;REPLICATION SAMPLE SIZE;REGION;CHR_ID;CHR_POS;REPORTED GENE(S);MAPPED_GENE;UPSTREAM_GENE_ID;DOWNSTREAM_GENE_ID;SNP_GENE_IDS;UPSTREAM_GENE_DISTANCE;DOWNSTREAM_GENE_DISTANCE;STRONGEST SNP-RISK ALLELE;SNPS;MERGED;SNP_ID_CURRENT;CONTEXT;INTERGENIC;RISK ALLELE FREQUENCY;P-VALUE;PVALUE_MLOG;P-VALUE (TEXT);OR or BETA;95% CI (TEXT);PLATFORM [SNPS PASSING QC];CNV;MAPPED_TRAIT;MAPPED_TRAIT_URI;STUDY ACCESSION;GENOTYPING TECHNOLOGY
18-12-2018;29360470;Miron J;19-01-2018;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/29360470;CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.;Late-onset Alzheimer's disease;966 Quebec (founder/genetic isolate) ancestry cases, 977 Quebec (founder/genetic isolate) controls;340 cases, 195 controls;;;;APOE;;;;;;;APOE-?;APOE;0;;;1;NR;1,00E-49;490;;;;Illumina [NR];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST006806;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9q21.31;9;81079667;Intergenic;AL138749.1 - RPS20P25;ENSG00000226798;ENSG00000228375;;208372;330612;rs144573434-T;rs144573434;0;144573434;regulatory_region_variant;1;0.997;0,0000005;6,30E+15;(liability model);114;[0.69-1.59] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q14.3;12;65859519;HMGA2;AC090673.1, HMGA2;;;ENSG00000197301, ENSG00000149948;;;rs145282773-T;rs145282773;0;145282773;non_coding_transcript_exon_variant;0;0.997;0,000002;5,70E+15;(liability model);104;[0.61-1.47] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;10q23.31;10;88850285;ANKRD22;ANKRD22;;;ENSG00000152766;;;rs147285445-T;rs147285445;0;147285445;intron_variant;0;0.998;0,000004;5,40E+16;(liability model);103;[0.6-1.46] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1p31.1;1;81589710;Intergenic;ADGRL2, AC117944.1;;;ENSG00000117114, ENSG00000236676;;;rs186891871-C;rs186891871;0;186891871;intron_variant;0;0.998;0,000009;5,05E+15;(liability model);98;[0.55-1.41] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1q21.1;1;147483513;Intergenic;LINC00624;;;ENSG00000278811;;;rs141976661-A;rs141976661;0;141976661;intron_variant;0;0.997;0,0000005;6,30E+15;(liability model);88;[0.55-1.21] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9q21.31;9;80903300;Intergenic;AL138749.1 - RPS20P25;ENSG00000226798;ENSG00000228375;;32005;506979;rs139638356-T;rs139638356;0;139638356;intergenic_variant;1;0.996;0,000002;5,70E+15;(liability model);83;[0.48-1.18] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7q21.11;7;83870966;Intergenic;RAD23BP2 - SEMA3A;ENSG00000230244;ENSG00000075213;;206341;84811;rs185170954-A;rs185170954;0;185170954;intergenic_variant;1;0.997;0,000009;5,05E+15;(liability model);82;[0.47-1.17] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;3q26.2;3;169273046;MECOM;MECOM;;;ENSG00000085276;;;rs115798104-A;rs115798104;0;115798104;intron_variant;0;0.997;0,0000009;6,05E+15;(liability model);8;[0.49-1.11] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8p23.1;8;6680850;Intergenic;MCPH1-AS1;;;ENSG00000249898;;;rs181696879-A;rs181696879;0;181696879;intron_variant;0;0.994;0,0000004;6,40E+16;(liability model);67;[0.42-0.92] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q14.3;2;123951121;Intergenic;RN7SKP102 - AC079154.1;ENSG00000223118;ENSG00000228400;;81551;65737;rs138449900-C;rs138449900;0;138449900;intergenic_variant;1;0.996;0,000003;5,52E+15;(liability model);66;[0.39-0.93] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8q21.13;8;80432793;Intergenic;AC034114.2;;;ENSG00000253238;;;rs141846544-T;rs141846544;0;141846544;intron_variant;0;0.996;0,000009;5,05E+15;(liability model);65;[0.36-0.94] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1p36.13;1;19288434;AKR7A3;AKR7A3;;;ENSG00000162482;;;rs117022236-A;rs117022236;0;117022236;intron_variant;0;0.995;0,000004;5,40E+16;(liability model);63;[0.36-0.9] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6q14.1;6;78889320;IRAK1BP1;IRAK1BP1;;;ENSG00000146243;;;rs140587050-C;rs140587050;0;140587050;intron_variant;0;0.995;0,000005;5,30E+15;(liability model);63;[0.36-0.9] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;15q24.3;15;76713822;SCAPER;SCAPER;;;ENSG00000140386;;;rs183291664-T;rs183291664;0;183291664;intron_variant;0;0.996;0,000003;5,52E+15;(liability model);58;[0.34-0.82] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;3q22.2;3;134501479;CEP63;CEP63;;;ENSG00000182923;;;rs142076474-A;rs142076474;0;142076474;intron_variant;0;0.994;0,000004;5,40E+16;(liability model);58;[0.34-0.82] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9q31.3;9;111149099;Intergenic;AL162414.1;;;ENSG00000227531;;;rs181299481-A;rs181299481;0;181299481;intron_variant;0;0.994;0,000004;5,40E+16;(liability model);58;[0.33-0.83] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;19q13.33;19;47635083;GLTSCR1;BICRA, AC010519.1;;;ENSG00000063169, ENSG00000268746;;;rs191404864-A;rs191404864;0;191404864;intron_variant;0;0.006;0,000005;5,30E+15;(liability model);53;[0.29-0.77] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7p12.1;7;51510325;COBL;AC005999.2;;;ENSG00000285741;;;rs112404845-A;rs112404845;0;112404845;intron_variant;0;0.991;0,00000004;7,40E+16;(liability model);47;[0.29-0.65] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;4q25;4;109373310;Intergenic;SEC24B-AS1;;;ENSG00000247950;;;rs183256737-A;rs183256737;0;183256737;intron_variant;0;0.993;0,000002;5,70E+15;(liability model);46;[0.26-0.66] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;11q22.3;11;104874043;Intergenic;AP002004.1 - CASP12;ENSG00000254569;ENSG00000204403;;626;11675;rs79930850-A;rs79930850;0;79930850;intergenic_variant;1;0.99;0,000003;5,52E+15;(liability model);45;[0.25-0.65] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;11q14.1;11;78938571;ODZ4;TENM4;;;ENSG00000149256;;;rs143261188-C;rs143261188;0;143261188;intron_variant;0;0.992;0,000003;5,52E+15;(liability model);44;[0.24-0.64] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1p36.13;1;19693032;TMCO4;TMCO4;;;ENSG00000162542;;;rs115078773-A;rs115078773;0;115078773;intron_variant;0;0.992;0,000007;5,15E+15;(liability model);44;[0.24-0.64] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5p15.1;5;16262936;Intergenic;NACAP6 - LINC02150;ENSG00000248403;ENSG00000248150;;70227;110425;rs139195876-A;rs139195876;0;139195876;intergenic_variant;1;0.99;0,000002;5,70E+15;(liability model);43;[0.25-0.61] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;13q33.1;13;103011595;SLC10A2;AL137246.2 - SLC10A2;ENSG00000278445;ENSG00000125255;;107595;32403;rs16961023-C;rs16961023;0;16961023;intergenic_variant;1;0.985;0,00000005;7,30E+15;(liability model);41;[0.27-0.55] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2p13.2;2;71938176;Intergenic;DYSF - RPS20P10;ENSG00000135636;ENSG00000233971;;251408;46006;rs72842919-A;rs72842919;0;72842919;intergenic_variant;1;0.985;0,0000005;6,30E+15;(liability model);38;[0.22-0.54] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8p22;8;13182155;DLC1;DLC1;;;ENSG00000164741;;;rs181990369-A;rs181990369;0;181990369;intron_variant;0;0.988;0,000004;5,40E+16;(liability model);37;[0.21-0.53] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;17q25.1;17;75453551;Intergenic;TMEM94;;;ENSG00000177728;;;rs181228315-A;rs181228315;0;181228315;intron_variant;0;0.986;0,000002;5,70E+15;(liability model);35;[0.21-0.49] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q33.1;2;198252846;Intergenic;PLCL1;;;ENSG00000115896;;;rs147150305-A;rs147150305;0;147150305;intron_variant;0;0.984;0,0000004;6,40E+16;(liability model);35;[0.21-0.49] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;13q32.1;13;94628579;GPR180;GPR180;;;ENSG00000152749;;;rs187295598-T;rs187295598;0;187295598;3_prime_UTR_variant;0;0.988;0,000006;5,22E+15;(liability model);34;[0.18-0.5] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;15q24.3;15;77611050;Intergenic;AC046168.2 - LINGO1;ENSG00000259420;ENSG00000169783;;2162;1977;rs142660142-T;rs142660142;0;142660142;regulatory_region_variant;1;0.986;0,000002;5,70E+15;(liability model);34;[0.2-0.48] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;11q23.3;11;116082456;Intergenic;AP000797.1 - LINC02151;ENSG00000239600;ENSG00000236437;;130965;414443;rs77544685-T;rs77544685;0;77544685;intergenic_variant;1;0.013;0,000005;5,30E+15;(liability model);33;[0.19-0.47] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1q24.2;1;168874774;Intergenic;AL135926.1;;;ENSG00000285622;;;rs144167489-T;rs144167489;0;144167489;intron_variant;0;0.017;0,000002;5,70E+15;(liability model);32;[0.18-0.46] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8q22.3;8;103186989;BAALC;BAALC-AS1, BAALC;;;ENSG00000247081, ENSG00000164929;;;rs75635567-T;rs75635567;0;75635567;intron_variant;0;0.985;0,000005;5,30E+15;(liability model);3;[0.16-0.44] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7p22.1;7;6830481;Intergenic;CCZ1B - OR7E39P;ENSG00000146574;ENSG00000273252;;3711;4939;rs146997164-C;rs146997164;0;146997164;intergenic_variant;1;0.97;0,000009;5,05E+15;(liability model);26;[0.14-0.38] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;15q26.3;15;101501820;Intergenic;PCSK6;;;ENSG00000140479;;;rs146322114-A;rs146322114;0;146322114;intron_variant;0;0.029;0,000002;5,70E+15;(liability model);25;[0.15-0.35] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6q16.3;6;103817252;Intergenic;RF00438 - R3HDM2P2;ENSG00000252045;ENSG00000216817;;233984;200381;rs12661302-C;rs12661302;0;12661302;intergenic_variant;1;0.977;0,000003;5,52E+15;(liability model);25;[0.15-0.35] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;17q12;17;38287606;Intergenic;AC244154.1 - MRPL45;ENSG00000274487;ENSG00000278845;;30414;9417;rs186588455-A;rs186588455;0;186588455;intergenic_variant;1;0.964;0,000006;5,22E+15;(liability model);22;[0.12-0.32] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;18q22.1;18;65993723;Intergenic;AC023394.1 - PRPF19P1;ENSG00000263622;ENSG00000264685;;72781;75027;rs115443594-T;rs115443594;0;115443594;regulatory_region_variant;1;0.966;0,000004;5,40E+16;(liability model);22;[0.12-0.32] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q15;12;69160349;Intergenic;CPM - AC127894.1;ENSG00000135678;ENSG00000258140;;188779;51759;rs114179644-T;rs114179644;0;114179644;intergenic_variant;1;0.969;0,000008;5,10E+15;(liability model);21;[0.11-0.31] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1p36.33;1;1950293;Intergenic;CFAP74;;;ENSG00000142609;;;rs145840463-A;rs145840463;0;145840463;intron_variant;0;0.036;0,000006;5,22E+15;(liability model);21;[0.11-0.31] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5q22.3;5;115357977;Intergenic;CCDC112 - CTNNA1P1;ENSG00000164221;ENSG00000249026;;61146;31666;rs10075047-A;rs10075047;0;10075047;intergenic_variant;1;0.032;0,000005;5,30E+15;(liability model);21;[0.11-0.31] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5p15.2;5;11930025;Intergenic;CTNND2 - RNU6-679P;ENSG00000169862;ENSG00000212305;;25982;367374;rs10060040-A;rs10060040;0;10060040;intergenic_variant;1;0.053;0,000008;5,10E+15;(liability model);17;[0.092-0.248] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q31.2;2;179270456;Intergenic;SESTD1 - AC093911.1;ENSG00000187231;ENSG00000237477;;5666;3375;rs62179067-T;rs62179067;0;62179067;intergenic_variant;1;0.941;0,0000008;6,10E+15;(liability model);16;[0.1-0.22] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9p13.1;9;38711009;Intergenic;FAM240B;;;ENSG00000283329;;;rs56249755-A;rs56249755;0;56249755;intron_variant;0;0.939;0,0000005;6,30E+15;(liability model);16;[0.1-0.22] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;3p14.3;3;57830215;SLMAP;SLMAP;;;ENSG00000163681;;;rs115317194-T;rs115317194;0;115317194;intron_variant;0;0.067;0,000002;5,70E+15;(liability model);15;[0.091-0.209] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q33.1;2;200653321;AOX1;AOX1;;;ENSG00000138356;;;rs75770912-A;rs75770912;0;75770912;intron_variant;0;0.074;0,000008;5,10E+15;(liability model);14;[0.081-0.199] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;4p16.3;4;4148701;Intergenic;UNC93B4;;;ENSG00000250381;;;rs7698880-C;rs7698880;0;7698880;intron_variant;0;0.124;0,000002;5,70E+15;(liability model);14;[0.081-0.199] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;16q22.1;16;68759780;CDH1;CDH1;;;ENSG00000039068;;;rs76816469-T;rs76816469;0;76816469;intron_variant;0;0.101;0,000001;60;(liability model);12;[0.061-0.179] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5q13.3;5;76567335;IQGAP2;IQGAP2;;;ENSG00000145703;;;rs61233297-A;rs61233297;0;61233297;intron_variant;0;0.094;0,000008;5,10E+15;(liability model);11;[0.051-0.169] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12p12.1;12;25965239;Intergenic;RASSF8;;;ENSG00000123094;;;rs853656-T;rs853656;0;853656;intron_variant;0;0.167;0,000004;5,40E+16;(liability model);9;[0.051-0.129] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;17q25.3;17;78891959;TIMP2;CEP295NL, TIMP2;;;ENSG00000178404, ENSG00000035862;;;rs8077028-T;rs8077028;0;8077028;missense_variant;0;0.751;0,000001;60;(liability model);9;[0.051-0.129] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1q24.2;1;169617708;SELP;SELP;;;ENSG00000174175;;;rs2244526-T;rs2244526;0;2244526;intron_variant;0;0.824;0,000006;5,22E+15;(liability model);9;[0.051-0.129] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;3p24.1;3;28837197;Intergenic;AC098650.1, RBMS3;;;ENSG00000283563, ENSG00000144642;;;rs17022021-T;rs17022021;0;17022021;intron_variant;0;0.843;0,000008;5,10E+15;(liability model);9;[0.051-0.129] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;22q13.32;22;48492443;FAM19A5;FAM19A5;;;ENSG00000219438;;;rs1034435-A;rs1034435;0;1034435;intron_variant;0;0.659;0,000003;5,52E+15;(liability model);7;[0.031-0.109] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q14.1;12;58828030;Intergenic;AC020637.1 - LRIG3;ENSG00000258231;ENSG00000139263;;14970;44119;rs4760243-A;rs4760243;0;4760243;intergenic_variant;1;0.566;0,000008;5,10E+15;(liability model);7;[0.031-0.109] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;19q13.32;19;46595170;Intergenic;PPP5D1, AC093503.1;;;ENSG00000230510, ENSG00000268423;;;rs7260181-T;rs7260181;0;7260181;intron_variant;0;0.57;0,000008;5,10E+15;(liability model);7;[0.031-0.109] unit decrease;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;16q24.1;16;84699678;Intergenic;KLHL36 - USP10;ENSG00000135686;ENSG00000103194;;31992;300;rs12716755-A;rs12716755;0;12716755;regulatory_region_variant;1;0.608;0,000006;5,22E+15;(liability model);7;[0.031-0.109] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1p13.2;1;111350283;C1orf88;PIFO;;;ENSG00000173947;;;rs3820443-T;rs3820443;0;3820443;intron_variant;0;0.611;0,000001;60;(liability model);7;[0.031-0.109] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;19q13.31;19;44625528;IGSF23;IGSF23;;;ENSG00000216588;;;rs846858-A;rs846858;0;846858;intron_variant;0;0.272;0,000003;5,52E+15;(liability model);8;[0.041-0.119] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;22q13.33;22;50201044;SELO;SELENOO;;;ENSG00000073169;;;rs5771225-T;rs5771225;0;5771225;missense_variant;0;0.217;0,000005;5,30E+15;(liability model);9;[0.051-0.129] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12p12.1;12;25269783;Intergenic;KRAS - AC087239.1;ENSG00000133703;ENSG00000278743;;18847;115887;rs7313581-T;rs7313581;0;7313581;regulatory_region_variant;1;0.218;0,0000008;6,10E+15;(liability model);9;[0.051-0.129] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7p15.3;7;22018573;Intergenic;CDCA7L - RAPGEF5;ENSG00000164649;ENSG00000136237;;72489;99665;rs2699450-A;rs2699450;0;2699450;intergenic_variant;1;0.211;0,000004;5,40E+16;(liability model);9;[0.051-0.129] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7q33;7;136477062;Intergenic;AC078845.1 - AC009541.1;ENSG00000232053;ENSG00000226066;;39636;8594;rs6945197-T;rs6945197;0;6945197;intergenic_variant;1;0.16;0,000006;5,22E+15;(liability model);9;[0.051-0.129] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;19p12;19;20064649;Intergenic;BNIP3P13 - ZNF90;ENSG00000269154;ENSG00000213988;;1329;13345;rs184992198-T;rs184992198;0;184992198;intergenic_variant;1;0.816;0,000002;5,70E+15;(liability model);11;[0.071-0.149] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7q36.1;7;149924921;Intergenic;AC092681.1 - AC092681.2;ENSG00000224016;ENSG00000260555;;15217;75831;rs115972394-A;rs115972394;0;115972394;intergenic_variant;1;0.147;0,000006;5,22E+15;(liability model);11;[0.051-0.169] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2p24.2;2;16736702;Intergenic;AC008164.1;;;ENSG00000223536;;;rs73215707-T;rs73215707;0;73215707;intron_variant;0;0.908;0,000008;5,10E+15;(liability model);12;[0.061-0.179] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6p21.32;6;33427745;SYNGAP1;SYNGAP1;;;ENSG00000197283;;;rs79926713-T;rs79926713;0;79926713;intron_variant;0;0.082;0,000008;5,10E+15;(liability model);13;[0.071-0.189] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5p15.33;5;1983817;Intergenic;AC126768.3 - RF00019;ENSG00000249731;ENSG00000201483;;14804;200893;rs73732514-A;rs73732514;0;73732514;intergenic_variant;1;0.929;0,000002;5,70E+15;(liability model);14;[0.081-0.199] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q31.2;2;179139721;SESTD1;SESTD1;;;ENSG00000187231;;;rs62177277-T;rs62177277;0;62177277;intron_variant;0;0.056;0,000002;5,70E+15;(liability model);16;[0.1-0.22] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7p21.3;7;13656708;Intergenic;AC011287.1;;;ENSG00000229618;;;rs73681522-A;rs73681522;0;73681522;intron_variant;0;0.051;0,000004;5,40E+16;(liability model);16;[0.082-0.238] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7q34;7;141791266;TAS2R5;TAS2R5;;;ENSG00000127366;;;rs2234017-C;rs2234017;0;2234017;3_prime_UTR_variant;0;0.056;0,000007;5,15E+15;(liability model);17;[0.092-0.248] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;20p13;20;566915;Intergenic;CSNK2A1 - TCF15;ENSG00000101266;ENSG00000125878;;23080;36882;rs147597631-T;rs147597631;0;147597631;intergenic_variant;1;0.061;0,000002;5,70E+15;(liability model);18;[0.1-0.26] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5q35.2;5;174587111;Intergenic;SUMO2P6 - AC108112.1;ENSG00000249031;ENSG00000250256;;25048;31053;rs145848414-A;rs145848414;0;145848414;intergenic_variant;1;0.04;0,000003;5,52E+15;(liability model);21;[0.13-0.29] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q15;12;69997949;Intergenic;LINC01481, LINC01481;;;ENSG00000257815, ENSG00000257613;;;rs147985478-A;rs147985478;0;147985478;intron_variant;0;0.977;0,000003;5,52E+15;(liability model);25;[0.15-0.35] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1p35.3;1;29684252;Intergenic;AL671862.1 - AC092265.1;ENSG00000225011;ENSG00000228176;;187359;24599;rs116050881-T;rs116050881;0;116050881;intergenic_variant;1;0.026;0,0000006;6,22E+15;(liability model);25;[0.15-0.35] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9q31.3;9;110213589;Intergenic;C9orf152 - TXN;ENSG00000188959;ENSG00000136810;;5400;30222;rs116530595-T;rs116530595;0;116530595;regulatory_region_variant;1;0.018;0,000009;5,05E+15;(liability model);26;[0.14-0.38] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;11q14.3;11;92422052;FAT3;FAT3, FAT3;;;ENSG00000165323, ENSG00000282908;;;rs147582129-T;rs147582129;0;147582129;intron_variant;0;0.016;0,000009;5,05E+15;(liability model);28;[0.16-0.4] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6q16.3;6;103969846;Intergenic;RF00438 - R3HDM2P2;ENSG00000252045;ENSG00000216817;;386578;47787;rs72998574-T;rs72998574;0;72998574;intergenic_variant;1;0.022;0,000002;5,70E+15;(liability model);28;[0.16-0.4] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;11q22.3;11;110058188;Intergenic;RDX;;;ENSG00000137710;;;rs144471255-A;rs144471255;0;144471255;intron_variant;0;0.018;0,000003;5,52E+15;(liability model);31;[0.17-0.45] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;17q24.2;17;68920354;ABCA8;ABCA8;;;ENSG00000141338;;;rs144216026-A;rs144216026;0;144216026;intron_variant;0;0.017;0,000008;5,10E+15;(liability model);31;[0.17-0.45] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8p12;8;31236084;Intergenic;KCTD9P6 - AC068672.2;ENSG00000229211;ENSG00000253377;;15100;39512;rs137869973-T;rs137869973;0;137869973;intergenic_variant;1;0.025;0,0000002;6,70E+15;(liability model);31;[0.19-0.43] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q14.2;2;119266116;Intergenic;STEAP3 - C2orf76;ENSG00000115107;ENSG00000186132;;464;36109;rs72840936-C;rs72840936;0;72840936;regulatory_region_variant;1;0.018;0,0000005;6,30E+15;(liability model);32;[0.2-0.44] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;3p24.1;3;27236975;NEK10;NEK10;;;ENSG00000163491;;;rs148587130-T;rs148587130;0;148587130;intron_variant;0;0.013;0,000007;5,15E+15;(liability model);36;[0.2-0.52] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;14q22.1;14;52702250;Intergenic;ERO1A - PSMC6;ENSG00000197930;ENSG00000100519;;6350;4922;rs185126971-A;rs185126971;0;185126971;regulatory_region_variant;1;0.011;0,000008;5,10E+15;(liability model);37;[0.21-0.53] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7q21.3;7;96446404;Intergenic;RNU7-188P - SEM1;ENSG00000252872;ENSG00000127922;;68484;35222;rs73239797-A;rs73239797;0;73239797;intergenic_variant;1;0.013;0,000002;5,70E+15;(liability model);39;[0.23-0.55] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2p16.2;2;53256902;Intergenic;AC010967.1 - RF00424;ENSG00000228033;ENSG00000252404;;346882;213545;rs113884973-C;rs113884973;0;113884973;intergenic_variant;1;0.008;0,000008;5,10E+15;(liability model);43;[0.23-0.63] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;4q25;4;109534350;SEC24B;SEC24B;;;ENSG00000138802;;;rs182972826-T;rs182972826;0;182972826;intron_variant;0;0.007;0,000004;5,40E+16;(liability model);44;[0.24-0.64] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7p15.3;7;23931916;Intergenic;AC003087.1 - RNA5SP228;ENSG00000227930;ENSG00000252041;;34581;200789;rs112920270-A;rs112920270;0;112920270;intergenic_variant;1;0.008;0,000009;5,05E+15;(liability model);45;[0.25-0.65] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q24.31;12;123635804;GTF2H3;GTF2H3;;;ENSG00000111358;;;rs141104697-A;rs141104697;0;141104697;intron_variant;0;0.007;0,000008;5,10E+15;(liability model);46;[0.26-0.66] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;19p13.3;19;5417482;Intergenic;PTPRS - ZNRF4;ENSG00000105426;ENSG00000105428;;76679;37949;rs144464515-C;rs144464515;0;144464515;regulatory_region_variant;1;0.01;0,000002;5,70E+15;(liability model);46;[0.26-0.66] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8p23.1;8;9182000;Intergenic;AC022784.2, AC022784.1;;;ENSG00000253252, ENSG00000248538;;;rs191707442-T;rs191707442;0;191707442;intron_variant;0;0.008;0,000006;5,22E+15;(liability model);47;[0.27-0.67] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1q32.1;1;206526352;RASSF5;RASSF5;;;ENSG00000266094;;;rs150269952-T;rs150269952;0;150269952;intron_variant;0;0.009;0,000006;5,22E+15;(liability model);48;[0.26-0.7] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;4q25;4;109251730;COL25A1;COL25A1;;;ENSG00000188517;;;rs144998240-A;rs144998240;0;144998240;intron_variant;0;0.006;0,0000008;6,10E+15;(liability model);5;[0.3-0.7] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9q31.2;9;107043881;Intergenic;AL807761.4;;;ENSG00000230782;;;rs138543081-T;rs138543081;0;138543081;intron_variant;0;0.009;0,000001;60;(liability model);5;[0.3-0.7] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;1q25.3;1;185780742;HMCN1;HMCN1;;;ENSG00000143341;;;rs192013290-T;rs192013290;0;192013290;intron_variant;0;0.006;0,000001;60;(liability model);51;[0.29-0.73] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;15q24.3;15;76352686;SCAPER;SCAPER;;;ENSG00000140386;;;rs144077517-A;rs144077517;0;144077517;intron_variant;0;0.005;0,000002;5,70E+15;(liability model);54;[0.32-0.76] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8q21.13;8;80555470;Intergenic;AC009812.4 - RPSAP47;ENSG00000260317;ENSG00000188856;;12366;3400;rs142835438-A;rs142835438;0;142835438;intergenic_variant;1;0.007;0,0000008;6,10E+15;(liability model);54;[0.32-0.76] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q15;12;67780260;Intergenic;AC022513.1 - LINC01479;ENSG00000279505;ENSG00000255772;;26443;148975;rs184695264-T;rs184695264;0;184695264;intergenic_variant;1;0.005;0,000004;5,40E+16;(liability model);58;[0.33-0.83] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5p15.32;5;4515659;Intergenic;AC106799.1, AC106799.2;;;ENSG00000231291, ENSG00000248973;;;rs921390-T;rs921390;0;921390;non_coding_transcript_exon_variant;0;0.005;0,000001;60;(liability model);58;[0.34-0.82] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;3q26.31;3;174769522;Intergenic;NAALADL2;;;ENSG00000177694;;;rs150291119-A;rs150291119;0;150291119;intron_variant;0;0.005;0,000003;5,52E+15;(liability model);6;[0.35-0.85] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6q14.1;6;78644638;Intergenic;AL121718.1 - AL450327.1;ENSG00000230309;ENSG00000229495;;38602;165077;rs186542490-A;rs186542490;0;186542490;intergenic_variant;1;0.006;0,000008;5,10E+15;(liability model);6;[0.35-0.85] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9p21.3;9;20013543;Intergenic;AL591222.3 - AL512635.1;ENSG00000277711;ENSG00000237434;;45549;317903;rs186076999-T;rs186076999;0;186076999;intergenic_variant;1;0.006;0,000007;5,15E+15;(liability model);62;[0.35-0.89] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;9p21.2;9;25669750;Intergenic;RN7SKP120 - TUSC1;ENSG00000222693;ENSG00000198680;;580599;6639;rs141521929-T;rs141521929;0;141521929;intergenic_variant;1;0.005;0,000004;5,40E+16;(liability model);62;[0.37-0.87] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;4q31.3;4;152043740;Intergenic;RNA5SP169 - LINC02273;ENSG00000253077;ENSG00000245954;;72127;57014;rs73865608-A;rs73865608;0;73865608;intergenic_variant;1;0.004;0,000001;60;(liability model);63;[0.38-0.88] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;12q24.23;12;117861676;KSR2;KSR2;;;ENSG00000171435;;;rs184614511-T;rs184614511;0;184614511;intron_variant;0;0.005;0,000006;5,22E+15;(liability model);64;[0.37-0.91] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6p22.3;6;23318629;Intergenic;RNU6-1060P - AL139231.1;ENSG00000207394;ENSG00000235743;;193542;19082;rs193129245-A;rs193129245;0;193129245;intergenic_variant;1;0.005;0,000001;60;(liability model);67;[0.4-0.94] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;14q21.3;14;47737481;Intergenic;MDGA2 - MIR548Y;ENSG00000139915;ENSG00000263945;;62527;23514;rs150061627-T;rs150061627;0;150061627;intergenic_variant;1;0.004;0,000005;5,30E+15;(liability model);68;[0.39-0.97] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;20q13.12;20;44233181;Intergenic;OSER1-DT - GDAP1L1;ENSG00000223891;ENSG00000124194;;7154;13918;rs190457471-A;rs190457471;0;190457471;intergenic_variant;1;0.004;0,000005;5,30E+15;(liability model);68;[0.39-0.97] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;10p11.22;10;31115466;Intergenic;ZNF438 - AL356258.1;ENSG00000183621;ENSG00000272381;;83529;72417;rs141387448-T;rs141387448;0;141387448;intergenic_variant;1;0.005;0,000004;5,40E+16;(liability model);68;[0.39-0.97] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;16q24.2;16;87653662;JPH3;JPH3;;;ENSG00000154118;;;rs117760708-T;rs117760708;0;117760708;non_coding_transcript_exon_variant;0;0.004;0,000003;5,52E+15;(liability model);73;[0.42-1.04] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;18q11.2;18;26735845;Intergenic;AQP4-AS1;;;ENSG00000260372;;;rs187423924-A;rs187423924;0;187423924;intron_variant;0;0.004;0,000004;5,40E+16;(liability model);74;[0.43-1.05] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5q23.1;5;121563422;Intergenic;AC008568.2 - RPL23AP44;ENSG00000279860;ENSG00000244088;;198108;12426;rs181634374-T;rs181634374;0;181634374;intergenic_variant;1;0.003;0,000008;5,10E+15;(liability model);77;[0.44-1.1] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;17p12;17;14641688;Intergenic;AC022816.1 - RPS18P12;ENSG00000230647;ENSG00000230897;;220662;63388;rs145228677-C;rs145228677;0;145228677;intergenic_variant;1;0.004;0,000007;5,15E+15;(liability model);79;[0.44-1.14] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;18q12.3;18;39619094;Intergenic;AC016205.1;;;ENSG00000267374;;;rs188699384-A;rs188699384;0;188699384;intron_variant;0;0.003;0,000005;5,30E+15;(liability model);79;[0.46-1.12] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;6p21.1;6;41696609;TFEB;TFEB;;;ENSG00000112561;;;rs148003968-A;rs148003968;0;148003968;intron_variant;0;0.003;0,000005;5,30E+15;(liability model);81;[0.46-1.16] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2p11.2;2;84597852;DNAH6;DNAH6;;;ENSG00000115423;;;rs185867524-A;rs185867524;0;185867524;intron_variant;0;0.004;0,000005;5,30E+15;(liability model);86;[0.49-1.23] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7p21.1;7;18212452;HDAC9;HDAC9;;;ENSG00000048052;;;rs117756856-A;rs117756856;0;117756856;intron_variant;0;0.003;0,000009;5,05E+15;(liability model);89;[0.5-1.28] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;11q13.4;11;70820116;SHANK2;SHANK2;;;ENSG00000162105;;;rs184457411-A;rs184457411;0;184457411;intron_variant;0;0.003;0,000008;5,10E+15;(liability model);92;[0.51-1.33] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;8p11.22;8;39576416;Intergenic;AC123767.1;;;ENSG00000254067;;;rs180751169-T;rs180751169;0;180751169;intron_variant;0;0.002;0,000005;5,30E+15;(liability model);94;[0.53-1.35] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;2q37.1;2;233651485;UGT1A8, UGT1A10;UGT1A10, UGT1A8;;;ENSG00000242515, ENSG00000242366;;;rs188392327-A;rs188392327;0;188392327;intron_variant;0;0.002;0,000002;5,70E+15;(liability model);99;[0.58-1.4] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;7q34;7;139942249;TBXAS1;TBXAS1;;;ENSG00000059377;;;rs192232892-T;rs192232892;0;192232892;intron_variant;0;0.002;0,000003;5,52E+15;(liability model);99;[0.58-1.4] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;16q21;16;57869386;Intergenic;KIFC3 - CNGB1;ENSG00000140859;ENSG00000070729;;6333;12954;rs149839710-A;rs149839710;0;149839710;intergenic_variant;1;0.002;0,000009;5,05E+15;(liability model);10;[0.55-1.45] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
24-03-2017;27770636;Mez J;20-10-2016;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/27770636;Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.;Late-onset Alzheimer's disease;1,825 African American ancestry cases, 3,784 African American ancestry controls;;5p14.1;5;28577827;Intergenic;LINC02103 - RNU6-909P;ENSG00000249785;ENSG00000252867;;290162;46830;rs150631144-T;rs150631144;0;150631144;intergenic_variant;1;0.002;0,0000001;70;(liability model);113;[0.72-1.54] unit increase;NR [19725427] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST003815;Genome-wide genotyping array
25-02-2009;19125160;Feulner TM;07-01-2009;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/19125160;Examination of the current top candidate genes for AD in a genome-wide association study.;Alzheimer's disease;491 European ancestry cases, 479 European ancestry controls;NA;19q13.32;19;44892009;APOE, TOMM40;TOMM40;;;ENSG00000130204;;;rs157580-?;rs157580;0;157580;intron_variant;0;NR;1,00E-40;400;;;;Illumina [~ 550000];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000313;Genome-wide genotyping array
21-01-2009;19118814;Beecham GW;03-01-2009;Am J Hum Genet;www.ncbi.nlm.nih.gov/pubmed/19118814;Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.;Alzheimer's disease;492 European ancestry cases, 496 European ancestry controls;238 European ancestry cases, 220 European ancestry controls;12q13.11;12;47245743;FAM113B;AC008083.1;;;ENSG00000257925;;;rs11610206-?;rs11610206;0;11610206;intron_variant;0;NR;0,0000003;6,52E+15;;;;Illumina [~ 2500000] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000310;Genome-wide genotyping array
21-01-2009;19118814;Beecham GW;03-01-2009;Am J Hum Genet;www.ncbi.nlm.nih.gov/pubmed/19118814;Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.;Alzheimer's disease;492 European ancestry cases, 496 European ancestry controls;238 European ancestry cases, 220 European ancestry controls;1q42.2;1;231708601;DISC1;DISC1, TSNAX-DISC1;;;ENSG00000162946, ENSG00000270106;;;rs12044355-?;rs12044355;0;12044355;intron_variant;0;NR;0,000009;5,05E+15;;;;Illumina [~ 2500000] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000310;Genome-wide genotyping array
21-01-2009;19118814;Beecham GW;03-01-2009;Am J Hum Genet;www.ncbi.nlm.nih.gov/pubmed/19118814;Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.;Alzheimer's disease;492 European ancestry cases, 496 European ancestry controls;238 European ancestry cases, 220 European ancestry controls;19q13.31;19;44110055;ZNF224;AC021092.1;;;ENSG00000186019;;;rs2061333-?;rs2061333;0;2061333;intron_variant;0;NR;0,000002;5,70E+15;;;;Illumina [~ 2500000] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000310;Genome-wide genotyping array
30-09-2009;20061627;Heinzen EL;11-09-2009;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/20061627;Genome-wide scan of copy number variation in late-onset Alzheimer's disease.;Alzheimer's disease;331 European ancestry cases, 368 European ancestry controls;NA;19q13.32;19;44892362;APOE, TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;0.15;3,00E-11;1,05E+16;;;;Illumina [~ 550000];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000484;Genome-wide genotyping array
30-09-2009;20061627;Heinzen EL;11-09-2009;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/20061627;Genome-wide scan of copy number variation in late-onset Alzheimer's disease.;Alzheimer's disease;331 European ancestry cases, 368 European ancestry controls;NA;13q13.2;13;34080781;RFC3;AL160394.1 - VDAC1P12;ENSG00000280431;ENSG00000227254;;647;1648;rs690705-?;rs690705;0;690705;intergenic_variant;1;0.25;0,0000006;6,22E+15;;;;Illumina [~ 550000];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000484;Genome-wide genotyping array
30-09-2009;20061627;Heinzen EL;11-09-2009;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/20061627;Genome-wide scan of copy number variation in late-onset Alzheimer's disease.;Alzheimer's disease;331 European ancestry cases, 368 European ancestry controls;NA;1p31.1;1;83789052;TTLL7;LINC01725;;;ENSG00000233008;;;rs7539409-?;rs7539409;0;7539409;intron_variant;0;0.18;0,000001;60;;;;Illumina [~ 550000];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000484;Genome-wide genotyping array
30-09-2009;20061627;Heinzen EL;11-09-2009;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/20061627;Genome-wide scan of copy number variation in late-onset Alzheimer's disease.;Alzheimer's disease;331 European ancestry cases, 368 European ancestry controls;NA;10q24.31;10;100741814;PAX2;PAX2;;;ENSG00000075891;;;rs4509693-?;rs4509693;0;4509693;intron_variant;0;0.18;0,000006;5,22E+15;;;;Illumina [~ 550000];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000484;Genome-wide genotyping array
30-09-2009;20061627;Heinzen EL;11-09-2009;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/20061627;Genome-wide scan of copy number variation in late-onset Alzheimer's disease.;Alzheimer's disease;331 European ancestry cases, 368 European ancestry controls;NA;6q24.3;6;148102235;SASH1;AL445123.1 - AL359382.1;ENSG00000234675;ENSG00000230205;;81261;31574;rs9390537-?;rs9390537;0;9390537;intergenic_variant;1;0.22;0,000008;5,10E+15;;;;Illumina [~ 550000];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000484;Genome-wide genotyping array
17-08-2018;29107063;Yashin AI;26-10-2017;Exp Gerontol;www.ncbi.nlm.nih.gov/pubmed/29107063;Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.;Alzheimer's disease (age of onset);12,169 European ancestry individuals, 2,078 Black individuals, 4,053 unknown ancestry individuals;NA;19q13.32;19;44892362;TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;NR;0,0000005;6,30E+15;;15;[NR];Illumina [up to 1329158];N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST006120;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;14q24.2;14;71199580;intergenic;AC004817.2 - AC004817.1;ENSG00000259907;ENSG00000258517;;17474;13053;rs17767225-T;rs17767225;0;17767225;intergenic_variant;1;0.2;0,000008;5,10E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
24-02-2012;22245343;Meda SA;08-01-2012;Neuroimage;www.ncbi.nlm.nih.gov/pubmed/22245343;A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort.;Alzheimer's disease;367 European ancestry individuals with mild cognitive impairment, 181 European ancestry individuals  with mild early-stage LOAD, 209 European ancestry controls;NA;;;;APOE;;;;;;;APOE-E4;APOE-E4;0;;;1;NR;7,00E-16;1,52E+16;;;;Illumina [533872];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001372;Genome-wide genotyping array
24-02-2012;22245343;Meda SA;08-01-2012;Neuroimage;www.ncbi.nlm.nih.gov/pubmed/22245343;A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort.;Alzheimer's disease;367 European ancestry individuals with mild cognitive impairment, 181 European ancestry individuals  with mild early-stage LOAD, 209 European ancestry controls;NA;;;;APOE;;;;;;;APOE-E3;APOE-E3;0;;;1;NR;0,000000004;8,40E+15;;;;Illumina [533872];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001372;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;3p26.1;3;6336008;intergenic;AC026167.1;;;ENSG00000226022;;;rs271066-?;rs271066;0;271066;intron_variant;0;NR;0,000003;5,52E+15;;6491;unit decrease;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;3p14.1;3;64941350;ADAMTS9;ADAMTS9-AS2;;;ENSG00000241684;;;rs704454-?;rs704454;0;704454;intron_variant;0;NR;0,000003;5,52E+15;;5038;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;4q31.3;4;154426241;DCHS2;DCHS2;;;ENSG00000197410;;;rs1466662-?;rs1466662;0;1466662;intron_variant;0;NR;0,0000005;6,30E+15;;9595;unit decrease;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;9p24.2;9;2742771;KCNV2, VLDLR;PUM3;;;ENSG00000080608;;;rs2034764-?;rs2034764;0;2034764;intron_variant;0;NR;0,000004;5,40E+16;;879;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;12q24.22;12;116857528;HRK, RNFT2;HRK;;;ENSG00000135116;;;rs17429217-?;rs17429217;0;17429217;3_prime_UTR_variant;0;NR;0,000003;5,52E+15;;2436;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;15q25.3;15;84887738;SLC28A1, ZNF592, ALPK3;SLC28A1;;;ENSG00000156222;;;rs3743162-?;rs3743162;0;3743162;splice_region_variant;0;NR;0,000009;5,05E+15;;8828;unit decrease;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;19q13.32;19;44919689;APOE, TOMM40, APOC1, PVRL2;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;340;7115;rs4420638-?;rs4420638;0;4420638;intergenic_variant;1;NR;1,00E-12;120;;22018;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;4p15.1;4;33201518;intergenic;AC017013.1 - AC093878.1;ENSG00000250076;ENSG00000249452;;189772;36721;rs10517270-?;rs10517270;0;10517270;intergenic_variant;1;NR;0,000004;5,40E+16;;33056;unit decrease;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;6p21.31;6;33857581;LEMD2, MLN, MIR1275;MLN - LINC01016;ENSG00000096395;ENSG00000249346;;53570;9925;rs2104362-?;rs2104362;0;2104362;intergenic_variant;1;NR;0,000007;5,15E+15;;8441;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;16q24.2;16;87078024;intergenic;AC106745.1 - C16orf95;ENSG00000261363;ENSG00000260456;;8272;5538;rs12933233-?;rs12933233;0;12933233;regulatory_region_variant;1;NR;0,000008;5,10E+15;;7869;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;18q21.32;18;59084822;LOC390958, Sec11C;AC040963.1;;;ENSG00000267215;;;rs1037757-?;rs1037757;0;1037757;non_coding_transcript_exon_variant;0;NR;0,000008;5,10E+15;;45618;unit decrease;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;15q25.3;15;84887738;ZNF592, ALPK3, SLC28A1;SLC28A1;;;ENSG00000156222;;;rs3743162-?;rs3743162;0;3743162;splice_region_variant;0;NR;0,000009;5,05E+15;;88;unit decrease;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
11-05-2015;22005931;Kamboh MI;18-10-2011;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22005931;Genome-wide association analysis of age-at-onset in Alzheimer's disease.;Alzheimer's disease (age of onset);1,190 European ancestry cases, 1,032 cases;NA;12q24.13;12;113810386;intergenic;DYNLL1P4 - RBM19;ENSG00000257231;ENSG00000122965;;20579;6352;rs12816806-?;rs12816806;0;12816806;intergenic_variant;1;NR;0,000009;5,05E+15;;8384;unit increase;Illumina [2543888] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST001280;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;1q24.3;1;171588461;PRRC2C;PRRC2C;;;ENSG00000117523;;;rs2421847-?;rs2421847;0;2421847;missense_variant;0;0.04;0,0000009;6,05E+15;;26;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;1q43;1;240441752;FMN2;FMN2;;;ENSG00000155816;;;rs12091371-?;rs12091371;0;12091371;intron_variant;0;0.07;0,00000007;7,15E+15;;17;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;2p12;2;80054047;CTNNA2;CTNNA2;;;ENSG00000066032;;;rs6738962-?;rs6738962;0;6738962;intron_variant;0;0.04;0,00000001;80;;18;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;2q14.3;2;127638592;LIMS2;LIMS2;;;ENSG00000072163;;;rs78022502-?;rs78022502;0;78022502;3_prime_UTR_variant;0;0.06;0,000002;5,70E+15;;23;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;3p22.1;3;39471787;MOBP;MOBP;;;ENSG00000168314;;;rs538867-?;rs538867;0;538867;intron_variant;0;0.03;0,0000001;70;;26;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;4p16.2;4;5235426;STK32B;STK32B;;;ENSG00000152953;;;rs78647349-?;rs78647349;0;78647349;intron_variant;0;0.04;0,0000005;6,30E+15;;3;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;4q21.3;4;87010252;AFF1;AFF1;;;ENSG00000172493;;;rs340635-?;rs340635;0;340635;intron_variant;0;0.03;0,0000002;6,70E+15;;23;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q11.2;5;56214829;ANKRD55;ANKRD55;;;ENSG00000164512;;;rs4700060-?;rs4700060;0;4700060;intron_variant;0;0.1;0,00000001;80;;21;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q21.3;5;109885325;PGAM5P1, MAN2A1;PGAM5P1;;;ENSG00000253224;;;rs112724034-?;rs112724034;0;112724034;non_coding_transcript_exon_variant;0;0.03;9,00E-13;1,20E+16;;31;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q22.1;5;111383489;CAMK4;CAMK4;;;ENSG00000152495;;;rs77636885-?;rs77636885;0;77636885;intron_variant;0;0.03;0,000002;5,70E+15;;3;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q23.1;5;119099432;DMXL1;DMXL1;;;ENSG00000172869;;;rs116348108-?;rs116348108;0;116348108;intron_variant;0;0.04;0,0000009;6,05E+15;;28;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q23.2;5;127393758;MEGF10;MEGF10;;;ENSG00000145794;;;rs143954261-?;rs143954261;0;143954261;intron_variant;0;0.04;0,0000008;6,10E+15;;29;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q23.3;5;128046610;FLJ33630;LINC01184;;;ENSG00000245937;;;rs146579248-?;rs146579248;0;146579248;intron_variant;0;0.04;0,0000004;6,40E+16;;21;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;5q33.2;5;154457546;SAP30L;SAP30L;;;ENSG00000164576;;;rs148763909-?;rs148763909;0;148763909;3_prime_UTR_variant;0;0.03;0,00000001;80;;15;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;6q22.31;6;124005082;NKAIN2;NKAIN2;;;ENSG00000188580;;;rs117780815-?;rs117780815;0;117780815;intron_variant;0;0.03;0,0000006;6,22E+15;;31;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;6q23.3;6;136046867;PDE7B;AL138828.1, PDE7B;;;ENSG00000237596, ENSG00000171408;;;rs11154851-?;rs11154851;0;11154851;intron_variant;0;0.04;0,00000001;80;;25;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;6q25.1;6;150781694;PLEKHG1;PLEKHG1;;;ENSG00000120278;;;rs75253868-?;rs75253868;0;75253868;intron_variant;0;0.03;0,000002;5,70E+15;;26;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;7p21.1;7;16668236;BZW2, TSPAN13;BZW2;;;ENSG00000136261;;;rs58370486-?;rs58370486;0;58370486;intron_variant;0;0.03;6,00E-11;1,02E+16;;36;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;7p15.3;7;25121983;CYCS;CYCS;;;ENSG00000172115;;;rs1861525-?;rs1861525;0;1861525;3_prime_UTR_variant;0;0.03;0,0000002;6,70E+15;;25;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;7p14.1;7;37325592;ELMO1;ELMO1;;;ENSG00000155849;;;rs2392492-?;rs2392492;0;2392492;intron_variant;0;0.04;0,000001;60;;32;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;7p13;7;43337677;HECW1;HECW1;;;ENSG00000002746;;;rs17172199-?;rs17172199;0;17172199;intron_variant;0;0.08;0,000001;60;;28;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;7q33;7;134063193;EXOC4;EXOC4;;;ENSG00000131558;;;rs11770757-?;rs11770757;0;11770757;intron_variant;0;0.04;0,0000005;6,30E+15;;16;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;8p23.2;8;3230651;CSMD1;CSMD1;;;ENSG00000183117;;;rs73660619-?;rs73660619;0;73660619;intron_variant;0;0.06;0,0000008;6,10E+15;;26;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;8q11.23;8;52301705;ST18;ST18, AC103831.1;;;ENSG00000147488, ENSG00000253924;;;rs7009219-?;rs7009219;0;7009219;intron_variant;0;0.06;0,0000005;6,30E+15;;16;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;9q34.11;9;130177513;NCS1;NCS1;;;ENSG00000107130;;;rs4836694-?;rs4836694;0;4836694;intron_variant;0;0.11;0,0000007;6,15E+15;;21;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;10q26.12;10;120519964;PPAPDC1A;PLPP4;;;ENSG00000203805;;;rs118048115-?;rs118048115;0;118048115;intron_variant;0;0.04;0,0000006;6,22E+15;;34;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;11p15.2;11;14202800;RRAS2, PSMA1, SPON1;SPON1;;;ENSG00000262655;;;rs11023139-?;rs11023139;0;11023139;intron_variant;0;0.05;7,00E-11;1,02E+16;;31;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;11q23.1;11;110628530;ARHGAP20;ARHGAP20;;;ENSG00000137727;;;rs326946-?;rs326946;0;326946;intron_variant;0;0.17;0,0000007;6,15E+15;;16;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;12q13.13;12;51484976;SLC4A8;SLC4A8;;;ENSG00000050438;;;rs147845115-?;rs147845115;0;147845115;intron_variant;0;0.03;0,0000003;6,52E+15;;29;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;12q22;12;93841389;CRADD;CRADD;;;ENSG00000169372;;;rs61144803-?;rs61144803;0;61144803;intron_variant;0;0.04;0,00000005;7,30E+15;;16;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;12q23.1;12;100827461;ANO4;ANO4;;;ENSG00000151572;;;rs1399439-?;rs1399439;0;1399439;intron_variant;0;0.04;0,0000004;6,40E+16;;2;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;13q31.3;13;93293605;GPC6;GPC6;;;ENSG00000183098;;;rs143258881-?;rs143258881;0;143258881;intron_variant;0;0.03;0,00000007;7,15E+15;;29;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;13q33.3;13;108821598;MYO16;MYO16;;;ENSG00000041515;;;rs17393344-?;rs17393344;0;17393344;intron_variant;0;0.06;0,00000002;7,70E+15;;26;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;14q32.13;14;95298227;CLMN;CLMN;;;ENSG00000165959;;;rs115102486-?;rs115102486;0;115102486;intron_variant;0;0.03;0,00000002;7,70E+15;;31;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;15q12;15;27467498;GABRG3;GABRG3;;;ENSG00000182256;;;rs74006954-?;rs74006954;0;74006954;intron_variant;0;0.03;0,0000003;6,52E+15;;28;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;15q21.3;15;58438440;LIPC;LIPC-AS1, LIPC, ALDH1A2;;;ENSG00000259293, ENSG00000166035, ENSG00000128918;;;rs17301739-?;rs17301739;0;17301739;intron_variant;0;0.07;0,000002;5,70E+15;;28;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;16p12.1;16;24664268;FLJ45256;TNRC6A, LINC01567;;;ENSG00000090905, ENSG00000224310;;;rs8045064-?;rs8045064;0;8045064;intron_variant;0;0.05;0,00000004;7,40E+16;;21;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;16q23.1;16;77842866;VAT1L;VAT1L;;;ENSG00000171724;;;rs9934540-?;rs9934540;0;9934540;intron_variant;0;0.03;0,0000004;6,40E+16;;25;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;17q21.32;17;47853173;OSBPL7, SP6, MRPL10;SP6;;;ENSG00000189120;;;rs4794202-?;rs4794202;0;4794202;intron_variant;0;0.08;0,00000008;7,10E+15;;19;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;17q21.33;17;50614721;CACNA1G;CACNA1G;;;ENSG00000006283;;;rs117964204-?;rs117964204;0;117964204;intron_variant;0;0.04;0,000000001;90;;28;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;17q23.2;17;61215075;BCAS3;BCAS3;;;ENSG00000141376;;;rs72832584-?;rs72832584;0;72832584;intron_variant;0;0.05;1,00E-11;110;;3;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;19q13.41;19;50927340;LOC390956;PPIAP59;;;ENSG00000228674;;;rs7245858-?;rs7245858;0;7245858;non_coding_transcript_exon_variant;0;0.04;0,000002;5,70E+15;;28;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;20p13;20;2404326;TGM6;TGM6;;;ENSG00000166948;;;rs34972666-?;rs34972666;0;34972666;intron_variant;0;0.11;0,00000003;7,52E+15;;23;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
26-06-2013;23535033;Sherva R;24-03-2013;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/23535033;Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.;Alzheimer's disease (cognitive decline);303 European ancestry cases;;22q13.31;22;44130225;PARVB;PARVB;;;ENSG00000188677;;;rs75617873-?;rs75617873;0;75617873;intron_variant;0;0.03;0,0000005;6,30E+15;;17;unit decrease;Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001915;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;19q13.32;19;44919589;APOC1;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;240;7215;rs56131196-A;rs56131196;0;56131196;intergenic_variant;1;0.29;4,00E-12;1,14E+16;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;19q13.32;19;44888997;PVRL2;AC011481.2, NECTIN2;;;ENSG00000267282, ENSG00000130202;;;rs6857-T;rs6857;0;6857;3_prime_UTR_variant;0;0.28;1,00E-10;100;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;19q13.32;19;44893408;TOMM40;TOMM40;;;ENSG00000130204;;;rs59007384-T;rs59007384;0;59007384;intron_variant;0;0.32;0,000000007;8,15E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;5q11.2;5;52509908;ITGA1;RPS17P11 - MFSD4BP1;ENSG00000244621;ENSG00000250827;;227049;69647;rs7702276-T;rs7702276;0;7702276;intergenic_variant;1;0.36;0,000001;60;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;;;;PIK3R1;;;;;;;rs24449894-A;rs24449894;0;24449894;;1;0.17;0,000002;5,70E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;9p23;9;14064742;NFIB;RPL3P11 - ATP5PDP3;ENSG00000223568;ENSG00000213954;;22881;4190;rs7039300-G;rs7039300;0;7039300;intergenic_variant;1;0.23;0,000002;5,70E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;6q25.3;6;156688247;ARID1B;AL355297.1 - AL355297.3;ENSG00000220347;ENSG00000271265;;25810;85970;rs9384488-A;rs9384488;0;9384488;regulatory_region_variant;1;0.35;0,000003;5,52E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;12q23.3;12;105714941;C12orf75, NUAK1;CASC18;;;ENSG00000257859;;;rs10219670-C;rs10219670;0;10219670;intron_variant;0;0.42;0,000004;5,40E+16;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
08-06-2010;20452100;Kramer PL;06-05-2010;Neurobiol Aging;www.ncbi.nlm.nih.gov/pubmed/20452100;Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.;Alzheimer's disease;185 European ancestry low NFT individuals, 114 European ancestry high NFT individuals;NA;7q22.1;7;103985430;RELN;RELN;;;ENSG00000189056;;;rs4298437-A;rs4298437;0;4298437;intron_variant;0;0.26;0,000002;5,70E+15;;;;Illumina [292175];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000676;Genome-wide genotyping array
08-06-2010;20452100;Kramer PL;06-05-2010;Neurobiol Aging;www.ncbi.nlm.nih.gov/pubmed/20452100;Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.;Alzheimer's disease;185 European ancestry low NFT individuals, 114 European ancestry high NFT individuals;NA;8p23.1;8;10477271;MSRA;AC104964.1, LINCR-0001;;;ENSG00000253678, ENSG00000253641;;;rs11782819-?;rs11782819;0;11782819;non_coding_transcript_exon_variant;0;NR;0,000003;5,52E+15;;;;Illumina [292175];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000676;Genome-wide genotyping array
29-06-2016;26339675;Tosto G;18-06-2015;Ann Clin Transl Neurol;www.ncbi.nlm.nih.gov/pubmed/26339675;F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease.;Alzheimer's disease (late onset);2,451 Caribbean Hispanic cases, 2,063 Caribbean Hispanic controls;550 Caribbean Hispanic cases, 236 Caribbean Hispanic controls;19q13.32;19;44901322;TOMM40, APOE;TOMM40;;;ENSG00000130204;;;rs394819-T;rs394819;0;394819;missense_variant;0;0.07;8,00E-11;1,01E+16;;189;[1.55-2.3];Affymetrix, Illumina [8837542] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002983;Genome-wide genotyping array
29-06-2016;26339675;Tosto G;18-06-2015;Ann Clin Transl Neurol;www.ncbi.nlm.nih.gov/pubmed/26339675;F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease.;Alzheimer's disease (late onset);2,451 Caribbean Hispanic cases, 2,063 Caribbean Hispanic controls;550 Caribbean Hispanic cases, 236 Caribbean Hispanic controls;5p15.1;5;15669858;FBXL7;FBXL7;;;ENSG00000183580;;;rs75002042-T;rs75002042;0;75002042;intron_variant;0;0.92;0,00000005;7,30E+15;(adjusted for APOE);159;[1.33-1.85];Affymetrix, Illumina [8837542] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002983;Genome-wide genotyping array
29-06-2016;26339675;Tosto G;18-06-2015;Ann Clin Transl Neurol;www.ncbi.nlm.nih.gov/pubmed/26339675;F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease.;Alzheimer's disease (late onset);2,451 Caribbean Hispanic cases, 2,063 Caribbean Hispanic controls;550 Caribbean Hispanic cases, 236 Caribbean Hispanic controls;3p21.1;3;54319213;CACNA2D3;CACNA2D3;;;ENSG00000157445;;;rs7431992-A;rs7431992;0;7431992;intron_variant;0;0.1;0,000002;5,70E+15;(adjusted for APOE);146;[1.25-1.71];Affymetrix, Illumina [8837542] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002983;Genome-wide genotyping array
02-12-2014;24755620;Perez-Palma E;22-04-2014;PLoS One;www.ncbi.nlm.nih.gov/pubmed/24755620;Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.;Alzheimer's disease;2,540 European ancestry cases, 2,029 European ancestry controls;NA;19q13.32;19;44892362;APOE, BCAM, PVR, EXOC3L2, TOMM40, PVRL2, BCL3, APOC1;TOMM40;;;ENSG00000130204;;;rs2075650-G;rs2075650;0;2075650;intron_variant;0;;9,00E-116;1,15E+16;;448;[NR];Affymetrix, Illumina [1216213] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002422;Genome-wide genotyping array
02-12-2014;24755620;Perez-Palma E;22-04-2014;PLoS One;www.ncbi.nlm.nih.gov/pubmed/24755620;Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.;Alzheimer's disease;2,540 European ancestry cases, 2,029 European ancestry controls;NA;12q22;12;94930613;intergenic;NDUFA12;;;ENSG00000184752;;;rs249153-C;rs249153;0;249153;intron_variant;0;;0,0000004;6,40E+16;;141;[NR];Affymetrix, Illumina [1216213] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002422;Genome-wide genotyping array
02-12-2014;24755620;Perez-Palma E;22-04-2014;PLoS One;www.ncbi.nlm.nih.gov/pubmed/24755620;Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.;Alzheimer's disease;2,540 European ancestry cases, 2,029 European ancestry controls;NA;5p13.3;5;30178906;intergenic;AC018765.1 - HPRT1P2;ENSG00000280305;ENSG00000250587;;195792;69444;rs13178362-T;rs13178362;0;13178362;intergenic_variant;1;;0,0000007;6,15E+15;;13333;[NR];Affymetrix, Illumina [1216213] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002422;Genome-wide genotyping array
02-12-2014;24755620;Perez-Palma E;22-04-2014;PLoS One;www.ncbi.nlm.nih.gov/pubmed/24755620;Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.;Alzheimer's disease;2,540 European ancestry cases, 2,029 European ancestry controls;NA;11q12.1;11;60071148;MS4A3;MS4A3 - AP000790.2;ENSG00000149516;ENSG00000255331;;20;6202;rs474951-T;rs474951;0;474951;intergenic_variant;1;;0,000001;60;;12658;[NR];Affymetrix, Illumina [1216213] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002422;Genome-wide genotyping array
02-12-2014;24755620;Perez-Palma E;22-04-2014;PLoS One;www.ncbi.nlm.nih.gov/pubmed/24755620;Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.;Alzheimer's disease;2,540 European ancestry cases, 2,029 European ancestry controls;NA;3p25.3;3;10093893;FANCD2, FANCD2OS;FANCD2, FANCD2OS;;;ENSG00000144554, ENSG00000163705;;;rs1552244-A;rs1552244;0;1552244;intron_variant;0;;0,000002;5,70E+15;;132;[NR];Affymetrix, Illumina [1216213] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002422;Genome-wide genotyping array
17-08-2018;29107063;Yashin AI;26-10-2017;Exp Gerontol;www.ncbi.nlm.nih.gov/pubmed/29107063;Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.;Alzheimer's disease;at least 3,569 European, Black, and unknown ancestry cases, at least 19,085 European, Black, and unknown ancestry controls;NA;19q13.32;19;44892362;TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;;0,0000002;6,70E+15;;15;[NR];Illumina [up to 1329158];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST006121;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;1q32.3;1;213944747;intergenic;PROX1-AS1;;;ENSG00000230461;;;rs340849-?;rs340849;0;340849;intron_variant;0;NR;0,000008;5,10E+15;;169;[1.33-2.13];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;2p24.2;2;17246318;intergenic;RN7SKP168 - ZFYVE9P2;ENSG00000222842;ENSG00000214843;;123178;37974;rs11889338-A;rs11889338;0;11889338;regulatory_region_variant;1;0.26;0,000009;5,05E+15;;155;[1.28-1.88];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;2p23.3;2;27684606;SLC4A1AP;SLC4A1AP;;;ENSG00000163798;;;rs17006206-G;rs17006206;0;17006206;intron_variant;0;0.10;0,000002;5,70E+15;;205;[1.52-2.76];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;3p24.1;3;28887369;intergenic;RBMS3, AC098650.1;;;ENSG00000144642, ENSG00000283563;;;rs2221154-?;rs2221154;0;2221154;intron_variant;0;NR;0,000003;5,52E+15;;175;[1.39-2.22];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;4p16.3;4;2101369;POLN;POLN;;;ENSG00000130997;;;rs1923775-T;rs1923775;0;1923775;intron_variant;0;0.25;0,000006;5,22E+15;;16;[1.30-1.95];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;7q35;7;147200311;CNTNAP2;CNTNAP2;;;ENSG00000174469;;;rs10273775-G;rs10273775;0;10273775;intron_variant;0;0.42;0,000009;5,05E+15;;152;[1.27-1.84];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;8q24.13;8;121897448;intergenic;HAS2-AS1;;;ENSG00000248690;;;rs956225-A;rs956225;0;956225;intron_variant;0;NR;0,000009;5,05E+15;;333;[1.96-5.56];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;12q24.21;12;114942588;intergenic;AC009804.1 - AC008125.1;ENSG00000274879;ENSG00000257958;;12653;134737;rs10850408-?;rs10850408;0;10850408;intergenic_variant;1;NR;0,0000009;6,05E+15;;159;[1.32-1.92];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;13q12.13;13;26150190;intergenic;RNF6, ATP8A2P3;;;ENSG00000127870, ENSG00000233963;;;rs17511627-C;rs17511627;0;17511627;intron_variant;0;0.17;0,000005;5,30E+15;;175;[1.37-2.22];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;13q32.2;13;98479040;STK24;STK24;;;ENSG00000102572;;;rs912330-?;rs912330;0;912330;intron_variant;0;NR;0,000004;5,40E+16;;185;[1.43-2.44];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
06-01-2012;22159054;Logue MW;01-12-2011;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/22159054;A comprehensive genetic association study of Alzheimer disease in African Americans.;Alzheimer's disease;513 African American cases, 496 African American controls;NA;19q13.32;19;44878777;PVRL2;NECTIN2;;;ENSG00000130202;;;rs6859-A;rs6859;0;6859;3_prime_UTR_variant;0;NR;0,0000005;6,30E+15;;158;[NR];Illumina [2505093] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001342;Genome-wide genotyping array
14-10-2010;20885792;Naj AC;23-09-2010;PLoS Genet;www.ncbi.nlm.nih.gov/pubmed/20885792;Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.;Alzheimer's disease (late onset);931 cases, 1,104 controls;1,338 cases, 2,003 controls;19q13.32;19;44892362;APOE, TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-G;rs2075650;0;2075650;intron_variant;0;0.20;5,00E-36;3,53E+15;;294;[2.48-3.47];Illumina [483399];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000808;Genome-wide genotyping array
14-10-2010;20885792;Naj AC;23-09-2010;PLoS Genet;www.ncbi.nlm.nih.gov/pubmed/20885792;Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.;Alzheimer's disease (late onset);931 cases, 1,104 controls;1,338 cases, 2,003 controls;6q25.1;6;150885942;MTHFD1L;MTHFD1L;;;ENSG00000120254;;;rs11754661-A;rs11754661;0;11754661;intron_variant;0;0.07;2,00E-10;9,70E+15;;21;[1.67-2.64];Illumina [483399];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000808;Genome-wide genotyping array
14-10-2010;20885792;Naj AC;23-09-2010;PLoS Genet;www.ncbi.nlm.nih.gov/pubmed/20885792;Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.;Alzheimer's disease (late onset);931 cases, 1,104 controls;1,338 cases, 2,003 controls;19q13.32;19;44878777;PVRL2;NECTIN2;;;ENSG00000130202;;;rs6859-A;rs6859;0;6859;3_prime_UTR_variant;0;0.46;0,0000001;70;;141;[1.24-1.60];Illumina [483399];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000808;Genome-wide genotyping array
14-10-2010;20885792;Naj AC;23-09-2010;PLoS Genet;www.ncbi.nlm.nih.gov/pubmed/20885792;Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.;Alzheimer's disease (late onset);931 cases, 1,104 controls;1,338 cases, 2,003 controls;2q13;2;109018801;intergenic;EDAR - RF00017;ENSG00000135960;ENSG00000277950;;29429;105556;rs4676049-A;rs4676049;0;4676049;intergenic_variant;1;0.08;0,00000004;7,40E+16;;176;[1.44-2.15];Illumina [483399];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000808;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;2q23.1;2;148800291;EPC2;EPC2 - RNU2-9P;ENSG00000135999;ENSG00000222126;;12723;25400;rs2121433-?;rs2121433;0;2121433;intergenic_variant;1;NR;0,000001;60;(t-tau);;;Illumina [322557];N;Alzheimer's disease, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004760;GCST000900;Genome-wide genotyping array
08-09-2008;17474819;Coon KD;01-04-2007;J Clin Psychiatry;www.ncbi.nlm.nih.gov/pubmed/17474819;A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.;Alzheimer's disease (late onset);664 European ancestry cases, 422 European ancestry controls;NA;19q13.32;19;44919689;APOE;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;340;7115;rs4420638-?;rs4420638;0;4420638;intergenic_variant;1;NR;1,00E-39;390;;401;[NR];Affymetrix [~ 502627];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000018;Genome-wide genotyping array
15-09-2008;17975299;Webster JA;01-11-2007;Neurodegener Dis;www.ncbi.nlm.nih.gov/pubmed/17975299;Sorl1 as an Alzheimer's disease predisposition gene?;Alzheimer's disease;664 cases, 422 controls;NA;19q13.32;19;44919689;APOE;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;340;7115;rs4420638-?;rs4420638;0;4420638;intergenic_variant;1;NR;1,00E-39;390;;;;Affymetrix [~ 502627];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000121;Genome-wide genotyping array
12-11-2008;18823527;Abraham R;29-09-2008;BMC Med Genomics;www.ncbi.nlm.nih.gov/pubmed/18823527;A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.;Alzheimer's disease;1,082 European ancestry cases, 1,239 European ancestry controls;1,400 controls;4q32.1;4;154733269;intergenic;LRAT;;;ENSG00000121207;;;rs727153-C;rs727153;0;727153;intron_variant;0;0.52;0,000003;5,52E+15;;163;[1.37-1.95];Illumina [561494];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000237;Genome-wide genotyping array
12-11-2008;18823527;Abraham R;29-09-2008;BMC Med Genomics;www.ncbi.nlm.nih.gov/pubmed/18823527;A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.;Alzheimer's disease;1,082 European ancestry cases, 1,239 European ancestry controls;1,400 controls;19q13.32;19;44878777;APOE, PVRL2, TOMM40;NECTIN2;;;ENSG00000130202;;;rs6859-A;rs6859;0;6859;3_prime_UTR_variant;0;NR;6,00E-14;1,32E+16;;;;Illumina [561494];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000237;Genome-wide genotyping array
09-12-2008;18976728;Bertram L;29-10-2008;Am J Hum Genet;www.ncbi.nlm.nih.gov/pubmed/18976728;Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.;Alzheimer's disease;941 European ancestry cases and 404 European ancestry controls from 410 families;1,767 European ancestry cases and 838 European ancestry controls from 875 families;14q31.2;14;84308865;intergenic;MTCYBP27 - RNU6-976P;ENSG00000259012;ENSG00000251895;;131777;431077;rs11159647-?;rs11159647;0;11159647;intergenic_variant;1;NR;0,000002;5,70E+15;;;;Affymetrix [484522];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000255;Genome-wide genotyping array
09-12-2008;18976728;Bertram L;29-10-2008;Am J Hum Genet;www.ncbi.nlm.nih.gov/pubmed/18976728;Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.;Alzheimer's disease;941 European ancestry cases and 404 European ancestry controls from 410 families;1,767 European ancestry cases and 838 European ancestry controls from 875 families;19q13.41;19;51223357;CD33;SIGLEC22P - CD33;ENSG00000268849;ENSG00000105383;;11269;1707;rs3826656-?;rs3826656;0;3826656;intergenic_variant;1;NR;0,000006;5,22E+15;;;;Affymetrix [484522];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000255;Genome-wide genotyping array
06-04-2011;21390209;Hu X;24-02-2011;PLoS One;www.ncbi.nlm.nih.gov/pubmed/21390209;Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);1,831 European ancestry cases, 1,764 European ancestry controls;751 cases, 751 controls;2q14.3;2;127137039;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;29684;32972;rs744373-?;rs744373;0;744373;intergenic_variant;1;NR;1,00E-10;100;;119;[NR];Affymetrix, Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000986;Genome-wide genotyping array
06-04-2011;21390209;Hu X;24-02-2011;PLoS One;www.ncbi.nlm.nih.gov/pubmed/21390209;Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);1,831 European ancestry cases, 1,764 European ancestry controls;751 cases, 751 controls;2q14.3;2;127130409;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;23054;39602;rs12989701-?;rs12989701;0;12989701;regulatory_region_variant;1;NR;3,00E-10;9,52E+15;;123;[NR];Affymetrix, Illumina [NR] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000986;Genome-wide genotyping array
27-02-2009;19136949;Carrasquillo MM;11-01-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19136949;Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.;Alzheimer's disease;844 European ancestry cases, 1,255 European ancestry controls;1,547 European ancestry cases, 1,209 European ancestry controls;Xq21.31;;92147221;PCDH11X;PCDH11X;;;ENSG00000102290;;;rs2573905-?;rs2573905;0;2573905;intron_variant;0;0.46;0,0000002;6,70E+15;;129;[1.17-1.42];Illumina [313504];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000315;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;;;;ITGA6;;;;;;;Position 173336636-A;Position 173336636;0;;;1;0.43;0,0000006;6,22E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;3q26.1;3;166296681;BCHE;AC104629.1 - LINC01326;ENSG00000244429;ENSG00000244321;;2328;273012;rs509208-G;rs509208;0;509208;intergenic_variant;1;0.16;0,00000003;7,52E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;5q14.3;5;84788958;EDIL3;AC113383.1 - PPIAP79;ENSG00000250320;ENSG00000214853;;298193;210854;rs113524839-T;rs113524839;0;113524839;intergenic_variant;1;0.11;0,0000008;6,10E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;5q21.3;5;107775475;EFNA5;RN7SL782P - RN7SKP122;ENSG00000239708;ENSG00000251732;;40409;35154;rs1422438-G;rs1422438;0;1422438;intergenic_variant;1;0.30;0,0000006;6,22E+15;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
06-06-2013;23419831;Ramanan VK;19-02-2013;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/23419831;APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.;Alzheimer's disease biomarkers;555 European ancestry individuals;NA;19q13.32;19;44908684;APOE;APOE;;;ENSG00000130203;;;rs429358-C;rs429358;0;429358;missense_variant;0;0.28;5,00E-14;1,33E+16;(Cortical Ab);;;Illumina [6108668] (imputed);N;Alzheimer's disease, amyloid-beta measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005194;GCST001868;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;1q32.1;1;206836565;IL19;IL19;;;ENSG00000142224;;;rs2243170-?;rs2243170;0;2243170;intron_variant;0;;0,0000007;6,15E+15;;165;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;2q21.2;2;133575190;NCKAP5;NCKAP5 - RN7SKP93;ENSG00000176771;ENSG00000200708;;6727;20901;rs7588354-?;rs7588354;0;7588354;intergenic_variant;1;;0,000001;60;;15151515;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;14q32.2;14;99570681;CCDC85C;CCDC85C;;;ENSG00000205476;;;rs2400749-?;rs2400749;0;2400749;intron_variant;0;;0,000002;5,70E+15;;13888888;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;12q13.3;12;56926927;SDR9C7;SDR9C7;;;ENSG00000170426;;;rs840163-?;rs840163;0;840163;intron_variant;0;;0,000002;5,70E+15;;14;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;11q14.1;11;78493334;NARS2, GAB2;NARS2;;;ENSG00000137513;;;rs4474465-?;rs4474465;0;4474465;intron_variant;0;;0,000003;5,52E+15;;144;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;1p36.13;1;18875425;ALDH4A1;AL080251.1, ALDH4A1;;;ENSG00000255275, ENSG00000159423;;;rs6695033-?;rs6695033;0;6695033;missense_variant;0;;0,000003;5,52E+15;;271;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
12-01-2016;25649651;Wang X;03-02-2015;J Alzheimers Dis;www.ncbi.nlm.nih.gov/pubmed/25649651;Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.;Alzheimer's disease (survival time);983 cases;NA;11q24.2;11;125323700;PKNOX2;PKNOX2;;;ENSG00000165495;;;rs11601321-?;rs11601321;0;11601321;intron_variant;0;;0,000008;5,10E+15;;163;[NR];Illumina [803323];N;Alzheimer's disease, survival time;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0000714;GCST002775;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;1q24.2;1;167749262;MPZL1;MPZL1;;;ENSG00000197965;;;rs4145462-T;rs4145462;0;4145462;intron_variant;0;0.05;0,000001;60;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;2p24.1;2;23016071;intergenic;RN7SKP27 - AC018467.1;ENSG00000222616;ENSG00000232451;;154187;2054;rs41458646-G;rs41458646;0;41458646;intergenic_variant;1;0.17;0,000008;5,10E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;2q33.3;2;204263298;intergenic;AC009498.1 - DSTNP5;ENSG00000237271;ENSG00000236681;;28313;43544;rs6738181-A;rs6738181;0;6738181;intergenic_variant;1;0.19;0,000005;5,30E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;3p14.1;3;69124224;intergenic;LMOD3 - FRMD4B;ENSG00000163380;ENSG00000114541;;1192;45766;rs7638995-A;rs7638995;0;7638995;intergenic_variant;1;0.11;0,000002;5,70E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;7q22.3;7;105640741;ATXN7L1;ATXN7L1;;;ENSG00000146776;;;rs11983798-T;rs11983798;0;11983798;intron_variant;0;0.08;0,000001;60;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;8q22.3;8;102963761;intergenic;AZIN1-AS1;;;ENSG00000253320;;;rs6468852-G;rs6468852;0;6468852;intron_variant;0;0.13;0,000001;60;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;9q31.2;9;105869669;intergenic;SLC25A6P5 - LINC01505;ENSG00000228948;ENSG00000234323;;18244;123641;rs9969729-A;rs9969729;0;9969729;intergenic_variant;1;0.08;0,000002;5,70E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;11p14.3;11;24589584;LUZP2;LUZP2;;;ENSG00000187398;;;rs12361953-C;rs12361953;0;12361953;intron_variant;0;0.15;0,0000008;6,10E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;11q24.2;11;126035363;CDON;CDON;;;ENSG00000064309;;;rs472926-C;rs472926;0;472926;intron_variant;0;0.15;0,000003;5,52E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;11q24.3;11;128319206;intergenic;LINC02098 - ETS1;ENSG00000272575;ENSG00000134954;;77765;139555;rs4937314-C;rs4937314;0;4937314;TF_binding_site_variant;1;0.17;0,000007;5,15E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;14q24.2;14;71040884;PCNX;PCNX1;;;ENSG00000100731;;;rs11848070-C;rs11848070;0;11848070;intron_variant;0;0.25;0,000006;5,22E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
19-11-2012;22881374;Cummings AC;01-09-2012;Ann Hum Genet;www.ncbi.nlm.nih.gov/pubmed/22881374;Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.;Alzheimer's disease (late onset);109 Amish cases, 689 Amish controls;NA;20p12.3;20;6999988;intergenic;BMP2 - AL096799.1;ENSG00000125845;ENSG00000232271;;219708;69626;rs6085820-A;rs6085820;0;6085820;intergenic_variant;1;0.09;0,000009;5,05E+15;;;;Affymetrix [614963];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001658;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q31.1;2;176778182;Intergenic;AC092162.2;;;ENSG00000230552;;;rs17639982-C;rs17639982;0;17639982;intron_variant;0;NR;0,000000008;8,10E+15;(between families);5774;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q31.2;2;178380259;OSBPL6;OSBPL6;;;ENSG00000079156;;;rs1347297-T;rs1347297;0;1347297;intron_variant;0;NR;0,00000005;7,30E+15;(within families);5469;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6p25.1;6;6316080;Intergenic;F13A1;;;ENSG00000124491;;;rs6927354-T;rs6927354;0;6927354;intron_variant;0;NR;0,00000005;7,30E+15;(between families);544;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q14.1;6;76439941;Intergenic;RNU6-248P - RNU6-261P;ENSG00000222652;ENSG00000238697;;347001;7047;rs16887604-T;rs16887604;0;16887604;regulatory_region_variant;1;NR;0,00000003;7,52E+15;(between families);5544;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q21.13;8;75905029;Intergenic;HNF4G - RNU2-54P;ENSG00000164749;ENSG00000222231;;338186;360514;rs183826639-T;rs183826639;0;183826639;intergenic_variant;1;NR;1,00E-12;120;(within families);7098;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q21.2;8;83837822;Intergenic;LINC01419 - AC015522.1;ENSG00000253898;ENSG00000254202;;428922;74891;rs79781504-A;rs79781504;0;79781504;intergenic_variant;1;NR;0,00000002;7,70E+15;(between families);5603;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q34;13;113312674;Intergenic;LAMP1;;;ENSG00000185896;;;rs146168866-A;rs146168866;0;146168866;intron_variant;0;NR;0,00000009;7,05E+15;(within families);5348;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16p13.3;16;7091262;Intergenic;RBFOX1;;;ENSG00000078328;;;rs75885813-A;rs75885813;0;75885813;intron_variant;0;NR;4,00E-10;9,40E+15;(within families);6258;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;19q13.32;19;44919589;Intergenic;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;240;7215;rs56131196-A;rs56131196;0;56131196;intergenic_variant;1;NR;3,00E-24;2,35E+16;(within families);10157;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;22q11.21;22;20016577;Intergenic;ARVCF;;;ENSG00000099889;;;rs144191434-A;rs144191434;0;144191434;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5189;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1p36.12;1;21911229;Intergenic;HSPG2;;;ENSG00000142798;;;rs2445130-A;rs2445130;0;2445130;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4933;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1p36.11;1;26294315;Intergenic;UBXN11;;;ENSG00000158062;;;rs56039743-T;rs56039743;0;56039743;missense_variant;0;NR;0,0000003;6,52E+15;(between families);5112;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1p34.3;1;37287106;Intergenic;AL353604.1;;;ENSG00000223944;;;rs12041233-A;rs12041233;0;12041233;intron_variant;0;NR;0,000000006;8,22E+15;(between families);5825;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1p34.2;1;43453815;Intergenic;SZT2, HYI;;;ENSG00000198198, ENSG00000178922;;;rs182798940-T;rs182798940;0;182798940;5_prime_UTR_variant;0;NR;0,0000007;6,15E+15;(between families);4971;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1p21.3;1;99242198;Intergenic;AL445433.2;;;ENSG00000232825;;;rs143083071-A;rs143083071;0;143083071;intron_variant;0;NR;0,00000001;80;(between families);5734;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1p13.3;1;109995242;Intergenic;AHCYL1;;;ENSG00000168710;;;rs11588387-T;rs11588387;0;11588387;intron_variant;0;NR;0,000001;60;(between families);4893;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1q23.3;1;164275038;Intergenic;RF00012 - NMNAT1P2;ENSG00000200318;ENSG00000225719;;351165;67967;rs79036927-A;rs79036927;0;79036927;intergenic_variant;1;NR;0,000001;60;(between families);4896;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1q41;1;218421142;Intergenic;TGFB2;;;ENSG00000092969;;;rs181424343-A;rs181424343;0;181424343;intron_variant;0;NR;0,00000008;7,10E+15;(within families);5375;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;1q42.2;1;233487182;MLK4;RNU4-77P - KCNK1;ENSG00000252501;ENSG00000135750;;38401;126822;rs36060340-A;rs36060340;0;36060340;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);4975;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p25.2;2;4989398;Intergenic;RNU6-649P - AC073143.1;ENSG00000207192;ENSG00000228585;;44015;324342;rs148822902-C;rs148822902;0;148822902;intergenic_variant;1;NR;0,000001;60;(between families);4901;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p23.3;2;24254185;Intergenic;ITSN2;;;ENSG00000198399;;;rs75009721-T;rs75009721;0;75009721;intron_variant;0;NR;0,00000002;7,70E+15;(between families);566;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p23.3;2;26471784;Intergenic;OTOF;;;ENSG00000115155;;;rs183562580-A;rs183562580;0;183562580;intron_variant;0;NR;0,0000006;6,22E+15;(within families);4996;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p21;2;47443115;Intergenic;MSH2;;;ENSG00000095002;;;rs186552003-A;rs186552003;0;186552003;intron_variant;0;NR;0,0000008;6,10E+15;(within families);4943;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p16.3;2;48435898;Intergenic;FOXN2 - AC093635.1;ENSG00000170802;ENSG00000272663;;56604;4145;rs186166314-A;rs186166314;0;186166314;intergenic_variant;1;NR;0,00000009;7,05E+15;(between families);5355;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p16.3;2;51894529;Intergenic;AC007402.1;;;ENSG00000231918;;;rs191975838-T;rs191975838;0;191975838;intron_variant;0;NR;0,00000005;7,30E+15;(between families);5467;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p16.1;2;60832908;Intergenic;LINC01185;;;ENSG00000228414;;;rs115291397-A;rs115291397;0;115291397;intron_variant;0;NR;0,000000002;8,70E+15;(between families);6033;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p14;2;65140292;Intergenic;RAB1A - RF00090;ENSG00000138069;ENSG00000272025;;9961;18370;rs182928794-T;rs182928794;0;182928794;intergenic_variant;1;NR;0,0000008;6,10E+15;(between families);4927;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2p14;2;65382753;Intergenic;SPRED2;;;ENSG00000198369;;;rs140661185-A;rs140661185;0;140661185;intron_variant;0;NR;0,000001;60;(between families);4893;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q11.2;2;100697607;Intergenic;LINC01868 - AC092168.1;ENSG00000234169;ENSG00000228488;;21569;24614;rs2970989-T;rs2970989;0;2970989;intergenic_variant;1;NR;0,00000004;7,40E+16;(between families);5479;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q12.1;2;104003000;Intergenic;LINC01965;;;ENSG00000256637;;;rs186971130-A;rs186971130;0;186971130;intron_variant;0;NR;0,0000001;70;(between families);5311;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q14.1;2;117717968;DDX18;AC092170.1 - AC009312.1;ENSG00000227291;ENSG00000238207;;536406;39595;rs982100-A;rs982100;0;982100;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);508;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q22.1;2;136433314;Intergenic;RN7SKP141 - SMC4P1;ENSG00000251976;ENSG00000229568;;42645;111398;rs140009341-A;rs140009341;0;140009341;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5186;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q24.3;2;167746937;Intergenic;CTAGE14P - AC016723.1;ENSG00000214211;ENSG00000235335;;30872;67837;rs116677506-A;rs116677506;0;116677506;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);4955;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q31.1;2;174268728;Intergenic;RF00019 - AC013467.1;ENSG00000201483;ENSG00000227180;;3747;30596;rs75286889-A;rs75286889;0;75286889;intergenic_variant;1;NR;0,00000007;7,15E+15;(between families);5379;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q32.1;2;184511570;ZNF804A;MIR548AE1 - AC096667.1;ENSG00000266808;ENSG00000283839;;132526;82007;rs1443024-A;rs1443024;0;1443024;intergenic_variant;1;NR;0,0000006;6,22E+15;(between families);4999;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q35;2;220047457;Intergenic;MIR4268 - AC009310.1;ENSG00000266518;ENSG00000225911;;140892;1365;rs187402274-C;rs187402274;0;187402274;intergenic_variant;1;NR;0,0000001;70;(between families);5264;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;2q36.3;2;227138926;Intergenic;COL4A4;;;ENSG00000081052;;;rs59904869-C;rs59904869;0;59904869;intron_variant;0;NR;0,0000004;6,40E+16;(between families);5054;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3p24.3;3;22933695;Intergenic;RANP7 - SALL4P5;ENSG00000226183;ENSG00000231915;;28544;56128;rs148471206-T;rs148471206;0;148471206;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5023;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3p24.2;3;26205084;LINC00692;RPEP2 - HMGB3P12;ENSG00000234158;ENSG00000237603;;188715;11238;rs7374058-T;rs7374058;0;7374058;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5137;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3p14.2;3;58807331;Intergenic;C3orf67;;;ENSG00000163689;;;rs181319480-T;rs181319480;0;181319480;intron_variant;0;NR;0,0000004;6,40E+16;(between families);5086;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3p14.2;3;61650482;PTPRG;PTPRG;;;ENSG00000144724;;;rs7609954-T;rs7609954;0;7609954;intron_variant;0;NR;0,00000004;7,40E+16;(between families);5492;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3p13;3;71931938;Intergenic;RN7SL271P - UBE2Q2P9;ENSG00000239250;ENSG00000244130;;104467;74836;rs58920042-T;rs58920042;0;58920042;regulatory_region_variant;1;NR;0,0000008;6,10E+15;(between families);4931;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3p12.2;3;82012036;Intergenic;LINC02008;;;ENSG00000239440;;;rs142710255-A;rs142710255;0;142710255;intron_variant;0;NR;0,0000003;6,52E+15;(between families);5135;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3q22.1;3;133712051;Intergenic;TFP1;;;ENSG00000242337;;;rs190500289-A;rs190500289;0;190500289;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4934;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;3q26.2;3;169741537;Intergenic;RNU6-637P - TERC;ENSG00000206777;ENSG00000270141;;21244;22983;rs28582745-A;rs28582745;0;28582745;regulatory_region_variant;1;NR;0,0000009;6,05E+15;(between families);4912;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4p16.1;4;9590409;Intergenic;SNRPCP13 - ENPP7P11;ENSG00000249799;ENSG00000250942;;6278;86899;rs189421534-A;rs189421534;0;189421534;intergenic_variant;1;NR;0,00000002;7,70E+15;(between families);5646;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4p12;4;46412095;Intergenic;AC095060.1, GABRA2;;;ENSG00000249330, ENSG00000151834;;;rs147028191-A;rs147028191;0;147028191;intron_variant;0;NR;0,000000001;90;(between families);6062;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4p12;4;46689227;Intergenic;RNU6-412P - RAC1P2;ENSG00000252243;ENSG00000249936;;157885;34603;rs183757472-A;rs183757472;0;183757472;intergenic_variant;1;NR;0,000000001;90;(between families);6062;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q23;4;98971324;Intergenic;AC019131.1;;;ENSG00000263923;;;rs115809613-A;rs115809613;0;115809613;intron_variant;0;NR;0,00000001;80;(between families);5688;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q24;4;102133052;Intergenic;BANK1 - SLC39A8;ENSG00000153064;ENSG00000138821;;58240;117989;rs115641191-T;rs115641191;0;115641191;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5237;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q31.1;4;139599374;Intergenic;SETD7;;;ENSG00000145391;;;rs72728723-A;rs72728723;0;72728723;3_prime_UTR_variant;0;NR;0,0000002;6,70E+15;(between families);5201;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q31.1;4;140579551;Intergenic;RN7SL152P - AC108019.1;ENSG00000242102;ENSG00000248621;;1329;20850;rs143638193-T;rs143638193;0;143638193;regulatory_region_variant;1;NR;0,000000004;8,40E+15;(between families);5895;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q31.23;4;148158346;NR3C2;NR3C2, AC069272.1;;;ENSG00000151623, ENSG00000250354;;;rs3931397-T;rs3931397;0;3931397;intron_variant;0;NR;0,0000006;6,22E+15;(between families);4984;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q32.3;4;168062923;Intergenic;AC116634.1;;;ENSG00000248601;;;rs13133687-A;rs13133687;0;13133687;intron_variant;0;NR;0,0000007;6,15E+15;(between families);4966;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q32.3;4;169173411;SH3RF1;SH3RF1;;;ENSG00000154447;;;rs9994441-C;rs9994441;0;9994441;intron_variant;0;NR;0,0000006;6,22E+15;(between families);499;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q34.1;4;174174724;Intergenic;LINC02268;;;ENSG00000248174;;;rs76930906-A;rs76930906;0;76930906;intron_variant;0;NR;3,00E-11;1,05E+16;(between families);6631;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;4q35.2;4;186821932;FAT1;FAT1 - AC108865.1;ENSG00000083857;ENSG00000250829;;95210;69037;rs75718659-T;rs75718659;0;75718659;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);5052;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5p12;5;44145829;FGF10;RNU6-381P - FGF10;ENSG00000212561;ENSG00000070193;;79098;157715;rs11749176-A;rs11749176;0;11749176;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5218;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5p12;5;44301065;Intergenic;RNU6-381P - FGF10;ENSG00000212561;ENSG00000070193;;234334;2479;rs11742761-A;rs11742761;0;11742761;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5107;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q13.3;5;76793184;Intergenic;F2R - F2RL1;ENSG00000181104;ENSG00000164251;;57403;25749;rs190204665-T;rs190204665;0;190204665;intergenic_variant;1;NR;0,0000001;70;(between families);5259;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q13.3;5;77556409;Intergenic;WDR41;;;ENSG00000164253;;;rs116300850-T;rs116300850;0;116300850;intron_variant;0;NR;0,0000007;6,15E+15;(between families);4963;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q14.3;5;89030013;Intergenic;MEF2C-AS1;;;ENSG00000248309;;;rs186292051-T;rs186292051;0;186292051;intron_variant;0;NR;0,0000002;6,70E+15;(between families);517;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q14.3;5;89179048;Intergenic;MEF2C-AS1;;;ENSG00000248309;;;rs141568462-T;rs141568462;0;141568462;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5183;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q14.3;5;89337967;Intergenic;MEF2C-AS1;;;ENSG00000248309;;;rs9293513-A;rs9293513;0;9293513;intron_variant;0;NR;0,0000005;6,30E+15;(between families);5035;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q21.3;5;105543433;Intergenic;AC099520.1 - RNA5SP189;ENSG00000251574;ENSG00000201790;;150463;379561;rs77780208-A;rs77780208;0;77780208;intergenic_variant;1;NR;0,0000009;6,05E+15;(between families);4917;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q22.3;5;114241467;KCNN2;KCNN2;;;ENSG00000080709;;;rs4705644-A;rs4705644;0;4705644;intron_variant;0;NR;0,0000009;6,05E+15;(between families);4905;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q23.1;5;116719736;Intergenic;RPS17P2 - LINC02214;ENSG00000197575;ENSG00000251311;;3086;23255;rs77296444-A;rs77296444;0;77296444;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5183;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q23.1;5;119985478;Intergenic;AC008550.1 - AC008574.1;ENSG00000234259;ENSG00000251293;;304398;259970;rs190338033-A;rs190338033;0;190338033;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5167;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q31.1;5;132994460;Intergenic;RF00019 - ZCCHC10;ENSG00000201483;ENSG00000155329;;49006;2525;rs7702102-A;rs7702102;0;7702102;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5034;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q31.3;5;143553786;Intergenic;RNU7-156P - AC016598.2;ENSG00000253023;ENSG00000251205;;11199;5433;rs188951355-T;rs188951355;0;188951355;regulatory_region_variant;1;NR;0,0000009;6,05E+15;(between families);4911;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q32;5;146158952;Intergenic;LARS;;;ENSG00000133706;;;rs2962508-T;rs2962508;0;2962508;intron_variant;0;NR;0,00000004;7,40E+16;(between families);5499;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q33.1;5;151801825;Intergenic;G3BP1;;;ENSG00000145907;;;rs186127414-A;rs186127414;0;186127414;intron_variant;0;NR;0,0000002;6,70E+15;(between families);517;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q33.2;5;154557919;Intergenic;AC026688.1 - CIR1P1;ENSG00000253886;ENSG00000253146;;63176;1389;rs143766413-C;rs143766413;0;143766413;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5024;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;5q35.3;5;177556462;Intergenic;AC139795.3 - TMED9;ENSG00000272459;ENSG00000184840;;1098;35696;rs61142792-T;rs61142792;0;61142792;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);5083;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6p22.3;6;18173684;Intergenic;KDM1B;;;ENSG00000165097;;;rs188911996-A;rs188911996;0;188911996;intron_variant;0;NR;0,00000002;7,70E+15;(between families);5578;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6p22.3;6;20592753;CDKAL1;CDKAL1;;;ENSG00000145996;;;rs62400067-T;rs62400067;0;62400067;intron_variant;0;NR;0,0000004;6,40E+16;(between families);5092;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6p21.1;6;44457063;CDC5L;CDC5L - AL136140.1;ENSG00000096401;ENSG00000237530;;6637;68196;rs543844-A;rs543844;0;543844;regulatory_region_variant;1;NR;0,0000001;70;(between families);5323;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6p12.1;6;56843712;DST;DST;;;ENSG00000151914;;;rs185968827-A;rs185968827;0;185968827;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5158;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q11.1;6;61662196;Intergenic;KHDRBS2-OT;;;ENSG00000250686;;;rs140996952-T;rs140996952;0;140996952;intron_variant;0;NR;0,0000009;6,05E+15;(between families);4912;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q13;6;75180632;Intergenic;COL12A1;;;ENSG00000111799;;;rs36099249-T;rs36099249;0;36099249;intron_variant;0;NR;0,00000007;7,15E+15;(between families);539;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q15;6;91867653;Intergenic;AL590635.1 - AL590814.1;ENSG00000219867;ENSG00000285961;;51225;134957;rs6908580-T;rs6908580;0;6908580;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5099;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q21;6;106832060;C6orf203;LINC02532 - CD24;ENSG00000235142;ENSG00000272398;;44519;137771;rs140633572-A;rs140633572;0;140633572;regulatory_region_variant;1;NR;0,0000005;6,30E+15;(between families);503;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q21;6;107689329;Intergenic;SOBP - AL096816.1;ENSG00000112320;ENSG00000280135;;29162;7970;rs847012-C;rs847012;0;847012;intergenic_variant;1;NR;0,0000003;6,52E+15;(within families);5096;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q21;6;113399037;Intergenic;AL589684.1 - LINC02518;ENSG00000223811;ENSG00000232316;;31093;29503;rs11961710-A;rs11961710;0;11961710;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);495;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q23.2;6;133383011;Intergenic;EYA4;;;ENSG00000112319;;;rs17062407-A;rs17062407;0;17062407;intron_variant;0;NR;0,0000002;6,70E+15;(between families);52;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q23.2;6;134242215;Intergenic;SGK1;;;ENSG00000118515;;;rs4896030-A;rs4896030;0;4896030;intron_variant;0;NR;0,0000006;6,22E+15;(between families);4988;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q24.1;6;139874946;Intergenic;AL050338.1;;;ENSG00000225148;;;rs17069431-T;rs17069431;0;17069431;intron_variant;0;NR;0,0000006;6,22E+15;(between families);4994;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q25.3;6;157844754;Intergenic;SNX9;;;ENSG00000130340;;;rs34804891-T;rs34804891;0;34804891;intron_variant;0;NR;0,00000006;7,22E+15;(between families);5425;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;6q25.3;6;158508928;Intergenic;TULP4;;;ENSG00000130338;;;rs116886320-A;rs116886320;0;116886320;3_prime_UTR_variant;0;NR;0,0000003;6,52E+15;(between families);5116;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7p21.3;7;11018769;Intergenic;PHF14;;;ENSG00000106443;;;rs183600932-T;rs183600932;0;183600932;intron_variant;0;NR;0,00000001;80;(between families);5706;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7p21.3;7;11188315;Intergenic;AC004160.1;;;ENSG00000230333;;;rs12374991-T;rs12374991;0;12374991;intron_variant;0;NR;0,0000005;6,30E+15;(between families);5046;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7p14.3;7;29210652;Intergenic;CHN2, AC004593.3;;;ENSG00000106069, ENSG00000285162;;;rs56357845-A;rs56357845;0;56357845;intron_variant;0;NR;0,0000007;6,15E+15;(between families);4958;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7p14.3;7;31262777;Intergenic;AC006466.1 - AC006380.1;ENSG00000232887;ENSG00000271027;;143205;67934;rs138090874-A;rs138090874;0;138090874;intergenic_variant;1;NR;0,00000004;7,40E+16;(between families);5511;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q11.21;7;64946786;ZNF273;MTDHP1 - ZNF117;ENSG00000270948;ENSG00000152926;;3860;24990;rs11773349-A;rs11773349;0;11773349;regulatory_region_variant;1;NR;0,0000006;6,22E+15;(between families);4991;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q21.13;7;88614935;Intergenic;PQLC1P1 - EEF1A1P28;ENSG00000231763;ENSG00000237709;;4266;24079;rs118071777-A;rs118071777;0;118071777;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);4951;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q21.3;7;97023147;Intergenic;DLX5;;;ENSG00000105880;;;rs75290158-A;rs75290158;0;75290158;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4943;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q21.3;7;97350347;Intergenic;AC073900.1 - AP1S2P1;ENSG00000224475;ENSG00000226046;;148864;87171;rs62496419-A;rs62496419;0;62496419;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5027;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q31.32;7;122425165;Intergenic;AC004594.1, CADPS2;;;ENSG00000240499, ENSG00000081803;;;rs12706411-T;rs12706411;0;12706411;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4928;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q31.32;7;123404453;Intergenic;LYPLA1P1 - IQUB;ENSG00000223595;ENSG00000164675;;173712;47947;rs71574743-T;rs71574743;0;71574743;intergenic_variant;1;NR;0,0000001;70;(between families);5329;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q36.1;7;149851920;Intergenic;AC004877.2, ZNF862;;;ENSG00000280149, ENSG00000106479;;;rs116932763-A;rs116932763;0;116932763;non_coding_transcript_exon_variant;0;NR;0,0000002;6,70E+15;(between families);5171;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q36.3;7;155309976;Intergenic;INSIG1;;;ENSG00000186480;;;rs191603973-C;rs191603973;0;191603973;3_prime_UTR_variant;0;NR;0,0000007;6,15E+15;(between families);4962;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;7q36.3;7;155432020;Intergenic;AC008060.3;;;ENSG00000236544;;;rs61510607-T;rs61510607;0;61510607;intron_variant;0;NR;0,0000005;6,30E+15;(between families);5012;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8p11.23;8;37276671;Intergenic;SMARCE1P4 - AC091182.1;ENSG00000253650;ENSG00000253123;;181281;49904;rs188420713-T;rs188420713;0;188420713;intergenic_variant;1;NR;2,00E-10;9,70E+15;(between families);6328;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q12.3;8;62931072;Intergenic;NKAIN3;;;ENSG00000185942;;;rs4557697-A;rs4557697;0;4557697;intron_variant;0;NR;0,000000008;8,10E+15;(between families);5761;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q13.1;8;66786417;Intergenic;SGK3;;;ENSG00000104205;;;rs191342285-A;rs191342285;0;191342285;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5233;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q13.1;8;66977235;Intergenic;PPP1R42;;;ENSG00000178125;;;rs182838111-T;rs182838111;0;182838111;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5233;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q21.13;8;83267319;Intergenic;AC090132.1 - AC090132.2;ENSG00000253423;ENSG00000274116;;64888;26606;rs192093332-A;rs192093332;0;192093332;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5179;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q22.3;8;103359219;Intergenic;FZD6 - CTHRC1;ENSG00000164930;ENSG00000164932;;26353;12296;rs76070545-T;rs76070545;0;76070545;intergenic_variant;1;NR;0,0000001;70;(between families);5262;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q23.3;8;113715373;Intergenic;AC103993.1 - RF00019;ENSG00000253207;ENSG00000201483;;98415;235513;rs189590409-A;rs189590409;0;189590409;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5243;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q24.13;8;122446223;Intergenic;SMILR - AC108136.1;ENSG00000255364;ENSG00000255325;;17672;39292;rs149038799-A;rs149038799;0;149038799;intergenic_variant;1;NR;0,00000007;7,15E+15;(between families);5382;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;8q24.21;8;126341293;Intergenic;AC087667.1 - AC084116.2;ENSG00000244791;ENSG00000253427;;11758;132896;rs118152978-A;rs118152978;0;118152978;intergenic_variant;1;NR;2,00E-10;9,70E+15;(between families);6359;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9p24.1;9;5538407;Intergenic;PDCD1LG2;;;ENSG00000197646;;;rs10975167-T;rs10975167;0;10975167;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4928;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9p23;9;11812813;Intergenic;AL353595.1;;;ENSG00000285784;;;rs147338646-A;rs147338646;0;147338646;intron_variant;0;NR;0,0000005;6,30E+15;(within families);5009;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9p21.1;9;31499715;Intergenic;LINC01243 - MTATP6P30;ENSG00000260720;ENSG00000226998;;118225;5565;rs78496360-A;rs78496360;0;78496360;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5026;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9q21.2;9;77060964;Intergenic;ATP5MFP3 - RFC5P1;ENSG00000232851;ENSG00000233526;;20291;11136;rs147213018-A;rs147213018;0;147213018;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5213;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9q22.32;9;95778950;DKFZP434H0512;LINC00476;;;ENSG00000175611;;;rs7047415-T;rs7047415;0;7047415;intron_variant;0;NR;0,0000003;6,52E+15;(between families);5096;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9q22.33;9;97869538;FOXE1;FOXE1 - TRMO;ENSG00000178919;ENSG00000136932;;12823;34951;rs12378800-A;rs12378800;0;12378800;regulatory_region_variant;1;NR;0,0000002;6,70E+15;(between families);5218;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9q31.1;9;101884874;GRIN3A;MTND3P4 - ARL2BPP7;ENSG00000230302;ENSG00000230418;;91118;170378;rs1774093-A;rs1774093;0;1774093;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);4956;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;9q34.3;9;137522127;Intergenic;PNPLA7;;;ENSG00000130653;;;rs139090762-A;rs139090762;0;139090762;intron_variant;0;NR;0,00000008;7,10E+15;(between families);5358;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10p12.1;10;28563093;Intergenic;WAC;;;ENSG00000095787;;;rs181666690-T;rs181666690;0;181666690;intron_variant;0;NR;0,0000001;70;(within families);5289;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10p11.23;10;29940940;Intergenic;AL353093.1 - JCAD;ENSG00000237936;ENSG00000165757;;49473;71860;rs146650065-A;rs146650065;0;146650065;intergenic_variant;1;NR;0,00000004;7,40E+16;(between families);5471;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10p11.22;10;31991363;Intergenic;RPL34P19 - RN7SL825P;ENSG00000230240;ENSG00000239731;;6809;724;rs211257-C;rs211257;0;211257;intergenic_variant;1;NR;0,00000002;7,70E+15;(between families);5641;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q11.23;10;49315703;Intergenic;C10orf71;;;ENSG00000177354;;;rs117850870-C;rs117850870;0;117850870;intron_variant;0;NR;0,000001;60;(between families);4893;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q21.2;10;59580135;Intergenic;AC026391.1;;;ENSG00000235140;;;rs61860854-T;rs61860854;0;61860854;intron_variant;0;NR;3,00E-11;1,05E+16;(between families);6651;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q22.1;10;69741141;Intergenic;AL450311.1 - RPL5P26;ENSG00000235645;ENSG00000230469;;48689;37821;rs79538733-A;rs79538733;0;79538733;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5015;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q23.1;10;83190139;Intergenic;RNU6-478P - MARK2P15;ENSG00000200774;ENSG00000234931;;122068;121489;rs190780914-T;rs190780914;0;190780914;intergenic_variant;1;NR;0,00000005;7,30E+15;(between families);5452;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q23.31;10;90473719;Intergenic;AL391704.1, AL391704.2;;;ENSG00000224750, ENSG00000236373;;;rs73320584-A;rs73320584;0;73320584;intron_variant;0;NR;0,0000007;6,15E+15;(between families);496;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q23.31;10;90679092;HTR7;AL390862.1 - HTR7;ENSG00000283053;ENSG00000148680;;55481;61731;rs73310256-T;rs73310256;0;73310256;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5123;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;10q25.1;10;105050857;Intergenic;SORCS3;;;ENSG00000156395;;;rs117792039-A;rs117792039;0;117792039;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5158;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11p15.4;11;10951303;Intergenic;ZBED5-AS1 - AC111188.1;ENSG00000247271;ENSG00000254401;;44501;69580;rs188188267-T;rs188188267;0;188188267;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5024;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11p15.3;11;12171710;Intergenic;MICAL2;;;ENSG00000133816;;;rs117250828-A;rs117250828;0;117250828;intron_variant;0;NR;0,0000003;6,52E+15;(between families);5134;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11p14.3;11;25871035;Intergenic;AC090592.1 - AC013799.1;ENSG00000254456;ENSG00000254754;;89277;53153;rs115514216-T;rs115514216;0;115514216;intergenic_variant;1;NR;0,000000003;8,52E+15;(between families);5958;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11p11.2;11;43611658;Intergenic;AC068205.2, AC068205.1;;;ENSG00000283341, ENSG00000283217;;;rs139675748-T;rs139675748;0;139675748;intron_variant;0;NR;0,000000002;8,70E+15;(between families);6022;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11p11.12;11;48948392;Intergenic;TRIM51CP;;;ENSG00000249910;;;rs3850930-A;rs3850930;0;3850930;non_coding_transcript_exon_variant;0;NR;0,0000006;6,22E+15;(between families);4991;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11p11.12;11;50114007;Intergenic;GTF2IP11 - AC109635.5;ENSG00000255199;ENSG00000255442;;11109;56149;rs2313143-A;rs2313143;0;2313143;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5224;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11q12.3;11;62481191;Intergenic;AHNAK;;;ENSG00000124942;;;rs141218484-T;rs141218484;0;141218484;intron_variant;0;NR;0,00000009;7,05E+15;(between families);5336;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11q14.1;11;85685837;Intergenic;CCDC89;;;ENSG00000179071;;;rs117983694-A;rs117983694;0;117983694;missense_variant;0;NR;0,00000007;7,15E+15;(between families);5399;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11q21;11;95362871;Intergenic;AP000787.1 - AP001790.1;ENSG00000245552;ENSG00000250390;;128767;119535;rs3911569-A;rs3911569;0;3911569;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5145;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11q23.1;11;112392241;Intergenic;AP002884.1 - AP003063.1;ENSG00000250303;ENSG00000254968;;29707;877;rs188168326-T;rs188168326;0;188168326;intergenic_variant;1;NR;0,00000009;7,05E+15;(between families);5352;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;11q24.2;11;125907477;Intergenic;AP000842.2, DDX25;;;ENSG00000255027, ENSG00000109832;;;rs11220271-A;rs11220271;0;11220271;intron_variant;0;NR;0,0000005;6,30E+15;(between families);5033;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12p13.32;12;4063960;Intergenic;AC007207.2 - HSPA8P5;ENSG00000256969;ENSG00000256356;;37302;33491;rs11062987-A;rs11062987;0;11062987;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);4964;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12p13.32;12;4699085;Intergenic;AC005833.1;;;ENSG00000255639;;;rs116938548-T;rs116938548;0;116938548;intron_variant;0;NR;0,0000002;6,70E+15;(between families);524;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12p13.31;12;8605947;Intergenic;AICDA;;;ENSG00000111732;;;rs3794318-A;rs3794318;0;3794318;intron_variant;0;NR;0,0000005;6,30E+15;(between families);5043;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12p11.22;12;29389844;Intergenic;OVCH1-AS1;;;ENSG00000257599;;;rs117154046-A;rs117154046;0;117154046;non_coding_transcript_exon_variant;0;NR;0,0000006;6,22E+15;(between families);5001;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12q13.2;12;56103857;Intergenic;AC034102.2;;;ENSG00000257411;;;rs79335261-T;rs79335261;0;79335261;intron_variant;0;NR;0,00000007;7,15E+15;(between families);5399;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12q21.2;12;75763576;Intergenic;AC078923.1;;;ENSG00000258077;;;rs187293782-T;rs187293782;0;187293782;intron_variant;0;NR;0,000000007;8,15E+15;(between families);578;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12q21.31;12;80080902;Intergenic;RNU7-106P - OTOGL;ENSG00000238842;ENSG00000165899;;12145;18635;rs190909796-T;rs190909796;0;190909796;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5038;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12q21.33;12;89830937;Intergenic;RNU6-148P - AC084200.1;ENSG00000252823;ENSG00000258216;;76785;51728;rs117483990-T;rs117483990;0;117483990;intergenic_variant;1;NR;0,000000001;90;(between families);607;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12q24.32;12;127489593;Intergenic;AC068787.1 - AC025252.1;ENSG00000279952;ENSG00000255945;;26396;108575;rs185806653-A;rs185806653;0;185806653;intergenic_variant;1;NR;0,0000008;6,10E+15;(between families);4932;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;12q24.32;12;128585137;Intergenic;TMEM132C;;;ENSG00000181234;;;rs144288546-A;rs144288546;0;144288546;intron_variant;0;NR;0,00000002;7,70E+15;(between families);5634;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q14.3;13;52557892;Intergenic;AL137058.1;;;ENSG00000244471;;;rs61960582-A;rs61960582;0;61960582;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4927;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q21.33;13;71297394;Intergenic;RABEPKP1 - DACH1;ENSG00000225801;ENSG00000276644;;159;140572;rs61956285-T;rs61956285;0;61956285;intergenic_variant;1;NR;0,000001;60;(between families);4902;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q31.1;13;80962230;Intergenic;ARF4P4 - LINC00377;ENSG00000231222;ENSG00000229246;;73363;81440;rs189465671-T;rs189465671;0;189465671;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5246;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q31.1;13;83172816;Intergenic;AL512782.1 - RNU6-67P;ENSG00000270400;ENSG00000222791;;26913;125255;rs9546312-T;rs9546312;0;9546312;intergenic_variant;1;NR;0,0000009;6,05E+15;(between families);492;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q32.2;13;98252314;FARP1;FARP1;;;ENSG00000152767;;;rs6491411-A;rs6491411;0;6491411;intron_variant;0;NR;0,0000009;6,05E+15;(between families);4911;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q32.3;13;100558935;Intergenic;GGACT, AL356966.1;;;ENSG00000134864, ENSG00000224356;;;rs117969561-T;rs117969561;0;117969561;intron_variant;0;NR;0,0000009;6,05E+15;(between families);4909;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q33.2;13;105740230;Intergenic;LINC00343;;;ENSG00000226620;;;rs115694210-A;rs115694210;0;115694210;intron_variant;0;NR;0,0000001;70;(between families);5336;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;13q33.3;13;109140829;Intergenic;MYO16;;;ENSG00000041515;;;rs150813880-A;rs150813880;0;150813880;synonymous_variant;0;NR;0,000001;60;(between families);4895;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;14q32.12;14;91453757;SMEK1;AL133153.2 - PPP4R3A;ENSG00000258798;ENSG00000100796;;32581;3854;rs56146971-A;rs56146971;0;56146971;regulatory_region_variant;1;NR;0,0000008;6,10E+15;(between families);4941;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;14q32.12;14;93925359;Intergenic;FAM181A, FAM181A, FAM181A-AS1, FAM181A-AS1;;;ENSG00000140067, ENSG00000273533, ENSG00000258584, ENSG00000281032;;;rs117161928-A;rs117161928;0;117161928;missense_variant;0;NR;0,0000001;70;(between families);5294;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;14q32.13;14;94816883;Intergenic;RPL15P2 - AL121612.1;ENSG00000240914;ENSG00000274379;;15420;101370;rs57602116-A;rs57602116;0;57602116;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5136;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;14q32.2;14;97442349;Intergenic;AL158800.1 - LINC02325;ENSG00000285584;ENSG00000246084;;224571;16467;rs150511909-T;rs150511909;0;150511909;regulatory_region_variant;1;NR;0,000000004;8,40E+15;(between families);5892;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;15q13.1;15;28136400;Intergenic;HERC2, HERC2;;;ENSG00000276802, ENSG00000128731;;;rs8033755-A;rs8033755;0;8033755;intron_variant;0;NR;0,0000001;70;(between families);5299;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;15q13.3;15;31116066;Intergenic;TRPM1, TRPM1;;;ENSG00000134160, ENSG00000274965;;;rs149916999-A;rs149916999;0;149916999;intron_variant;0;NR;0,0000001;70;(between families);5334;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;15q23;15;71449755;Intergenic;THSD4;;;ENSG00000187720;;;rs142200609-T;rs142200609;0;142200609;intron_variant;0;NR;0,0000003;6,52E+15;(within families);5118;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;15q25.3;15;86283609;Intergenic;AGBL1;;;ENSG00000273540;;;rs62013859-T;rs62013859;0;62013859;intron_variant;0;NR;0,0000004;6,40E+16;(between families);5094;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16p13.3;16;2608384;Intergenic;AC141586.1;;;ENSG00000215154;;;rs189794920-A;rs189794920;0;189794920;intron_variant;0;NR;0,0000006;6,22E+15;(between families);4999;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16p12.3;16;19423707;Intergenic;TMC5;;;ENSG00000103534;;;rs118099348-T;rs118099348;0;118099348;intron_variant;0;NR;0,000000001;90;(between families);605;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16p12.2;16;22190681;Intergenic;SDR42E2;;;ENSG00000183921;;;rs145049847-C;rs145049847;0;145049847;3_prime_UTR_variant;0;NR;0,000000008;8,10E+15;(between families);5771;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16q12.1;16;49948846;Intergenic;RPL34P29 - AC007603.3;ENSG00000244551;ENSG00000283365;;13494;6139;rs77414823-T;rs77414823;0;77414823;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);524;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16q21;16;62536445;Intergenic;AC009161.1 - AC009110.1;ENSG00000237901;ENSG00000231589;;178699;59927;rs150252171-A;rs150252171;0;150252171;intergenic_variant;1;NR;0,0000002;6,70E+15;(between families);5224;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16q23.2;16;80264653;Intergenic;AC105411.1;;;ENSG00000259867;;;rs79358781-A;rs79358781;0;79358781;intron_variant;0;NR;0,0000001;70;(between families);5268;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16q23.2;16;80433296;Intergenic;AC105411.1;;;ENSG00000259867;;;rs137967137-A;rs137967137;0;137967137;intron_variant;0;NR;0,0000001;70;(between families);5331;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16q23.3;16;83521415;Intergenic;CDH13;;;ENSG00000140945;;;rs77894924-A;rs77894924;0;77894924;intron_variant;0;NR;0,0000002;6,70E+15;(between families);5208;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;16q24.1;16;86374577;Intergenic;LINC00917 - AC092327.1;ENSG00000168367;ENSG00000268473;;24894;60253;rs78910009-T;rs78910009;0;78910009;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5024;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17p13.1;17;6979124;Intergenic;ALOX12-AS1;;;ENSG00000215067;;;rs111816999-T;rs111816999;0;111816999;intron_variant;0;NR;0,0000007;6,15E+15;(between families);4967;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17p12;17;13791198;Intergenic;COX10-AS1;;;ENSG00000236088;;;rs139471609-A;rs139471609;0;139471609;non_coding_transcript_exon_variant;0;NR;0,00000006;7,22E+15;(between families);5433;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17q21.31;17;43843285;Intergenic;MPP3 - CD300LG;ENSG00000161647;ENSG00000161649;;10115;3863;rs56176358-T;rs56176358;0;56176358;intergenic_variant;1;NR;0,0000006;6,22E+15;(between families);5004;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17q23.3;17;63576864;Intergenic;DCAF7;;;ENSG00000136485;;;rs79480822-T;rs79480822;0;79480822;intron_variant;0;NR;0,0000007;6,15E+15;(between families);4952;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17q23.3;17;63716838;Intergenic;AC046185.1, STRADA;;;ENSG00000125695, ENSG00000266173;;;rs34111070-T;rs34111070;0;34111070;intron_variant;0;NR;0,000001;60;(between families);4892;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17q23.3;17;63852268;Intergenic;TCAM1P;;;ENSG00000240280;;;rs71377714-T;rs71377714;0;71377714;intron_variant;0;NR;0,0000003;6,52E+15;(between families);5128;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17q24.2;17;68907860;Intergenic;ABCA8;;;ENSG00000141338;;;rs16973424-A;rs16973424;0;16973424;missense_variant;0;NR;0,0000003;6,52E+15;(between families);5144;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;17q25.3;17;80973533;Intergenic;AC127496.1 - RPL12P37;ENSG00000261924;ENSG00000240270;;2320;2921;rs149464898-T;rs149464898;0;149464898;intergenic_variant;1;NR;0,0000003;6,52E+15;(between families);5136;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;18p11.31;18;5958062;Intergenic;L3MBTL4, AP001021.1;;;ENSG00000154655, ENSG00000265487;;;rs62076840-A;rs62076840;0;62076840;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4927;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;18p11.31;18;6974460;Intergenic;LAMA1;;;ENSG00000101680;;;rs183708309-T;rs183708309;0;183708309;intron_variant;0;NR;0,0000006;6,22E+15;(between families);5001;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;18q21.32;18;59914255;Intergenic;PMAIP1 - AC107990.1;ENSG00000141682;ENSG00000267066;;9949;14971;rs142176337-T;rs142176337;0;142176337;intergenic_variant;1;NR;0,00000008;7,10E+15;(between families);536;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;18q22.1;18;66840171;Intergenic;CDH19 - RNU6-1037P;ENSG00000071991;ENSG00000238680;;236033;105945;rs138098194-A;rs138098194;0;138098194;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);5084;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;19p13.2;19;11323255;Intergenic;AC011472.2, TSPAN16, RAB3D, AC011472.3;;;ENSG00000267174, ENSG00000130167, ENSG00000105514, ENSG00000267576;;;rs148273964-A;rs148273964;0;148273964;3_prime_UTR_variant;0;NR;0,0000008;6,10E+15;(between families);4936;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;19q13.11;19;34780984;ZNF599;AC020910.2 - LINC01801;ENSG00000270281;ENSG00000267767;;963;7598;rs9304861-A;rs9304861;0;9304861;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);5082;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;19q13.42;19;53470531;Intergenic;ZNF813;;;ENSG00000198346;;;rs2927694-C;rs2927694;0;2927694;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4928;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;20p11.21;20;23514209;Intergenic;AL109954.1;;;ENSG00000260202;;;rs113118940-T;rs113118940;0;113118940;intron_variant;0;NR;0,00000001;80;(between families);5733;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;20p11.21;20;23762403;Intergenic;CST1 - CSTP2;ENSG00000170373;ENSG00000277975;;11135;10382;rs147525344-T;rs147525344;0;147525344;intergenic_variant;1;NR;0,000000005;8,30E+15;(between families);5856;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;20q11.22;20;34149795;Intergenic;RPS2P1 - ASIP;ENSG00000225246;ENSG00000101440;;26505;44774;rs115786578-A;rs115786578;0;115786578;intergenic_variant;1;NR;0,0000006;6,22E+15;(between families);4992;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;20q13.13;20;50382958;Intergenic;LINC01271 - RN7SL636P;ENSG00000233077;ENSG00000244376;;61616;46232;rs147775533-T;rs147775533;0;147775533;intergenic_variant;1;NR;0,0000006;6,22E+15;(between families);4993;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;21q21.3;21;28702102;Intergenic;AF165147.1 - RF00026;ENSG00000232855;ENSG00000266784;;27254;41106;rs2409317-T;rs2409317;0;2409317;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);5088;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;21q22.11;21;32716160;Intergenic;SYNJ1;;;ENSG00000159082;;;rs147991290-T;rs147991290;0;147991290;intron_variant;0;NR;0,000000003;8,52E+15;(between families);5943;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;21q22.3;21;42641102;Intergenic;LINC01671 - AP001626.1;ENSG00000225431;ENSG00000235023;;26044;7169;rs189677472-A;rs189677472;0;189677472;regulatory_region_variant;1;NR;0,0000001;70;(between families);5324;unit decrease;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;21q22.3;21;43410112;SIK1;AP001046.1 - SIK1;ENSG00000225637;ENSG00000142178;;43546;4371;rs857551-A;rs857551;0;857551;intergenic_variant;1;NR;0,0000007;6,15E+15;(between families);4949;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;21q22.3;21;45486796;Intergenic;COL18A1;;;ENSG00000182871;;;rs79985863-T;rs79985863;0;79985863;intron_variant;0;NR;0,0000008;6,10E+15;(between families);4925;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;22q11.21;22;19704370;Intergenic;AC000067.1 - SEPT5;ENSG00000225007;ENSG00000184702;;36815;10094;rs141503849-T;rs141503849;0;141503849;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5042;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;22q12.3;22;37009621;Intergenic;TEX33 - TST;ENSG00000185264;ENSG00000128311;;1780;1238;rs117496069-T;rs117496069;0;117496069;intergenic_variant;1;NR;0,0000005;6,30E+15;(between families);5043;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;22q13.31;22;48098836;Intergenic;FP325330.2 - BX284656.2;ENSG00000278890;ENSG00000238192;;40561;40625;rs150927461-T;rs150927461;0;150927461;intergenic_variant;1;NR;0,0000004;6,40E+16;(between families);508;unit increase;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
08-12-2016;26830138;Herold C;02-02-2016;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/26830138;Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.;Alzheimer disease and age of onset;2,478 European ancestry cases, 979 ancestry controls both from the same 1,070 families;NA;19q13.32;19;44919689;APOE;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;340;7115;rs4420638-A;rs4420638;0;4420638;intergenic_variant;1;NR;2,00E-16;1,57E+16;(between families);;;Affymetrix [up to 15107142] (imputed);N;Alzheimer's disease, age at onset;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004847;GCST003427;Genome-wide genotyping array
13-02-2014;23150908;Jonsson T;14-11-2012;N Engl J Med;www.ncbi.nlm.nih.gov/pubmed/23150908;Variant of TREM2 associated with the risk of Alzheimer's disease.;Alzheimer's disease;3,550 European ancestry cases, 8,888 European ancestry controls;694 European ancestry cases, 4,375 European ancestry controls, 1,343 cases, 5,352 controls;6p21.1;6;41161514;TREM2;TREM2;;;ENSG00000095970;;;rs75932628-T;rs75932628;0;75932628;missense_variant;0;0.0063;2,00E-12;1,17E+16;;29;[2.16-3.91];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001743;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;19q13.32;19;44919689;APOE, TOMM40, APOC1;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;340;7115;rs4420638-?;rs4420638;0;4420638;intergenic_variant;1;NR;8,00E-149;1,48E+16;;345;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;2q14.3;2;127132061;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;24706;37950;rs7561528-?;rs7561528;0;7561528;intergenic_variant;1;NR;6,00E-11;1,02E+16;;125;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;11q14.2;11;85966428;PICALM;PICALM;;;ENSG00000073921;;;rs17817600-?;rs17817600;0;17817600;intron_variant;0;NR;0,00000002;7,70E+15;;133;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;8p23.1;8;9141509;PPP1R3B;AC022784.5, PPP1R3B;;;ENSG00000254340, ENSG00000173281;;;rs3748140-?;rs3748140;0;3748140;missense_variant;0;NR;0,0000003;6,52E+15;;243;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;11q22.2;11;102862432;MMP3, MMP12;MMP3 - MMP12;ENSG00000149968;ENSG00000262406;;18629;304;rs12808148-?;rs12808148;0;12808148;intergenic_variant;1;NR;0,000001;60;;123;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;4p15.1;4;30466544;intergenic;AC106868.1 - PCDH7;ENSG00000248281;ENSG00000169851;;458228;253871;rs6856768-?;rs6856768;0;6856768;intergenic_variant;1;NR;0,000005;5,30E+15;;118;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;5q12.1;5;61654384;FLJ37543;C5orf64;;;ENSG00000178722;;;rs11738335-?;rs11738335;0;11738335;intron_variant;0;NR;0,000005;5,30E+15;;12;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
14-08-2012;22832961;Kamboh MI;15-05-2012;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22832961;Genome-wide association study of Alzheimer's disease.;Alzheimer's disease;1,291 European ancestry cases, 938 European ancestry controls;509 European ancestry cases, 753 European ancestry controls, 2,218 cases, 2,583 controls;2q12.3;2;107062032;intergenic;AC005040.1 - LINC01789;ENSG00000226905;ENSG00000229457;;98358;192659;rs1357692-?;rs1357692;0;1357692;intergenic_variant;1;NR;0,000009;5,05E+15;;116;[NR];Illumina [2543888] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001529;Genome-wide genotyping array
13-11-2014;24770881;Nelson PT;27-04-2014;Acta Neuropathol;www.ncbi.nlm.nih.gov/pubmed/24770881;ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.;Alzheimer's disease;1443 cases and 99 controls;NA;19q13.32;19;44892362;APOE, TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;NR;4,00E-13;1,24E+16;;;;NR [4913579] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002429;Genome-wide genotyping array
13-11-2014;24770881;Nelson PT;27-04-2014;Acta Neuropathol;www.ncbi.nlm.nih.gov/pubmed/24770881;ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.;Alzheimer's disease;1443 cases and 99 controls;NA;7p14.3;7;34054385;BMPER;BMPER;;;ENSG00000164619;;;rs17169634-?;rs17169634;0;17169634;intron_variant;0;NR;0,0000001;70;;;;NR [4913579] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002429;Genome-wide genotyping array
13-11-2014;24770881;Nelson PT;27-04-2014;Acta Neuropathol;www.ncbi.nlm.nih.gov/pubmed/24770881;ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.;Alzheimer's disease;1443 cases and 99 controls;NA;2p22.1;2;39954377;SLC8A1-AS1;SLC8A1-AS1;;;ENSG00000227028;;;rs75847378-?;rs75847378;0;75847378;intron_variant;0;NR;0,0000007;6,15E+15;;;;NR [4913579] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002429;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86150377;NR;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;80495;2850;rs7480193-?;rs7480193;0;7480193;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86158695;NR;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;5361;34092;rs7113976-?;rs7113976;0;7113976;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86120391;NR;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;50509;32836;rs580887-?;rs580887;0;580887;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86134431;NR;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;64549;18796;rs7938634-?;rs7938634;0;7938634;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86163280;NR;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;9946;29507;rs11603136-?;rs11603136;0;11603136;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;14q32.12;14;92466484;NR;SLC24A4;;;ENSG00000140090;;;rs12881735-?;rs12881735;0;12881735;intron_variant;0;NR;0,00000002;7,70E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;14q32.12;14;92472511;NR;SLC24A4;;;ENSG00000140090;;;rs12590654-?;rs12590654;0;12590654;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;17p13.2;17;5233752;NR;AC087500.1, SCIMP;;;ENSG00000261879, ENSG00000161929;;;rs7225151-?;rs7225151;0;7225151;intron_variant;0;NR;1,00E-10;100;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;17p13.2;17;5104941;NR;ZFP3 - ZNF232;ENSG00000180787;ENSG00000167840;;8567;600;rs3845261-?;rs3845261;0;3845261;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;17q23.3;17;63483402;NR;ACE;;;ENSG00000159640;;;rs4311-?;rs4311;0;4311;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19p13.3;19;1063444;NR;ABCA7;;;ENSG00000064687;;;rs4147929-?;rs4147929;0;4147929;intron_variant;0;NR;0,00000003;7,52E+15;;10491707;[1.03-1.07];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44567824;NR;CEACAM22P;;;ENSG00000230666;;;rs11083742-?;rs11083742;0;11083742;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44557839;NR;CEACAM22P;;;ENSG00000230666;;;rs118104581-?;rs118104581;0;118104581;intron_variant;0;NR;0,00000004;7,40E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44628686;NR;IGSF23;;;ENSG00000216588;;;rs11670070-?;rs11670070;0;11670070;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44677956;NR;CEACAM19, AC243964.2;;;ENSG00000186567, ENSG00000266903;;;rs2919845-?;rs2919845;0;2919845;non_coding_transcript_exon_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44718495;NR;AC243964.2;;;ENSG00000266903;;;rs79638902-?;rs79638902;0;79638902;non_coding_transcript_exon_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44695666;NR;AC243964.2;;;ENSG00000266903;;;rs2965162-?;rs2965162;0;2965162;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44698782;NR;AC243964.2;;;ENSG00000266903;;;rs2965164-?;rs2965164;0;2965164;intron_variant;0;NR;1,00E-11;110;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44693311;NR;AC243964.2;;;ENSG00000266903;;;rs76670936-?;rs76670936;0;76670936;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44728895;NR;RF00285 - BCL3;ENSG00000264452;ENSG00000069399;;2837;18810;rs62117160-?;rs62117160;0;62117160;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44719517;NR;AC243964.2 - RF00285;ENSG00000266903;ENSG00000264452;;758;6467;rs73037426-?;rs73037426;0;73037426;regulatory_region_variant;1;NR;4,00E-22;2,14E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44723891;NR;AC243964.2 - RF00285;ENSG00000266903;ENSG00000264452;;5132;2093;rs150820726-?;rs150820726;0;150820726;TF_binding_site_variant;1;NR;0,00000003;7,52E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44747899;NR;BCL3;;;ENSG00000069399;;;rs2965169-?;rs2965169;0;2965169;non_coding_transcript_exon_variant;0;NR;1,00E-49;490;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44793107;NR;CBLC;;;ENSG00000142273;;;rs112450640-?;rs112450640;0;112450640;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44815094;NR;BCAM;;;ENSG00000187244;;;rs28399657-?;rs28399657;0;28399657;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44867684;NR;NECTIN2;;;ENSG00000130202;;;rs41290100-?;rs41290100;0;41290100;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44820881;NR;BCAM;;;ENSG00000187244;;;rs28399637-?;rs28399637;0;28399637;intron_variant;0;NR;7,00E-120;1,19E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44794671;NR;CBLC;;;ENSG00000142273;;;rs2889414-?;rs2889414;0;2889414;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q12.2;11;60141154;NR;MS4A2 - AP001257.1;ENSG00000149534;ENSG00000254952;;42688;18533;rs1786140-?;rs1786140;0;1786140;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q12.2;11;60331752;NR;MS4A4A - MS4A6E;ENSG00000110079;ENSG00000166926;;13808;3079;rs4939338-?;rs4939338;0;4939338;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44851039;NR;NECTIN2;;;ENSG00000130202;;;rs11666329-?;rs11666329;0;11666329;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44854120;NR;NECTIN2;;;ENSG00000130202;;;rs4803764-?;rs4803764;0;4803764;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44840322;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;18901;5853;rs55840414-?;rs55840414;0;55840414;intergenic_variant;1;NR;2,00E-15;1,47E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44832419;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;10998;13756;rs56394238-?;rs56394238;0;56394238;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44842530;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;21109;3645;rs111371860-?;rs111371860;0;111371860;intergenic_variant;1;NR;5,00E-24;2,33E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44848259;NR;NECTIN2;;;ENSG00000130202;;;rs41289512-?;rs41289512;0;41289512;intron_variant;0;NR;5,00E-175;1,74E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44821499;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;78;24676;rs28399664-?;rs28399664;0;28399664;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44838691;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;17270;7484;rs10407439-?;rs10407439;0;10407439;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44840407;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;18986;5768;rs2972562-?;rs2972562;0;2972562;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44874077;NR;NECTIN2;;;ENSG00000130202;;;rs393584-?;rs393584;0;393584;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44890259;NR;AC011481.2;;;ENSG00000267282;;;rs117310449-?;rs117310449;0;117310449;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44876259;NR;NECTIN2;;;ENSG00000130202;;;rs412776-?;rs412776;0;412776;intron_variant;0;NR;5,00E-15;1,43E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44878777;NR;NECTIN2;;;ENSG00000130202;;;rs6859-?;rs6859;0;6859;3_prime_UTR_variant;0;NR;1,00E-155;1550;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44879709;NR;NECTIN2;;;ENSG00000130202;;;rs3852860-?;rs3852860;0;3852860;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44895376;NR;TOMM40;;;ENSG00000130204;;;rs11668327-?;rs11668327;0;11668327;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44910109;NR;AC011481.3;;;ENSG00000280087;;;rs1081106-?;rs1081106;0;1081106;non_coding_transcript_exon_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44913034;NR;AC011481.3;;;ENSG00000280087;;;rs59325138-?;rs59325138;0;59325138;non_coding_transcript_exon_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44905307;NR;TOMM40 - APOE;ENSG00000130204;ENSG00000130203;;1618;447;rs449647-?;rs449647;0;449647;regulatory_region_variant;1;NR;2,00E-58;5,77E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44858389;NR;NECTIN2;;;ENSG00000130202;;;rs365653-?;rs365653;0;365653;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44908822;NR;APOE;;;ENSG00000130203;;;rs7412-?;rs7412;0;7412;missense_variant;0;NR;2,00E-76;7,57E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44799247;NR;CBLC;;;ENSG00000142273;;;rs148933445-?;rs148933445;0;148933445;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44920687;NR;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;1338;6117;rs144311893-?;rs144311893;0;144311893;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44917843;NR;APOC1;;;ENSG00000130208;;;rs3925681-?;rs3925681;0;3925681;intron_variant;0;NR;7,00E-162;1,61E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44926286;NR;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;6937;518;rs71352239-?;rs71352239;0;71352239;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44937272;NR;APOC1P1 - APOC4;ENSG00000214855;ENSG00000267467;;5886;4966;rs73045691-?;rs73045691;0;73045691;intergenic_variant;1;NR;2,00E-19;1,87E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44946776;NR;APOC2, APOC4-APOC2;;;ENSG00000234906, ENSG00000224916;;;rs9304644-?;rs9304644;0;9304644;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45013623;NR;RELB;;;ENSG00000104856;;;rs34874378-?;rs34874378;0;34874378;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44982891;NR;CLPTM1;;;ENSG00000104853;;;rs57270598-?;rs57270598;0;57270598;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45020861;NR;RELB;;;ENSG00000104856;;;rs114248186-?;rs114248186;0;114248186;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45049329;NR;CLASRP;;;ENSG00000104859;;;rs147188206-?;rs147188206;0;147188206;intron_variant;0;NR;0,000000002;8,70E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45077114;NR;GEMIN7-AS1;;;ENSG00000267348;;;rs60239918-?;rs60239918;0;60239918;intron_variant;0;NR;3,00E-13;1,25E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45137507;NR;PPP1R37, MARK4;;;ENSG00000104866, ENSG00000007047;;;rs536518226-?;rs536518226;0;536518226;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45209421;NR;MARK4, AC005779.1;;;ENSG00000007047, ENSG00000266958;;;rs73566293-?;rs73566293;0;73566293;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;1q32.2;1;207612944;NR;CR1;;;ENSG00000203710;;;rs6701713-?;rs6701713;0;6701713;intron_variant;0;NR;9,00E-24;2,30E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;1q32.2;1;207619564;NR;CR1;;;ENSG00000203710;;;rs12036785-?;rs12036785;0;12036785;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;1q32.2;1;207677194;NR;CR1L;;;ENSG00000197721;;;rs11118328-?;rs11118328;0;11118328;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127072643;NR;BIN1;;;ENSG00000136717;;;rs17014873-?;rs17014873;0;17014873;intron_variant;0;NR;0,000000004;8,40E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127068957;NR;BIN1;;;ENSG00000136717;;;rs1060743-?;rs1060743;0;1060743;synonymous_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127135234;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;27879;34777;rs6733839-?;rs6733839;0;6733839;intergenic_variant;1;NR;2,00E-64;6,37E+15;;11470575;[1.12899064608461-1.16541354700668];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127082205;NR;BIN1;;;ENSG00000136717;;;rs10194375-?;rs10194375;0;10194375;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127104478;NR;BIN1;;;ENSG00000136717;;;rs72838215-?;rs72838215;0;72838215;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127104557;NR;BIN1;;;ENSG00000136717;;;rs6431219-?;rs6431219;0;6431219;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127120856;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;13501;49155;rs4663099-?;rs4663099;0;4663099;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127124606;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;17251;45405;rs35103166-?;rs35103166;0;35103166;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127126547;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;19192;43464;rs7575209-?;rs7575209;0;7575209;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127127671;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;20316;42340;rs58682665-?;rs58682665;0;58682665;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127128657;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;21302;41354;rs13025765-?;rs13025765;0;13025765;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127129099;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;21744;40912;rs13031703-?;rs13031703;0;13031703;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127136321;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;28966;33690;rs745717-?;rs745717;0;745717;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q14.3;2;127136908;NR;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;29553;33103;rs730482-?;rs730482;0;730482;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q37.1;2;233159830;NR;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs35349669-?;rs35349669;0;35349669;intron_variant;0;NR;2,00E-10;9,70E+15;;10525334;[1.03595530394875-1.06937674771915];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;2q37.1;2;233117202;NR;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs10933431-?;rs10933431;0;10933431;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;6p12.3;6;47464901;NR;B3GNTL1P2 - AL355353.1;ENSG00000271328;ENSG00000270761;;95671;12342;rs9381563-?;rs9381563;0;9381563;intergenic_variant;1;NR;1,00E-12;120;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;6p12.3;6;47424807;NR;B3GNTL1P2 - AL355353.1;ENSG00000271328;ENSG00000270761;;55577;52436;rs9395255-?;rs9395255;0;9395255;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;6p12.3;6;47630389;NR;CD2AP - ADGRF2;ENSG00000198087;ENSG00000164393;;3126;26047;rs9395288-?;rs9395288;0;9395288;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;6p12.3;6;47679485;NR;ADGRF2;;;ENSG00000164393;;;rs10948374-?;rs10948374;0;10948374;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q22.1;7;100374211;NR;PILRA;;;ENSG00000085514;;;rs1859788-?;rs1859788;0;1859788;missense_variant;0;NR;3,00E-18;1,75E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q22.1;7;100561944;NR;AGFG2;;;ENSG00000106351;;;rs2734897-?;rs2734897;0;2734897;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q22.1;7;100106335;NR;AP4M1;;;ENSG00000221838;;;rs2293479-?;rs2293479;0;2293479;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q22.1;7;100242838;NR;CASTOR3;;;ENSG00000239521;;;rs866500-?;rs866500;0;866500;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q22.1;7;100245730;NR;CASTOR3;;;ENSG00000239521;;;rs858502-?;rs858502;0;858502;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q22.1;7;100341332;NR;STAG3L5P-PVRIG2P-PILRB, PMS2P1, STAG3L5P;;;ENSG00000272752, ENSG00000078319, ENSG00000242294;;;rs35305377-?;rs35305377;0;35305377;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143411065;NR;EPHA1-AS1;;;ENSG00000229153;;;rs7810606-?;rs7810606;0;7810606;intron_variant;0;NR;1,00E-11;110;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143406388;NR;EPHA1;;;ENSG00000146904;;;rs56402156-?;rs56402156;0;56402156;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143407238;NR;EPHA1;;;ENSG00000146904;;;rs3935067-?;rs3935067;0;3935067;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143418968;NR;EPHA1-AS1;;;ENSG00000229153;;;rs62472729-?;rs62472729;0;62472729;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143413669;NR;EPHA1-AS1;;;ENSG00000229153;;;rs11771145-?;rs11771145;0;11771145;intron_variant;0;NR;4,00E-11;1,04E+16;;10548515;[1.04-1.07];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143427203;NR;EPHA1-AS1;;;ENSG00000229153;;;rs7805776-?;rs7805776;0;7805776;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7q35;7;143435090;NR;EPHA1-AS1;;;ENSG00000229153;;;rs9640386-?;rs9640386;0;9640386;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.2;8;27337604;NR;PTK2B;;;ENSG00000120899;;;rs28834970-?;rs28834970;0;28834970;intron_variant;0;NR;6,00E-16;1,52E+16;;10666256;[1.05003132808944-1.08348207689744];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.2;8;27354759;NR;PTK2B;;;ENSG00000120899;;;rs10109834-?;rs10109834;0;10109834;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.2;8;27472579;NR;CHRNA2;;;ENSG00000120903;;;rs2741342-?;rs2741342;0;2741342;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.2;8;27462330;NR;CHRNA2;;;ENSG00000120903;;;rs79145239-?;rs79145239;0;79145239;intron_variant;0;NR;1,00E-10;100;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.1;8;27541103;NR;EPHX2;;;ENSG00000120915;;;rs2269461-?;rs2269461;0;2269461;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.1;8;27607412;NR;CLU;;;ENSG00000120885;;;rs4236673-?;rs4236673;0;4236673;intron_variant;0;NR;4,00E-25;2,44E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.1;8;27584004;NR;GULOP;;;ENSG00000234770;;;rs4732728-?;rs4732728;0;4732728;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.1;8;27606101;NR;CLU;;;ENSG00000120885;;;rs9331908-?;rs9331908;0;9331908;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.1;8;27629399;NR;CLU - SCARA3;ENSG00000120885;ENSG00000168077;;14368;4469;rs576748-?;rs576748;0;576748;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;8p21.1;8;27632442;NR;CLU - SCARA3;ENSG00000120885;ENSG00000168077;;17411;1426;rs485902-?;rs485902;0;485902;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;10p14;10;11678309;NR;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66082;1366;rs7920721-?;rs7920721;0;7920721;TF_binding_site_variant;1;NR;1,00E-10;100;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11p11.2;11;47427521;NR;PSMC3 - RAPSN;ENSG00000165916;ENSG00000165917;;1048;10236;rs12292911-?;rs12292911;0;12292911;regulatory_region_variant;1;NR;0,00000004;7,40E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11p11.2;11;47358789;NR;SPI1;;;ENSG00000066336;;;rs3740688-?;rs3740688;0;3740688;missense_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q12.2;11;60161199;NR;AP001257.1 - MS4A6A;ENSG00000254952;ENSG00000110077;;377;10815;rs11605427-?;rs11605427;0;11605427;regulatory_region_variant;1;NR;8,00E-17;1,61E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q12.1;11;60076769;NR;MS4A3 - AP000790.2;ENSG00000149516;ENSG00000255331;;5641;581;rs501945-?;rs501945;0;501945;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q12.2;11;60101646;NR;MS4A2 - AP001257.1;ENSG00000149534;ENSG00000254952;;3180;58041;rs580064-?;rs580064;0;580064;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q12.2;11;60313801;NR;MS4A4A;;;ENSG00000110079;;;rs7108879-?;rs7108879;0;7108879;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86152038;NR;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;82156;1189;rs56157503-?;rs56157503;0;56157503;intergenic_variant;1;NR;0,000000008;8,10E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86128893;NR;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;59011;24334;rs7114401-?;rs7114401;0;7114401;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86156833;NR;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;3499;35954;rs10792832-?;rs10792832;0;10792832;regulatory_region_variant;1;NR;6,00E-33;3,22E+16;;11004289;[1.08330873363297- 1.1178195976052];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86004693;NR;PICALM;;;ENSG00000073921;;;rs527162-?;rs527162;0;527162;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86101743;NR;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;31861;51484;rs17745409-?;rs17745409;0;17745409;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86160142;NR;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;6808;32645;rs7129687-?;rs7129687;0;7129687;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q14.2;11;86160172;NR;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;6838;32615;rs61904266-?;rs61904266;0;61904266;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11q24.1;11;121564878;NR;SORL1;;;ENSG00000137642;;;rs11218343-?;rs11218343;0;11218343;intron_variant;0;NR;0,000000001;90;;10624738;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;14q22.1;14;52924962;NR;AL139317.5, FERMT2;;;ENSG00000285664, ENSG00000073712;;;rs17125924-?;rs17125924;0;17125924;intron_variant;0;NR;0,000000006;8,22E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;14q32.12;14;92470346;NR;SLC24A4;;;ENSG00000140090;;;rs8008388-?;rs8008388;0;8008388;intron_variant;0;NR;6,00E-11;1,02E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;15q21.3;15;58753575;NR;ADAM10 - AC090515.3;ENSG00000137845;ENSG00000259173;;3597;2050;rs593742-?;rs593742;0;593742;intergenic_variant;1;NR;6,00E-11;1,02E+16;;106;[1.04- 1.07];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;16p11.2;16;31111250;NR;BCKDK;;;ENSG00000103507;;;rs889555-?;rs889555;0;889555;intron_variant;0;NR;0,00000003;7,52E+15;;10526316;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;17p13.2;17;5110917;NR;ZNF232;;;ENSG00000167840;;;rs73976310-?;rs73976310;0;73976310;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;17q23.3;17;63468418;NR;AC005828.5 - PPIAP55;ENSG00000265971;ENSG00000228979;;12601;3186;rs6504163-?;rs6504163;0;6504163;intergenic_variant;1;NR;0,000000005;8,30E+15;;105;[1.03- 1.07];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19p13.3;19;1043639;NR;ABCA7;;;ENSG00000064687;;;rs3752231-?;rs3752231;0;3752231;intron_variant;0;NR;6,00E-11;1,02E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19p13.3;19;1039445;NR;CNN2 - ABCA7;ENSG00000064666;ENSG00000064687;;377;656;rs3795065-?;rs3795065;0;3795065;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44516798;NR;CEACAM20;;;ENSG00000273777;;;rs80257887-?;rs80257887;0;80257887;intron_variant;0;NR;3,00E-10;9,52E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44673285;NR;AC243964.2, CEACAM19;;;ENSG00000266903, ENSG00000186567;;;rs142034848-?;rs142034848;0;142034848;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44549809;NR;CEACAM22P;;;ENSG00000230666;;;rs73046410-?;rs73046410;0;73046410;intron_variant;0;NR;2,00E-10;9,70E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44854769;NR;NECTIN2;;;ENSG00000130202;;;rs143459034-?;rs143459034;0;143459034;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44646342;NR;AC243964.2, PVR;;;ENSG00000266903, ENSG00000073008;;;rs56261258-?;rs56261258;0;56261258;intron_variant;0;NR;1,00E-21;210;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44544863;NR;CEACAM22P;;;ENSG00000230666;;;rs75161053-?;rs75161053;0;75161053;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44685157;NR;AC243964.2;;;ENSG00000266903;;;rs2965156-?;rs2965156;0;2965156;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44696254;NR;AC243964.2;;;ENSG00000266903;;;rs73035597-?;rs73035597;0;73035597;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44750911;NR;BCL3;;;ENSG00000069399;;;rs8103315-?;rs8103315;0;8103315;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44658298;NR;AC243964.2, PVR;;;ENSG00000266903, ENSG00000073008;;;rs203709-?;rs203709;0;203709;intron_variant;0;NR;7,00E-17;1,62E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44697256;NR;AC243964.2;;;ENSG00000266903;;;rs2965163-?;rs2965163;0;2965163;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.31;19;44698757;NR;AC243964.2;;;ENSG00000266903;;;rs12150984-?;rs12150984;0;12150984;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44717621;NR;AC243964.2;;;ENSG00000266903;;;rs11881756-?;rs11881756;0;11881756;intron_variant;0;NR;1,00E-14;140;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44750234;NR;BCL3;;;ENSG00000069399;;;rs10401176-?;rs10401176;0;10401176;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44752009;NR;BCL3;;;ENSG00000069399;;;rs62117205-?;rs62117205;0;62117205;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44738381;NR;RF00285 - BCL3;ENSG00000264452;ENSG00000069399;;12323;9324;rs2927437-?;rs2927437;0;2927437;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44746404;NR;RF00285 - BCL3;ENSG00000264452;ENSG00000069399;;20346;1301;rs12459810-?;rs12459810;0;12459810;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44724478;NR;AC243964.2 - RF00285;ENSG00000266903;ENSG00000264452;;5719;1506;rs7254776-?;rs7254776;0;7254776;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44750325;NR;BCL3;;;ENSG00000069399;;;rs8100197-?;rs8100197;0;8100197;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44799694;NR;CBLC;;;ENSG00000142273;;;rs2967668-?;rs2967668;0;2967668;intron_variant;0;NR;4,00E-18;1,74E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44828429;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;7008;17746;rs112262807-?;rs112262807;0;112262807;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44839558;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;18137;6617;rs1466435-?;rs1466435;0;1466435;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44807827;NR;AC092306.1 - BCAM;ENSG00000285128;ENSG00000187244;;3817;1232;rs140824606-?;rs140824606;0;140824606;regulatory_region_variant;1;NR;4,00E-26;2,54E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44730236;NR;RF00285 - BCL3;ENSG00000264452;ENSG00000069399;;4178;17469;rs186110295-?;rs186110295;0;186110295;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44819487;NR;BCAM;;;ENSG00000187244;;;rs1135062-?;rs1135062;0;1135062;missense_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44824052;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;2631;22123;rs10412413-?;rs10412413;0;10412413;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44849230;NR;NECTIN2;;;ENSG00000130202;;;rs12974942-?;rs12974942;0;12974942;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44826181;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;4760;19994;rs78986976-?;rs78986976;0;78986976;intergenic_variant;1;NR;0,000000005;8,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44845920;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;24499;255;rs77241309-?;rs77241309;0;77241309;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44860443;NR;NECTIN2;;;ENSG00000130202;;;rs12978931-?;rs12978931;0;12978931;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44849547;NR;NECTIN2;;;ENSG00000130202;;;rs4802240-?;rs4802240;0;4802240;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44885967;NR;AC011481.2, NECTIN2;;;ENSG00000267282, ENSG00000130202;;;rs283814-?;rs283814;0;283814;synonymous_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44897490;NR;TOMM40;;;ENSG00000130204;;;rs61679753-?;rs61679753;0;61679753;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44843409;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;21988;2766;rs148601586-?;rs148601586;0;148601586;intergenic_variant;1;NR;2,00E-43;4,27E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45019803;NR;RELB;;;ENSG00000104856;;;rs112380717-?;rs112380717;0;112380717;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44854682;NR;NECTIN2;;;ENSG00000130202;;;rs2927468-?;rs2927468;0;2927468;intron_variant;0;NR;4,00E-108;1,07E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44830577;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;9156;15598;rs4803760-?;rs4803760;0;4803760;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44844304;NR;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;22883;1871;rs11668738-?;rs11668738;0;11668738;regulatory_region_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44852884;NR;NECTIN2;;;ENSG00000130202;;;rs2972558-?;rs2972558;0;2972558;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44876489;NR;NECTIN2;;;ENSG00000130202;;;rs73050293-?;rs73050293;0;73050293;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44857231;NR;NECTIN2;;;ENSG00000130202;;;rs375972689-?;rs375972689;0;375972689;intron_variant;0;NR;1,00E-32;320;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44857505;NR;NECTIN2;;;ENSG00000130202;;;rs8112526-?;rs8112526;0;8112526;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44879460;NR;NECTIN2;;;ENSG00000130202;;;rs406456-?;rs406456;0;406456;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44899461;NR;TOMM40;;;ENSG00000130204;;;rs35568738-?;rs35568738;0;35568738;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44892009;NR;TOMM40;;;ENSG00000130204;;;rs157580-?;rs157580;0;157580;intron_variant;0;NR;2,00E-208;2,08E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44879727;NR;NECTIN2;;;ENSG00000130202;;;rs11669338-?;rs11669338;0;11669338;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44900601;NR;TOMM40;;;ENSG00000130204;;;rs760136-?;rs760136;0;760136;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44901434;NR;TOMM40;;;ENSG00000130204;;;rs405697-?;rs405697;0;405697;3_prime_UTR_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44922203;NR;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;2854;4601;rs157595-?;rs157595;0;157595;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44928401;NR;APOC1P1;;;ENSG00000214855;;;rs8106813-?;rs8106813;0;8106813;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44902242;NR;TOMM40;;;ENSG00000130204;;;rs141864196-?;rs141864196;0;141864196;3_prime_UTR_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44878035;NR;NECTIN2;;;ENSG00000130202;;;rs150639620-?;rs150639620;0;150639620;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44879418;NR;NECTIN2;;;ENSG00000130202;;;rs41290120-?;rs41290120;0;41290120;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44912028;NR;AC011481.3;;;ENSG00000280087;;;rs138235833-?;rs138235833;0;138235833;non_coding_transcript_exon_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44884984;NR;NECTIN2, AC011481.2;;;ENSG00000130202, ENSG00000267282;;;rs283810-?;rs283810;0;283810;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44905371;NR;TOMM40 - APOE;ENSG00000130204;ENSG00000130203;;1682;383;rs769446-?;rs769446;0;769446;TF_binding_site_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44943964;NR;APOC4-APOC2, APOC4;;;ENSG00000224916, ENSG00000267467;;;rs12721109-?;rs12721109;0;12721109;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44909698;NR;AC011481.3;;;ENSG00000280087;;;rs1081105-?;rs1081105;0;1081105;non_coding_transcript_exon_variant;0;NR;1,00E-162;1620;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44935297;NR;APOC1P1 - APOC4;ENSG00000214855;ENSG00000267467;;3911;6941;rs7254133-?;rs7254133;0;7254133;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44926451;NR;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;7102;353;rs60049679-?;rs60049679;0;60049679;regulatory_region_variant;1;NR;2,00E-70;6,97E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44935386;NR;APOC1P1 - APOC4;ENSG00000214855;ENSG00000267467;;4000;6852;rs4263041-?;rs4263041;0;4263041;intergenic_variant;1;NR;5,00E-10;9,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;44997454;NR;CLPTM1 - RELB;ENSG00000104853;ENSG00000104856;;4113;3976;rs2376866-?;rs2376866;0;2376866;intergenic_variant;1;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45012792;NR;RELB;;;ENSG00000104856;;;rs35194383-?;rs35194383;0;35194383;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45020325;NR;RELB;;;ENSG00000104856;;;rs4803791-?;rs4803791;0;4803791;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45001269;NR;CLPTM1 - RELB;ENSG00000104853;ENSG00000104856;;7928;161;rs117612135-?;rs117612135;0;117612135;regulatory_region_variant;1;NR;9,00E-31;3,00E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45040497;NR;CLASRP;;;ENSG00000104859;;;rs76856627-?;rs76856627;0;76856627;non_coding_transcript_exon_variant;0;NR;9,00E-11;1,00E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45087826;NR;GEMIN7, MARK4, GEMIN7-AS1;;;ENSG00000142252, ENSG00000007047, ENSG00000267348;;;rs78620885-?;rs78620885;0;78620885;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45045877;NR;CLASRP;;;ENSG00000104859;;;rs112481437-?;rs112481437;0;112481437;intron_variant;0;NR;6,00E-15;1,42E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45079144;NR;GEMIN7-AS1;;;ENSG00000267348;;;rs7251911-?;rs7251911;0;7251911;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45125846;NR;PPP1R37, MARK4;;;ENSG00000104866, ENSG00000007047;;;rs145903417-?;rs145903417;0;145903417;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45193381;NR;AC005779.2, MARK4, AC005779.1;;;ENSG00000267545, ENSG00000007047, ENSG00000266958;;;rs149495476-?;rs149495476;0;149495476;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45098343;NR;PPP1R37, MARK4;;;ENSG00000104866, ENSG00000007047;;;rs138137383-?;rs138137383;0;138137383;intron_variant;0;NR;2,00E-15;1,47E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45102050;NR;MARK4, PPP1R37;;;ENSG00000007047, ENSG00000104866;;;rs12461065-?;rs12461065;0;12461065;intron_variant;0;NR;1,00E-17;170;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45081434;NR;MARK4, GEMIN7-AS1, GEMIN7;;;ENSG00000007047, ENSG00000267348, ENSG00000142252;;;rs8100183-?;rs8100183;0;8100183;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45128558;NR;MARK4, PPP1R37;;;ENSG00000007047, ENSG00000104866;;;rs17643262-?;rs17643262;0;17643262;intron_variant;0;NR;2,00E-30;2,97E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45131424;NR;MARK4, PPP1R37;;;ENSG00000007047, ENSG00000104866;;;rs10408847-?;rs10408847;0;10408847;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45187692;NR;MARK4, AC005779.1, AC005779.2;;;ENSG00000007047, ENSG00000266958, ENSG00000267545;;;rs12463049-?;rs12463049;0;12463049;3_prime_UTR_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45188312;NR;MARK4, AC005779.1, AC005779.2;;;ENSG00000007047, ENSG00000266958, ENSG00000267545;;;rs111243475-?;rs111243475;0;111243475;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45205150;NR;AC005779.1, MARK4;;;ENSG00000266958, ENSG00000007047;;;rs595290-?;rs595290;0;595290;intron_variant;0;NR;7,00E-21;2,02E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45203694;NR;AC005779.1, MARK4;;;ENSG00000266958, ENSG00000007047;;;rs620807-?;rs620807;0;620807;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45222481;NR;EXOC3L2, MARK4;;;ENSG00000283632, ENSG00000007047;;;rs346758-?;rs346758;0;346758;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45226017;NR;EXOC3L2, MARK4;;;ENSG00000283632, ENSG00000007047;;;rs346763-?;rs346763;0;346763;intron_variant;0;NR;1,00E-12;120;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45220448;NR;MARK4, EXOC3L2;;;ENSG00000007047, ENSG00000283632;;;rs12461144-?;rs12461144;0;12461144;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45231493;NR;EXOC3L2, MARK4;;;ENSG00000283632, ENSG00000007047;;;rs62118504-?;rs62118504;0;62118504;intron_variant;0;NR;5,00E-14;1,33E+16;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;19q13.32;19;45236417;NR;EXOC3L2, MARK4;;;ENSG00000283632, ENSG00000007047;;;rs11667829-?;rs11667829;0;11667829;intron_variant;0;NR;0,00000005;7,30E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;20q13.31;20;56408019;NR;CSTF1 - CASS4;ENSG00000101138;ENSG00000087589;;1650;4093;rs6069736-?;rs6069736;0;6069736;intergenic_variant;1;NR;0,00000003;7,52E+15;;;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;6p21.32;6;32610753;NR;HLA-DRB1 - HLA-DQA1;ENSG00000206240;ENSG00000196735;;20905;17426;rs9271192-?;rs9271192;0;9271192;intergenic_variant;1;NR;7,00E-10;9,15E+15;;10530598;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;7p14.1;7;37801932;NR;GPR141, EPDR1;;;ENSG00000187037, ENSG00000086289;;;rs2718058-?;rs2718058;0;2718058;intron_variant;0;NR;0,000002;5,70E+15;;10383158;;Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
20-07-2018;29777097;Marioni RE;18-05-2018;Transl Psychiatry;www.ncbi.nlm.nih.gov/pubmed/29777097;GWAS on family history of Alzheimer's disease.;Alzheimer's disease or family history of Alzheimer's disease;up to 42,034 British ancestry individuals with parental history of Alzheimer's disease, at least 272,244 British ancestry individuals with no parental history of Alzheimer's disease, 25,580 Alzheimer's disease cases, 48,466 controls;NA;11p11.2;11;47536319;NR;CELF1;;;ENSG00000149187;;;rs10838725-?;rs10838725;0;10838725;intron_variant;0;NR;0,000002;5,70E+15;;10392507;[1.02288186365195- 1.05588153898494];Affymetrix [7795605] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST005922;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with memory domain impairment;Up to 1,107 European ancestry cases, 3,447 European ancestry controls;NA;1q42.2;1;230716523;NR;AL512328.1;;;ENSG00000244137;;;rs1977412-C;rs1977412;0;1977412;intron_variant;0;0.14;0,0000006;6,22E+15;;15625;[1.39-1.74];NR [up to 6398204] (imputed);N;Alzheimer's disease, memory impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0001072;GCST007330;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with memory domain impairment;Up to 1,107 European ancestry cases, 3,447 European ancestry controls;NA;16p13.2;16;9158799;NR;RPL21P119 - LINC02177;ENSG00000220793;ENSG00000261617;;1918;196789;rs9937469-T;rs9937469;0;9937469;regulatory_region_variant;1;0.06;0,000002;5,70E+15;;214;[1.83-2.45];NR [up to 6398204] (imputed);N;Alzheimer's disease, memory impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0001072;GCST007330;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with language domain impairment;Up to 510 European ancestry cases, 3,447 European ancestry controls;NA;1q25.2;1;179780639;NR;FAM163A;;;ENSG00000143340;;;rs13374908-A;rs13374908;0;13374908;intron_variant;0;0.24;0,000002;5,70E+15;;159;[1.39-1.79];NR [up to 6398204] (imputed);N;Alzheimer's disease, language impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005425;GCST007334;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with language domain impairment;Up to 510 European ancestry cases, 3,447 European ancestry controls;NA;2q34;2;211695376;NR;ERBB4;;;ENSG00000178568;;;rs28715896-G;rs28715896;0;28715896;intron_variant;0;0.43;0,000004;5,40E+16;;15873016;[1.39-1.78];NR [up to 6398204] (imputed);N;Alzheimer's disease, language impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005425;GCST007334;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with language domain impairment;Up to 510 European ancestry cases, 3,447 European ancestry controls;NA;3p14.3;3;54550560;NR;CACNA2D3;;;ENSG00000157445;;;rs75337321-T;rs75337321;0;75337321;intron_variant;0;0.06;0,000005;5,30E+15;;221;[1.88-2.54];NR [up to 6398204] (imputed);N;Alzheimer's disease, language impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005425;GCST007334;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with language domain impairment;Up to 510 European ancestry cases, 3,447 European ancestry controls;NA;4p16.1;4;6759326;NR;BLOC1S4 - KIAA0232;ENSG00000186222;ENSG00000170871;;41655;22049;rs10222981-T;rs10222981;0;10222981;intergenic_variant;1;0.08;0,000001;60;;206;[1.77-2.35];NR [up to 6398204] (imputed);N;Alzheimer's disease, language impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005425;GCST007334;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with language domain impairment;Up to 510 European ancestry cases, 3,447 European ancestry controls;NA;10p15.3;10;2717604;NR;AL713851.1 - AC026396.1;ENSG00000235281;ENSG00000231743;;150365;218417;rs61835453-C;rs61835453;0;61835453;intergenic_variant;1;0.06;0,0000008;6,10E+15;;2173913;[1.86-2.49];NR [up to 6398204] (imputed);N;Alzheimer's disease, language impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005425;GCST007334;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with language domain impairment;Up to 510 European ancestry cases, 3,447 European ancestry controls;NA;17q23.2;17;62944934;NR;AC005972.3;;;ENSG00000283538;;;rs365521-G;rs365521;0;365521;intron_variant;0;0.53;0,000001;60;;15873016;[1.39-1.78];NR [up to 6398204] (imputed);N;Alzheimer's disease, language impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0005425;GCST007334;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;1p31.1;1;83475611;NR;LINC01712 - LINC01725;ENSG00000231364;ENSG00000233008;;12924;100165;rs2795228-T;rs2795228;0;2795228;intergenic_variant;1;0.18;0,0000006;6,22E+15;;16949153;[1.48-1.91];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;1q42.13;1;229029741;NR;AL137793.2;;;ENSG00000282111;;;rs484947-C;rs484947;0;484947;intron_variant;0;0.38;0,000002;5,70E+15;;15625;[1.37-1.76];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;2q24.1;2;155547356;NR;RNU6-546P - LINC01876;ENSG00000206718;ENSG00000226383;;216829;464174;rs16839220-G;rs16839220;0;16839220;intergenic_variant;1;0.8;0,000005;5,30E+15;;18867927;[1.61-2.16];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;3q12.2;3;100346058;NR;NIT2;;;ENSG00000114021;;;rs2289506-T;rs2289506;0;2289506;non_coding_transcript_exon_variant;0;0.34;0,0000003;6,52E+15;;161;[1.43-1.79];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;6p21.1;6;44340892;NR;AL353588.1;;;ENSG00000272442;;;rs9369477-C;rs9369477;0;9369477;intron_variant;0;0.08;0,0000002;6,70E+15;;20408163;[1.77-2.32];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;6q21;6;105869321;NR;AL591518.1;;;ENSG00000284999;;;rs9372110-A;rs9372110;0;9372110;intron_variant;0;0.06;0,0000002;6,70E+15;;216;[1.87-2.45];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;8p23.2;8;3762230;NR;CSMD1;;;ENSG00000183117;;;rs2046197-C;rs2046197;0;2046197;intron_variant;0;0.59;0,0000003;6,52E+15;;166;[1.46-1.86];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;14q21.2;14;43701423;NR;AL358913.2 - LINC02307;ENSG00000258894;ENSG00000258969;;104740;294358;rs8021600-G;rs8021600;0;8021600;intergenic_variant;1;0.08;0,000003;5,52E+15;;19607843;[1.69-2.24];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
17-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with visuospatial domain impairment;Up to 497 European ancestry cases, 3,447 European ancestry controls;NA;18q12.3;18;45640366;NR;SLC14A2;;;ENSG00000132874;;;rs8091629-G;rs8091629;0;8091629;intron_variant;0;0.1;0,000002;5,70E+15;;18518518;[1.60-2.11];NR [up to 6398204] (imputed);N;Alzheimer's disease, visuospatial impairment;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009752;GCST007318;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;2q31.1;2;174042477;NR;LINC01960 - RPSAP24;ENSG00000260868;ENSG00000235414;;15314;531;rs4972634-T;rs4972634;0;4972634;intergenic_variant;1;0.59;0,000004;5,40E+16;;131;[1.19-1.43];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;3q25.1;3;151401938;NR;MED12L;;;ENSG00000144893;;;rs11708767-A;rs11708767;0;11708767;intron_variant;0;0.43;0,0000003;6,52E+15;;133;[1.21-1.45];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;6p12.3;6;51233850;NR;FTH1P5 - AL158050.2;ENSG00000230204;ENSG00000270306;;320594;151432;rs4533991-T;rs4533991;0;4533991;intergenic_variant;1;0.46;0,000002;5,70E+15;;132;[1.2-1.44];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;6q14.3;6;86795185;NR;AL353133.2 - AL157777.1;ENSG00000219190;ENSG00000217769;;26253;101933;rs78358979-A;rs78358979;0;78358979;intergenic_variant;1;0.06;0,0000005;6,30E+15;;176;[1.54-1.98];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;7q22.3;7;106078297;NR;AC004836.1 - SYPL1;ENSG00000280439;ENSG00000008282;;41866;12206;rs6978679-A;rs6978679;0;6978679;intergenic_variant;1;0.73;0,000002;5,70E+15;;136;[1.24-1.48];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;17p13.1;17;7228873;NR;DVL2;;;ENSG00000004975;;;rs72839770-T;rs72839770;0;72839770;non_coding_transcript_exon_variant;0;0.36;0,000004;5,40E+16;;131;[1.19-1.43];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with no specific cognitive domain impairment;Up to 1,584 European ancestry cases, 3,447 European ancestry controls;NA;20p11.23;20;17974063;NR;MGME1, OVOL2;;;ENSG00000125871, ENSG00000125850;;;rs7264688-T;rs7264688;0;7264688;intron_variant;0;0.67;0,000005;5,30E+15;;147;[1.31-1.63];NR [up to 6398204] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007333;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;2p16.3;2;50662958;NR;NRXN1;;;ENSG00000179915;;;rs698842-A;rs698842;0;698842;intron_variant;0;0.22;0,000002;5,70E+15;;196;[1.69-2.23];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;2p16.1;2;59202672;NR;AC007092.1;;;ENSG00000285673;;;rs10175975-T;rs10175975;0;10175975;intron_variant;0;0.19;0,000003;5,52E+15;;199;[1.7-2.28];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;7p21.1;7;18976853;NR;HDAC9;;;ENSG00000048052;;;rs78872508-C;rs78872508;0;78872508;intron_variant;0;0.13;0,000002;5,70E+15;;22222223;[1.89-2.56];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;8p21.3;8;22166649;NR;BMP1;;;ENSG00000168487;;;rs4348488-C;rs4348488;0;4348488;intron_variant;0;0.21;0,000003;5,52E+15;;197;[1.68-2.26];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;8p21.2;8;23714294;NR;AC012574.1;;;ENSG00000253471;;;rs17089546-A;rs17089546;0;17089546;intron_variant;0;0.25;0,000003;5,52E+15;;186;[1.61-2.11];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;8q21.13;8;75384073;NR;PKMP4 - HNF4G;ENSG00000254023;ENSG00000164749;;7059;23841;rs74717330-A;rs74717330;0;74717330;intergenic_variant;1;0.05;0,000002;5,70E+15;;309;[2.62-3.56];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;9q21.31;9;80763069;NR;MTND2P9 - RPS19P6;ENSG00000225901;ENSG00000234637;;197107;19269;rs191325450-G;rs191325450;0;191325450;intergenic_variant;1;0.09;0,000002;5,70E+15;;23255813;[1.97-2.68];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;11q14.3;11;92934492;NR;AP003171.2 - SNRPGP16;ENSG00000255127;ENSG00000255287;;3170;2949;rs4543939-A;rs4543939;0;4543939;intergenic_variant;1;0.43;0,000004;5,40E+16;;243;[2.06-2.8];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
18-03-2019;30514930;Mukherjee S;04-12-2018;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/30514930;Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.;Alzheimer's disease with multiple cognitive domain impairments;Up to 248 European ancestry cases, 3,447 European ancestry controls;NA;16q24.1;16;86323639;NR;LINC01081 - LINC00917;ENSG00000268754;ENSG00000168367;;22336;8205;rs8059356-A;rs8059356;0;8059356;regulatory_region_variant;1;0.21;0,0000006;6,22E+15;;223;[1.92-2.54];NR [up to 6398204] (imputed);N;cognitive impairment, Alzheimer's disease;http://purl.obolibrary.org/obo/HP_0100543, http://www.ebi.ac.uk/efo/EFO_0000249;GCST007332;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;19q13.32;19;44892009;TOMM40;TOMM40;;;ENSG00000130204;;;rs157580-?;rs157580;0;157580;intron_variant;0;NR;0,000001;60;(AB1-42);;;Illumina [322557];N;Alzheimer's disease, beta-amyloid 1-42 measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004670;GCST000900;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;19q13.32;19;44908684;APOE;APOE;;;ENSG00000130203;;;rs429358-?;rs429358;0;429358;missense_variant;0;NR;0,000001;60;(AB1-42, p-tau181p, p-tau181p/AB1-42, t-tau/AB1-42);;;Illumina [322557];N;Alzheimer's disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004763, http://www.ebi.ac.uk/efo/EFO_0004670, http://www.ebi.ac.uk/efo/EFO_0004760;GCST000900;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;19q13.32;19;44911194;LOC100129500;AC011481.3;;;ENSG00000280087;;;rs439401-?;rs439401;0;439401;non_coding_transcript_exon_variant;0;NR;0,000001;60;(AB1-42);;;Illumina [322557];N;Alzheimer's disease, beta-amyloid 1-42 measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004670;GCST000900;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;22q13.2;22;41822852;CCDC134;CCDC134;;;ENSG00000100147;;;rs7364180-?;rs7364180;0;7364180;intron_variant;0;NR;0,000001;60;(AB1-42);;;Illumina [322557];N;Alzheimer's disease, beta-amyloid 1-42 measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004670;GCST000900;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;2q23.1;2;148810827;EPC2;EPC2 - RNU2-9P;ENSG00000135999;ENSG00000222126;;23259;14864;rs4499362-?;rs4499362;0;4499362;intergenic_variant;1;NR;0,000001;60;(t-tau/AB1-42);;;Illumina [322557];N;Alzheimer's disease, beta-amyloid 1-42 measurement, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004670, http://www.ebi.ac.uk/efo/EFO_0004760;GCST000900;Genome-wide genotyping array
12-01-2011;21123754;Kim S;01-12-2010;Neurology;www.ncbi.nlm.nih.gov/pubmed/21123754;Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.;Alzheimer's disease biomarkers;96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls;NA;19q13.32;19;44892362;TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;NR;0,000001;60;(p-tau181p/AB1-42, t-tau/AB1-42);;;Illumina [322557];N;Alzheimer's disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004763, http://www.ebi.ac.uk/efo/EFO_0004670, http://www.ebi.ac.uk/efo/EFO_0004760;GCST000900;Genome-wide genotyping array
16-06-2008;17553421;Reiman EM;07-06-2007;Neuron;www.ncbi.nlm.nih.gov/pubmed/17553421;GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.;Alzheimer's disease (late onset);446 cases, 290 controls;415 cases, 260 controls;11q14.1;11;78380104;GAB2;AP003086.2, GAB2;;;ENSG00000254420, ENSG00000033327;;;rs2373115-G;rs2373115;0;2373115;intron_variant;0;0.70;1,00E-10;100;;406;[2.81-14.69];Affymetrix [312316];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000046;Genome-wide genotyping array
04-04-2011;21379329;Wijsman EM;17-02-2011;PLoS Genet;www.ncbi.nlm.nih.gov/pubmed/21379329;Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.;Alzheimer's disease (late onset);1,848 European ancestry affected individuals, 1,991 European ancestry unaffected individuals;231 Caribbean Hispanic cases, 187 Caribbean Hispanic controls, 386 European ancestry cases, 386 European ancestry controls;10p14;10;10958376;CUGBP2;CELF2;;;ENSG00000048740;;;rs62209-C;rs62209;0;62209;intron_variant;0;NR;0,0000002;6,70E+15;(APOE E4 homozygotes);204;[1.56-2.67];Illumina [565336];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000980;Genome-wide genotyping array
23-06-2011;21627779;Antunez C;31-05-2011;Genome Med;www.ncbi.nlm.nih.gov/pubmed/21627779;The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.;Alzheimer's disease;319 European ancestry cases, 769 European ancestry controls, 2,690 cases, 2,237 controls;4,982 European ancestry cases, 7,961 European ancestry controls, 2,190 cases, 3,374 controls;11q12.2;11;60255614;MS4A;MS4A4A;;;ENSG00000110079;;;rs1562990-?;rs1562990;0;1562990;intron_variant;0;0.58;4,00E-11;1,04E+16;;114;[1.10-1.18];Affymetrix, Illumina [696707] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001087;Genome-wide genotyping array
23-06-2011;21627779;Antunez C;31-05-2011;Genome Med;www.ncbi.nlm.nih.gov/pubmed/21627779;The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.;Alzheimer's disease;319 European ancestry cases, 769 European ancestry controls, 2,690 cases, 2,237 controls;4,982 European ancestry cases, 7,961 European ancestry controls, 2,190 cases, 3,374 controls;19q13.32;19;44892009;APOE;TOMM40;;;ENSG00000130204;;;rs157580-?;rs157580;0;157580;intron_variant;0;NR;8,00E-89;8,81E+15;;169;[NR];Affymetrix, Illumina [696707] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001087;Genome-wide genotyping array
23-06-2011;21627779;Antunez C;31-05-2011;Genome Med;www.ncbi.nlm.nih.gov/pubmed/21627779;The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.;Alzheimer's disease;319 European ancestry cases, 769 European ancestry controls, 2,690 cases, 2,237 controls;4,982 European ancestry cases, 7,961 European ancestry controls, 2,190 cases, 3,374 controls;11q14.2;11;86076782;PICALM;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;6900;76445;rs536841-?;rs536841;0;536841;intergenic_variant;1;NR;0,000000003;8,52E+15;;116;[NR];Affymetrix, Illumina [696707] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001087;Genome-wide genotyping array
23-06-2011;21627779;Antunez C;31-05-2011;Genome Med;www.ncbi.nlm.nih.gov/pubmed/21627779;The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.;Alzheimer's disease;319 European ancestry cases, 769 European ancestry controls, 2,690 cases, 2,237 controls;4,982 European ancestry cases, 7,961 European ancestry controls, 2,190 cases, 3,374 controls;8p21.1;8;27630273;CLU;CLU - SCARA3;ENSG00000120885;ENSG00000168077;;15242;3595;rs569214-?;rs569214;0;569214;intergenic_variant;1;NR;0,00000004;7,40E+16;;114;[NR];Affymetrix, Illumina [696707] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001087;Genome-wide genotyping array
23-06-2011;21627779;Antunez C;31-05-2011;Genome Med;www.ncbi.nlm.nih.gov/pubmed/21627779;The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.;Alzheimer's disease;319 European ancestry cases, 769 European ancestry controls, 2,690 cases, 2,237 controls;4,982 European ancestry cases, 7,961 European ancestry controls, 2,190 cases, 3,374 controls;2q14.3;2;127137039;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;29684;32972;rs744373-?;rs744373;0;744373;intergenic_variant;1;NR;0,000000002;8,70E+15;;118;[NR];Affymetrix, Illumina [696707] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001087;Genome-wide genotyping array
28-04-2016;26049409;Hirano A;05-06-2015;Psychiatr Genet;www.ncbi.nlm.nih.gov/pubmed/26049409;A genome-wide association study of late-onset Alzheimer's disease in a Japanese population.;Alzheimer's disease (late onset);489 Japanese ancestry APOE-ε4 noncarrier cases, 6,463 Japanese ancestry APOE-ε4 noncarrier controls, 323 Japanese ancestry APOE-ε4 carrier cases, 1,484 Japanese ancestry APOE-ε4 carrier controls, 4 Japanese ancestry cases, 45 Japanese ancestry controls;528 Japanese ancestry APOE-ε4 noncarrier cases, 5,824 Japanese ancestry APOE-ε4 noncarrier controls, 480 Japanese ancestry APOE-ε4 carrier cases, 1,364 Japanese ancestry APOE-ε4 carrier controls, 3 Japanese ancestry cases, 24 Japanese ancestry controls;18p11.32;18;1872316;intergenic;AP005057.1 - AP005230.1;ENSG00000264080;ENSG00000263745;;90252;11208;rs1992269-A;rs1992269;0;1992269;intergenic_variant;1;0.076;0,000001;60;;166;[1.35-2.03];Illumina [561143];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002954;Genome-wide genotyping array
28-04-2016;26049409;Hirano A;05-06-2015;Psychiatr Genet;www.ncbi.nlm.nih.gov/pubmed/26049409;A genome-wide association study of late-onset Alzheimer's disease in a Japanese population.;Alzheimer's disease (late onset);489 Japanese ancestry APOE-ε4 noncarrier cases, 6,463 Japanese ancestry APOE-ε4 noncarrier controls, 323 Japanese ancestry APOE-ε4 carrier cases, 1,484 Japanese ancestry APOE-ε4 carrier controls, 4 Japanese ancestry cases, 45 Japanese ancestry controls;528 Japanese ancestry APOE-ε4 noncarrier cases, 5,824 Japanese ancestry APOE-ε4 noncarrier controls, 480 Japanese ancestry APOE-ε4 carrier cases, 1,364 Japanese ancestry APOE-ε4 carrier controls, 3 Japanese ancestry cases, 24 Japanese ancestry controls;7q35;7;146265094;CNTNAP2;CNTNAP2;;;ENSG00000174469;;;rs802571-T;rs802571;0;802571;intron_variant;0;0.916;0,000001;60;(noncarrier);1923077;[1.47-2.50];Illumina [561143];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002954;Genome-wide genotyping array
28-04-2016;26049409;Hirano A;05-06-2015;Psychiatr Genet;www.ncbi.nlm.nih.gov/pubmed/26049409;A genome-wide association study of late-onset Alzheimer's disease in a Japanese population.;Alzheimer's disease (late onset);489 Japanese ancestry APOE-ε4 noncarrier cases, 6,463 Japanese ancestry APOE-ε4 noncarrier controls, 323 Japanese ancestry APOE-ε4 carrier cases, 1,484 Japanese ancestry APOE-ε4 carrier controls, 4 Japanese ancestry cases, 45 Japanese ancestry controls;528 Japanese ancestry APOE-ε4 noncarrier cases, 5,824 Japanese ancestry APOE-ε4 noncarrier controls, 480 Japanese ancestry APOE-ε4 carrier cases, 1,364 Japanese ancestry APOE-ε4 carrier controls, 3 Japanese ancestry cases, 24 Japanese ancestry controls;12q24.23;12;118455443;intergenic;AC026367.2 - LINC02460;ENSG00000275409;ENSG00000255714;;24744;189872;rs11613092-G;rs11613092;0;11613092;intergenic_variant;1;0.093;0,000007;5,15E+15;(noncarrier);164;[1.32-2.04];Illumina [561143];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002954;Genome-wide genotyping array
12-07-2013;23565137;Miyashita A;02-04-2013;PLoS One;www.ncbi.nlm.nih.gov/pubmed/23565137;SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians.;Alzheimer's disease (late onset);891 Japanese ancestry cases, 844 Japanese ancestry controls;1,224 East Asian ancestry cases, 2,114 East Asian ancestry controls, 11,840 European ancestry cases, 10,931 European ancestry controls;19q13.32;19;44873027;APOE, CEACAM16, BCL3, PVRL2, TOMM40, PPP1R37;NECTIN2;;;ENSG00000130202;;;rs519113-G;rs519113;0;519113;intron_variant;0;0.29;5,00E-39;3,83E+15;(Japanese);209;[1.87-2.34];Affymetrix [5877918] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001947;Genome-wide genotyping array
14-06-2010;20460622;Seshadri S;12-05-2010;JAMA;www.ncbi.nlm.nih.gov/pubmed/20460622;Genome-wide analysis of genetic loci associated with Alzheimer disease.;Alzheimer's disease;973 incident AD cases, 2,033 prevalent AD cases, 22,604  controls of European and Hispanic ancestry;6,505 European ancestry cases, 13,532 European ancestry controls;19q13.32;19;44892362;APOE;TOMM40;;;ENSG00000130204;;;rs2075650-G;rs2075650;0;2075650;intron_variant;0;0.14;1,00E-295;2950;;253;[2.41-2.66];Affymetrix, Illumina [~ 2500000] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000682;Genome-wide genotyping array
28-09-2009;17998437;Li H;12-11-2007;Arch Neurol;www.ncbi.nlm.nih.gov/pubmed/17998437;Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.;Alzheimer's disease;753 European ancestry cases, 736 European ancestry controls;418 European ancestry cases, 249 European ancestry controls;19q13.32;19;44919689;APOE, APOC1;APOC1 - APOC1P1;ENSG00000130208;ENSG00000214855;;340;7115;rs4420638-?;rs4420638;0;4420638;intergenic_variant;1;NR;2,00E-44;4,37E+15;;;;Affymetrix [469438];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000124;Genome-wide genotyping array
29-09-2009;19734903;Lambert JC;06-09-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19734903;Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.;Alzheimer's disease;2,032 European ancestry cases, 5,328 European ancestry controls;3,978 European ancestry cases, 3,297 European ancestry controls;8p21.1;;;CLU;"CLU; CLU; CLU";;;;;;"rs9331888-G; rs2279590-C; rs11136000-C";"rs9331888; rs2279590; rs11136000";0;;"5_prime_UTR_variant; non_coding_transcript_exon_variant; intron_variant";;0.26;6,00E-10;9,22E+15;;122;[1.14-1.29];Illumina [537029];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000480;Genome-wide genotyping array
29-09-2009;19734903;Lambert JC;06-09-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19734903;Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.;Alzheimer's disease;2,032 European ancestry cases, 5,328 European ancestry controls;3,978 European ancestry cases, 3,297 European ancestry controls;1q32.2;;;CR1;"CR1; CR1";;;;;;"rs6656401-A; rs3818361-A";"rs6656401; rs3818361";0;;"intron_variant; intron_variant";;0.18;3,00E-10;9,52E+15;(AA);122;[1.15-1.30];Illumina [537029];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000480;Genome-wide genotyping array
29-09-2009;19734903;Lambert JC;06-09-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19734903;Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.;Alzheimer's disease;2,032 European ancestry cases, 5,328 European ancestry controls;3,978 European ancestry cases, 3,297 European ancestry controls;19q13.32;19;44892362;APOE;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;0.90;2,00E-16;1,57E+16;;;;Illumina [537029];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000480;Genome-wide genotyping array
12-07-2013;23565137;Miyashita A;02-04-2013;PLoS One;www.ncbi.nlm.nih.gov/pubmed/23565137;SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians.;Alzheimer's disease (late onset);891 Japanese ancestry cases, 844 Japanese ancestry controls;1,224 East Asian ancestry cases, 2,114 East Asian ancestry controls, 11,840 European ancestry cases, 10,931 European ancestry controls;11q24.1;11;121564878;SORL1;SORL1;;;ENSG00000137642;;;rs11218343-?;rs11218343;0;11218343;intron_variant;0;0.96;0,000000002;8,70E+15;;123;[1.15-1.33];Affymetrix [5877918] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001947;Genome-wide genotyping array
27-09-2013;23562540;Cruchaga C;04-04-2013;Neuron;www.ncbi.nlm.nih.gov/pubmed/23562540;GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.;Alzheimer's disease biomarkers;591 European ancestry cases, 687 European ancestry controls;;19q13.32;19;44906745;APOE, TOMM40;APOE;;;ENSG00000130203;;;rs769449-A;rs769449;0;769449;non_coding_transcript_exon_variant;0;NR;2,00E-16;1,57E+16;(tau);82;[NR] unit increase;Illumina [5815690] (imputed);N;Alzheimer's disease, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004760;GCST001951;Genome-wide genotyping array
27-09-2013;23562540;Cruchaga C;04-04-2013;Neuron;www.ncbi.nlm.nih.gov/pubmed/23562540;GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.;Alzheimer's disease biomarkers;591 European ancestry cases, 687 European ancestry controls;;19q13.32;19;44906745;APOE, TOMM40;APOE;;;ENSG00000130203;;;rs769449-A;rs769449;0;769449;non_coding_transcript_exon_variant;0;NR;2,00E-18;1,77E+15;(ptau);91;[NR] unit increase;Illumina [5815690] (imputed);N;Alzheimer's disease, p-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004763;GCST001951;Genome-wide genotyping array
27-09-2013;23562540;Cruchaga C;04-04-2013;Neuron;www.ncbi.nlm.nih.gov/pubmed/23562540;GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.;Alzheimer's disease biomarkers;591 European ancestry cases, 687 European ancestry controls;;3q28;3;190951729;UTS2D, SNAR-I, GEMC1, OSTNIL1-RAP, CCDC50;GMNC - OSTN;ENSG00000205835;ENSG00000188729;;59300;247512;rs9877502-A;rs9877502;0;9877502;intergenic_variant;1;NR;0,000000005;8,30E+15;(tau);52;[NR] unit increase;Illumina [5815690] (imputed);N;Alzheimer's disease, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004760;GCST001951;Genome-wide genotyping array
27-09-2013;23562540;Cruchaga C;04-04-2013;Neuron;www.ncbi.nlm.nih.gov/pubmed/23562540;GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.;Alzheimer's disease biomarkers;591 European ancestry cases, 687 European ancestry controls;;9p24.2;9;3929424;GLIS3;GLIS3;;;ENSG00000107249;;;rs514716-G;rs514716;0;514716;intron_variant;0;NR;0,00000001;80;(tau);71;[NR] unit decrease;Illumina [5815690] (imputed);N;Alzheimer's disease, t-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004760;GCST001951;Genome-wide genotyping array
27-09-2013;23562540;Cruchaga C;04-04-2013;Neuron;www.ncbi.nlm.nih.gov/pubmed/23562540;GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.;Alzheimer's disease biomarkers;591 European ancestry cases, 687 European ancestry controls;;9p24.2;9;3929424;GLIS3;GLIS3;;;ENSG00000107249;;;rs514716-G;rs514716;0;514716;intron_variant;0;NR;0,000000003;8,52E+15;(ptau);72;[NR] unit decrease;Illumina [5815690] (imputed);N;Alzheimer's disease, p-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004763;GCST001951;Genome-wide genotyping array
27-09-2013;23562540;Cruchaga C;04-04-2013;Neuron;www.ncbi.nlm.nih.gov/pubmed/23562540;GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.;Alzheimer's disease biomarkers;591 European ancestry cases, 687 European ancestry controls;;6p21.1;6;41368363;TREM, NCR2;NCR2 - AL136967.1;ENSG00000096264;ENSG00000279284;;17476;13029;rs6922617-A;rs6922617;0;6922617;regulatory_region_variant;1;NR;0,00000004;7,40E+16;(ptau);94;[NR] unit decrease;Illumina [5815690] (imputed);N;Alzheimer's disease, p-tau measurement;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0004763;GCST001951;Genome-wide genotyping array
24-08-2013;23571587;Reitz C;10-04-2013;JAMA;www.ncbi.nlm.nih.gov/pubmed/23571587;Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.;Alzheimer's disease (late onset);1,968 African American cases, 3,928 African American controls;;19p13.3;19;1050421;ABCA7, HMHA1, GRIN3B;ABCA7;;;ENSG00000064687;;;rs115550680-G;rs115550680;0;115550680;intron_variant;0;0.07;0,000000002;8,70E+15;;179;[1.47-2.12];Illumina [17332474] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001963;Genome-wide genotyping array
24-08-2013;23571587;Reitz C;10-04-2013;JAMA;www.ncbi.nlm.nih.gov/pubmed/23571587;Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.;Alzheimer's disease (late onset);1,968 African American cases, 3,928 African American controls;;5q35.2;5;174587111;intergenic;SUMO2P6 - AC108112.1;ENSG00000249031;ENSG00000250256;;25048;31053;rs145848414-A;rs145848414;0;145848414;intergenic_variant;1;0.04;0,00000007;7,15E+15;;229;[1.69-3.09];Illumina [17332474] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001963;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;5q31.3;5;140327854;HBEGF, PFDN1;PFDN1 - HBEGF;ENSG00000113068;ENSG00000113070;;24733;4989;rs11168036-T;rs11168036;0;11168036;intergenic_variant;1;0.5;0,000000007;8,15E+15;;108;[1.06-1.10];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;10p14;10;11678309;USP6NL, ECHDC3;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66082;1366;rs7920721-G;rs7920721;0;7920721;TF_binding_site_variant;1;0.4;0,00000003;7,52E+15;;108;[1.06-1.10];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;17q22;17;58331728;BZRAP1, BZRAP1-AS1;AC004687.1, TSPOAP1-AS1;;;ENSG00000265206, ENSG00000265148;;;rs2632516-?;rs2632516;0;2632516;non_coding_transcript_exon_variant;0;0.6;0,00000004;7,40E+16;;10869565;[1.06-1.1];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;19q13.32;19;44885243;NR;AC011481.2, NECTIN2;;;ENSG00000267282, ENSG00000130202;;;rs283811-G;rs283811;0;283811;intron_variant;0;NR;0,000000007;8,15E+15;(AA);134;[1.21-1.47];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;19q13.32;19;44888997;NR;AC011481.2, NECTIN2;;;ENSG00000267282, ENSG00000130202;;;rs6857-T;rs6857;0;6857;3_prime_UTR_variant;0;NR;0,0000006;6,22E+15;(AA);127;[1.15-1.40];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;19q13.32;19;44885243;NR;AC011481.2, NECTIN2;;;ENSG00000267282, ENSG00000130202;;;rs283811-G;rs283811;0;283811;intron_variant;0;NR;1,00E-15;150;(Japanese);256;[2.02-3.24];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;19q13.32;19;44888997;NR;AC011481.2, NECTIN2;;;ENSG00000267282, ENSG00000130202;;;rs6857-T;rs6857;0;6857;3_prime_UTR_variant;0;NR;7,00E-18;1,72E+16;(Japanese);322;[2.45-4.24];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;19q13.32;19;44912921;NR;AC011481.3;;;ENSG00000280087;;;rs483082-T;rs483082;0;483082;non_coding_transcript_exon_variant;0;NR;1,00E-15;150;(Japanese);28;[2.17-3.61];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;5q31.3;5;140327854;NR;PFDN1 - HBEGF;ENSG00000113068;ENSG00000113070;;24733;4989;rs11168036-T;rs11168036;0;11168036;intergenic_variant;1;NR;0,000000007;8,15E+15;;108;[1.06-1.10];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;10p14;10;11679103;NR;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66876;572;rs12358692-T;rs12358692;0;12358692;intergenic_variant;1;NR;0,00000003;7,52E+15;;10869565;[1.04-1.12];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease;13,100 European ancestry cases, 13,220 European ancestry controls, 1,472 African American cases, 3,511 African American controls, 951 Japanese ancestry cases, 894 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;5,813 European ancestry cases, 20,474 European ancestry controls;17q22;17;58331728;NR;AC004687.1, TSPOAP1-AS1;;;ENSG00000265206, ENSG00000265148;;;rs2632516-G;rs2632516;0;2632516;non_coding_transcript_exon_variant;0;NR;0,00000004;7,40E+16;;10869565;[1.06-1.1];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004246;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease (APOE e4 interaction);8,271 European ancestry APOE e4+ cases, 3,480 European ancestry APOE e4+ controls, 4,829 European ancestry APOE e4- cases, 9,740 European ancestry APOE e4- controls, 865 African American APOE e4+ cases, 1,241 African American APOE e4+ control, 607 African American APOE 4e- cases, 2,270 African American APOE 4e- controls, 535 Japanese ancestry APOE 4e+ cases, 151  Japanese ancestry APOE 4+ controls, 416  Japanese ancestry APOE 4- cases, 743 Japanese ancestry APOE 4- controls, 51 Arab-Israeli ancestry APOE e4- cases, 64 Arab-Israeli ancestry e4- controls;3,062 European ancestry APOE e4+ cases, 8,977 European ancestry APOE e4+ controls, 2,751 European ancestry APOE e4- cases, 11,497 European ancestry APOE e4- controls;19p13.3;19;3405594;NFIC;NFIC;;;ENSG00000141905;;;rs9749589-T;rs9749589;0;9749589;intron_variant;0;;0,00000002;7,70E+15;;13157895;[1.2-1.45];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004247;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease in APOE e4- carriers;4,829 European ancestry cases, 9,740 European ancestry controls, 607 African American cases, 2,270 African American controls, 416  Japanese ancestry cases, 743 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;2,751 European ancestry cases, 11,497 European ancestry controls;5q31.3;5;140327854;NR;PFDN1 - HBEGF;ENSG00000113068;ENSG00000113070;;24733;4989;rs11168036-T;rs11168036;0;11168036;intergenic_variant;1;NR;0,000001;60;;111;[1.06-1.15];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004249;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease in APOE e4- carriers;4,829 European ancestry cases, 9,740 European ancestry controls, 607 African American cases, 2,270 African American controls, 416  Japanese ancestry cases, 743 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;2,751 European ancestry cases, 11,497 European ancestry controls;10p14;10;11675398;NR;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;63171;4277;rs11257238-T;rs11257238;0;11257238;intergenic_variant;1;NR;0,000000005;8,30E+15;;114;[1.10-1.18];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004249;Genome-wide genotyping array
27-06-2017;28183528;Jun GR;06-02-2017;Alzheimers Dement;www.ncbi.nlm.nih.gov/pubmed/28183528;Transethnic genome-wide scan identifies novel Alzheimer's disease loci.;Alzheimer's disease in APOE e4- carriers;4,829 European ancestry cases, 9,740 European ancestry controls, 607 African American cases, 2,270 African American controls, 416  Japanese ancestry cases, 743 Japanese ancestry controls, 51 Israeli-Arab ancestry cases, 64 Israeli-Arab ancestry controls;2,751 European ancestry cases, 11,497 European ancestry controls;17q22;17;58331728;NR;AC004687.1, TSPOAP1-AS1;;;ENSG00000265206, ENSG00000265148;;;rs2632516-G;rs2632516;0;2632516;non_coding_transcript_exon_variant;0;NR;0,000004;5,40E+16;;1098901;[1.05-1.14];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST004249;Genome-wide genotyping array
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;19q13.32;19;44848259;APOE;NECTIN2;;;ENSG00000130202;;;rs41289512-G;rs41289512;0;41289512;intron_variant;0;NR;3,00E-194;1,94E+16;;29735075;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;2q14.3;2;127133851;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;26496;36160;rs4663105-C;rs4663105;0;4663105;intergenic_variant;1;NR;4,00E-29;2,84E+16;;1121158;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;17q22;17;58331728;BZRAP1-AS1;AC004687.1, TSPOAP1-AS1;;;ENSG00000265206, ENSG00000265148;;;rs2632516-C;rs2632516;0;2632516;non_coding_transcript_exon_variant;0;NR;0,000000001;90;;60526648;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;20q13.31;20;56423488;CASS4;CASS4;;;ENSG00000087589;;;rs6014724-G;rs6014724;0;6014724;intron_variant;0;NR;0,00000009;7,05E+15;;5351533;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;6p12.3;6;47464901;CD2AP;B3GNTL1P2 - AL355353.1;ENSG00000271328;ENSG00000270761;;95671;12342;rs9381563-C;rs9381563;0;9381563;intergenic_variant;1;NR;0,000000005;8,30E+15;;5835869;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;19q13.41;19;51224706;CD33;SIGLEC22P - CD33;ENSG00000268849;ENSG00000105383;;12618;358;rs3865444-A;rs3865444;0;3865444;intergenic_variant;1;NR;0,00000004;7,40E+16;;54802556;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;8p21.1;8;27607412;CLU, PTK2B;CLU;;;ENSG00000120885;;;rs4236673-A;rs4236673;0;4236673;intron_variant;0;NR;6,00E-20;1,92E+16;;913808;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;10p14;10;11679120;ECHDC3;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66893;555;rs11257242-C;rs11257242;0;11257242;intergenic_variant;1;NR;0,00000002;7,70E+15;;55817;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;7q35;7;143411748;EPHA1;EPHA1-AS1;;;ENSG00000229153;;;rs11763230-T;rs11763230;0;11763230;intron_variant;0;NR;3,00E-11;1,05E+16;;66686625;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;6p21.32;6;32582545;HLA-DRB1;HLA-DRB1, HLA-DRB1;;;ENSG00000206306, ENSG00000206240;;;rs9269853-A;rs9269853;0;9269853;intron_variant;0;NR;0,00000003;7,52E+15;;55623274;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;4p15.33;4;11721611;HS3ST1;AC005699.1;;;ENSG00000249631;;;rs7657553-A;rs7657553;0;7657553;intron_variant;0;NR;0,00000002;7,70E+15;;55982833;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;2q37.1;2;233117202;INPPD5;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs10933431-G;rs10933431;0;10933431;intron_variant;0;NR;0,000002;5,70E+15;;47898254;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;11q12.2;11;60175342;MS4A6A;MS4A6A;;;ENSG00000110077;;;rs7935829-G;rs7935829;0;7935829;intron_variant;0;NR;8,00E-13;1,21E+16;;71575665;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;17p13.2;17;5235685;SCIMP;AC087500.1;;;ENSG00000261879;;;rs113260531-A;rs113260531;0;113260531;intron_variant;0;NR;0,000003;5,52E+15;;46568017;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;14q32.12;14;92472511;SLC24A4;SLC24A4;;;ENSG00000140090;;;rs12590654-A;rs12590654;0;12590654;intron_variant;0;NR;0,00000002;7,70E+15;;5614125;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;18q12.1;18;31508995;SUZ12P1;DSG2;;;ENSG00000046604;;;rs8093731-T;rs8093731;0;8093731;intron_variant;0;NR;0,00000005;7,30E+15;;54649644;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;7q22.1;7;100374211;ZCWPW1;PILRA;;;ENSG00000085514;;;rs1859788-A;rs1859788;0;1859788;missense_variant;0;NR;0,000000006;8,22E+15;;58154516;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;1q32.2;1;207518704;CR1;CR1;;;ENSG00000203710;;;rs6656401-A;rs6656401;0;6656401;intron_variant;0;NR;1,00E-17;170;;854;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;2q14.3;2;127135234;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;27879;34777;rs6733839-T;rs6733839;0;6733839;intergenic_variant;1;NR;1,00E-29;290;;113;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;2q37.1;2;233159830;INPP5D;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs35349669-T;rs35349669;0;35349669;intron_variant;0;NR;0,000008;5,10E+15;;446;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;6p21.32;6;32610753;HLA-DRB5, HLA-DRB1;HLA-DRB1 - HLA-DQA1;ENSG00000206240;ENSG00000196735;;20905;17426;rs9271192-C;rs9271192;0;9271192;intergenic_variant;1;NR;0,0000005;6,30E+15;;502;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;6p12.3;6;47520026;CD2AP;CD2AP;;;ENSG00000198087;;;rs10948363-G;rs10948363;0;10948363;intron_variant;0;NR;0,00000007;7,15E+15;;539;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;7p14.1;7;37801932;NME8;GPR141, EPDR1;;;ENSG00000187037, ENSG00000086289;;;rs2718058-G;rs2718058;0;2718058;intron_variant;0;NR;0,000001;60;;487;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;7q22.1;7;100406823;ZCWPW1;ZCWPW1;;;ENSG00000078487;;;rs1476679-C;rs1476679;0;1476679;intron_variant;0;NR;0,0000002;6,70E+15;;521;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;7q35;7;143413669;EPHA1;EPHA1-AS1;;;ENSG00000229153;;;rs11771145-A;rs11771145;0;11771145;intron_variant;0;NR;0,00000004;7,40E+16;;549;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;8p21.2;8;27337604;PTK2B;PTK2B;;;ENSG00000120899;;;rs28834970-C;rs28834970;0;28834970;intron_variant;0;NR;0,00000007;7,15E+15;;539;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;8p21.1;8;27610169;CLU;CLU;;;ENSG00000120885;;;rs9331896-C;rs9331896;0;9331896;intron_variant;0;NR;1,00E-18;180;;882;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;11q12.2;11;60156035;MS4A6A;MS4A2 - AP001257.1;ENSG00000149534;ENSG00000254952;;57569;3652;rs983392-G;rs983392;0;983392;intergenic_variant;1;NR;5,00E-11;1,03E+16;;656;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;11q14.2;11;86156833;PICALM;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;3499;35954;rs10792832-A;rs10792832;0;10792832;regulatory_region_variant;1;NR;1,00E-17;170;;856;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;11q24.1;11;121564878;SORL1;SORL1;;;ENSG00000137642;;;rs11218343-C;rs11218343;0;11218343;intron_variant;0;NR;6,00E-11;1,02E+16;;655;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;14q32.12;14;92460608;SLC24A4, RIN3;SLC24A4;;;ENSG00000140090;;;rs10498633-T;rs10498633;0;10498633;intron_variant;0;NR;0,0000001;70;;53;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;19p13.3;19;1063444;ABCA7;ABCA7;;;ENSG00000064687;;;rs4147929-A;rs4147929;0;4147929;intron_variant;0;NR;0,000000009;8,05E+15;;576;NR z-score increase;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease (late onset);24,087 European ancestry cases, 55,058 European ancestry controls;NA;20q13.31;20;56443204;CASS4;CASS4;;;ENSG00000087589;;;rs7274581-C;rs7274581;0;7274581;intron_variant;0;NR;0,0000002;6,70E+15;;521;NR z-score decrease;Illumina [up to 9862738] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST007319;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44909698;APOE;AC011481.3;;;ENSG00000280087;;;rs1081105-C;rs1081105;0;1081105;non_coding_transcript_exon_variant;0;0.02756;1,00E-231;2310;;3250298;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44892009;TOMM40;TOMM40;;;ENSG00000130204;;;rs157580-G;rs157580;0;157580;intron_variant;0;0.3949;8,00E-220;2,19E+16;;316502;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44878777;PVRL2;NECTIN2;;;ENSG00000130202;;;rs6859-A;rs6859;0;6859;3_prime_UTR_variant;0;0.4218;1,00E-152;1520;;26320562;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44820881;BCAM;BCAM;;;ENSG00000187244;;;rs28399637-A;rs28399637;0;28399637;intron_variant;0;0.3156;2,00E-143;1,43E+16;;25508192;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44908822;APOE;APOE;;;ENSG00000130203;;;rs7412-T;rs7412;0;7412;missense_variant;0;0.07994;1,00E-99;990;;21199877;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44860563;PVRL2;NECTIN2;;;ENSG00000130202;;;rs138607350-G;rs138607350;0;138607350;intron_variant;0;0.00629;3,00E-65;6,45E+15;;17060017;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44881674;PVRL2;NECTIN2;;;ENSG00000130202;;;rs79701229-A;rs79701229;0;79701229;intron_variant;0;0.01276;1,00E-64;640;;16990263;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44838691;PVRL2;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;17270;7484;rs10407439-A;rs10407439;0;10407439;intergenic_variant;1;0.296;1,00E-58;580;;16138115;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44747899;BCL3;BCL3;;;ENSG00000069399;;;rs2965169-C;rs2965169;0;2965169;non_coding_transcript_exon_variant;0;0.3883;3,00E-57;5,65E+15;;15944032;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44960129;CLPTM1;CLPTM1;;;ENSG00000104853;;;rs116949436-A;rs116949436;0;116949436;intron_variant;0;0.01073;7,00E-50;4,92E+15;;14848961;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44737327;BCL3;RF00285 - BCL3;ENSG00000264452;ENSG00000069399;;11269;10378;rs55923289-C;rs55923289;0;55923289;intergenic_variant;1;0.13;3,00E-44;4,35E+15;;13958599;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45152075;MARK4, NKPD1;MARK4, NKPD1;;;ENSG00000007047, ENSG00000179846;;;rs28469095-C;rs28469095;0;28469095;missense_variant;0;0.09149;2,00E-38;3,77E+15;;12963469;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44842530;PVRL2;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;21109;3645;rs111371860-T;rs111371860;0;111371860;intergenic_variant;1;0.06009;6,00E-35;3,42E+16;;12327317;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44799694;CBLC;CBLC;;;ENSG00000142273;;;rs2967668-G;rs2967668;0;2967668;intron_variant;0;0.1098;7,00E-25;2,42E+16;;103022;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44890954;TOMM40;TOMM40;;;ENSG00000130204;;;rs76692773-T;rs76692773;0;76692773;intron_variant;0;0.07319;9,00E-24;2,30E+16;;1004716;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44986934;CLPTM1;CLPTM1;;;ENSG00000104853;;;rs11672748-G;rs11672748;0;11672748;non_coding_transcript_exon_variant;0;0.3171;1,00E-23;230;;10028075;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45205150;MARK4, AC006126.3;AC005779.1, MARK4;;;ENSG00000266958, ENSG00000007047;;;rs595290-C;rs595290;0;595290;intron_variant;0;0.1582;7,00E-23;2,22E+16;;9847612;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45222190;MARK4, EXOC3L2;MARK4, EXOC3L2;;;ENSG00000007047, ENSG00000283632;;;rs346757-C;rs346757;0;346757;intron_variant;0;0.08386;2,00E-22;2,17E+15;;9756002;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45013623;RELB;RELB;;;ENSG00000104856;;;rs34874378-A;rs34874378;0;34874378;intron_variant;0;0.04366;9,00E-22;2,10E+16;;9593067;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44863241;PVRL2;NECTIN2;;;ENSG00000130202;;;rs183427010-A;rs183427010;0;183427010;intron_variant;0;0.004629;3,00E-21;2,05E+16;;9459884;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44720227;CTB-171A8.1;AC243964.2 - RF00285;ENSG00000266903;ENSG00000264452;;1468;5757;rs111740474-A;rs111740474;0;111740474;intergenic_variant;1;0.01165;5,00E-21;2,03E+15;;9402366;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44900667;TOMM40;TOMM40;;;ENSG00000130204;;;rs1160984-T;rs1160984;0;1160984;intron_variant;0;0.05762;2,00E-20;1,97E+15;;9292308;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44875462;PVRL2;NECTIN2;;;ENSG00000130202;;;rs11665676-T;rs11665676;0;11665676;intron_variant;0;0.05183;1,00E-19;190;;9089448;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44890947;TOMM40;TOMM40;;;ENSG00000130204;;;rs561654715-A;rs561654715;0;561654715;intron_variant;0;0.002832;9,00E-19;1,80E+16;;8842536;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44840322;PVRL2;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;18901;5853;rs55840414-A;rs55840414;0;55840414;intergenic_variant;1;0.1183;5,00E-18;1,73E+15;;8655959;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45045877;CLASRP;CLASRP;;;ENSG00000104859;;;rs112481437-A;rs112481437;0;112481437;intron_variant;0;0.02337;1,00E-17;170;;8578216;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44658298;CTB-171A8.1, PVR;AC243964.2, PVR;;;ENSG00000266903, ENSG00000073008;;;rs203709-A;rs203709;0;203709;intron_variant;0;0.2645;4,00E-17;1,64E+16;;8408471;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44717621;CTB-171A8.1;AC243964.2;;;ENSG00000266903;;;rs11881756-C;rs11881756;0;11881756;intron_variant;0;0.1138;5,00E-17;1,63E+15;;8381871;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45040497;CLASRP;CLASRP;;;ENSG00000104859;;;rs76856627-G;rs76856627;0;76856627;non_coding_transcript_exon_variant;0;0.0329;1,00E-16;160;;8306043;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45077114;CTB-179K24.3;GEMIN7-AS1;;;ENSG00000267348;;;rs60239918-T;rs60239918;0;60239918;intron_variant;0;0.03999;2,00E-15;1,47E+16;;7945099;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44867684;PVRL2;NECTIN2;;;ENSG00000130202;;;rs41290100-T;rs41290100;0;41290100;intron_variant;0;0.02432;2,00E-15;1,47E+16;;79216814;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44576817;CEACAM22P;CEACAM22P;;;ENSG00000230666;;;rs846876-C;rs846876;0;846876;intron_variant;0;0.3755;1,00E-14;140;;7715924;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45049329;CLASRP;CLASRP;;;ENSG00000104859;;;rs147188206-C;rs147188206;0;147188206;intron_variant;0;0.008636;3,00E-14;1,35E+16;;75976734;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44698782;CTB-171A8.1;AC243964.2;;;ENSG00000266903;;;rs2965164-T;rs2965164;0;2965164;intron_variant;0;0.3456;1,00E-13;130;;7438834;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44874585;PVRL2;NECTIN2;;;ENSG00000130202;;;rs41290108-C;rs41290108;0;41290108;non_coding_transcript_exon_variant;0;0.03803;3,00E-13;1,25E+16;;7317556;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44828004;BCAM;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;6583;18171;rs547509922-T;rs547509922;0;547509922;intergenic_variant;1;0.003614;3,00E-13;1,25E+16;;7314314;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45231493;MARK4, EXOC3L2;EXOC3L2, MARK4;;;ENSG00000283632, ENSG00000007047;;;rs62118504-G;rs62118504;0;62118504;intron_variant;0;0.3957;5,00E-13;1,23E+16;;72163415;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45012792;RELB;RELB;;;ENSG00000104856;;;rs35194383-T;rs35194383;0;35194383;intron_variant;0;0.4234;8,00E-13;1,21E+16;;71647267;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44516798;CEACAM20;CEACAM20;;;ENSG00000273777;;;rs80257887-A;rs80257887;0;80257887;intron_variant;0;0.03562;1,00E-12;120;;7089606;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44544863;CEACAM22P;CEACAM22P;;;ENSG00000230666;;;rs75161053-A;rs75161053;0;75161053;intron_variant;0;0.04757;2,00E-12;1,17E+16;;70672655;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44900801;TOMM40;TOMM40;;;ENSG00000130204;;;rs142412517-T;rs142412517;0;142412517;missense_variant;0;0.001157;2,00E-12;1,17E+16;;7033927;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45220448;MARK4, EXOC3L2;MARK4, EXOC3L2;;;ENSG00000007047, ENSG00000283632;;;rs12461144-T;rs12461144;0;12461144;intron_variant;0;0.1266;4,00E-12;1,14E+16;;69530225;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44820087;BCAM;BCAM;;;ENSG00000187244;;;rs142092405-G;rs142092405;0;142092405;3_prime_UTR_variant;0;0.00433;6,00E-12;1,12E+16;;68754373;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44723891;snoZ6;AC243964.2 - RF00285;ENSG00000266903;ENSG00000264452;;5132;2093;rs150820726-T;rs150820726;0;150820726;TF_binding_site_variant;1;0.008836;1,00E-11;110;;680423;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45077818;CTB-179K24.3;GEMIN7-AS1;;;ENSG00000267348;;;rs183321458-A;rs183321458;0;183321458;intron_variant;0;0.003582;2,00E-11;1,07E+16;;67473207;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44634022;IGSF23, CTB-171A8.1;AC243964.2, IGSF23;;;ENSG00000266903, ENSG00000216588;;;rs539159088-C;rs539159088;0;539159088;intron_variant;0;0.01086;2,00E-11;1,07E+16;;6705168;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44960141;CLPTM1;CLPTM1;;;ENSG00000104853;;;rs576651896-G;rs576651896;0;576651896;intron_variant;0;0.004649;2,00E-11;1,07E+16;;66975107;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44730236;snoZ6;RF00285 - BCL3;ENSG00000264452;ENSG00000069399;;4178;17469;rs186110295-T;rs186110295;0;186110295;intergenic_variant;1;0.01273;4,00E-11;1,04E+16;;65884266;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44826181;BCAM;BCAM - NECTIN2;ENSG00000187244;ENSG00000130202;;4760;19994;rs78986976-A;rs78986976;0;78986976;intergenic_variant;1;0.05489;8,00E-11;1,01E+16;;6508301;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44958739;CLPTM1;CLPTM1;;;ENSG00000104853;;;rs204907-G;rs204907;0;204907;intron_variant;0;0.049;9,00E-11;1,00E+16;;6482148;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p21.32;6;32447376;HLA-DRA;HLA-DRA - HLA-DRB9;ENSG00000234794;ENSG00000226035;;2330;12445;rs9469112-T;rs9469112;0;9469112;intergenic_variant;1;0.1734;1,00E-10;100;;64424515;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44902242;TOMM40;TOMM40;;;ENSG00000130204;;;rs141864196-A;rs141864196;0;141864196;3_prime_UTR_variant;0;0.02628;3,00E-10;9,52E+15;;6313068;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44759439;BCL3;BCL3;;;ENSG00000069399;;;rs114036675-A;rs114036675;0;114036675;missense_variant;0;0.002756;3,00E-10;9,52E+15;;62855;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19p13.3;19;1053525;ABCA7;ABCA7;;;ENSG00000064687;;;rs3752241-G;rs3752241;0;3752241;synonymous_variant;0;0.1656;4,00E-10;9,40E+15;;6273173;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.31;19;44621921;IGSF23;IGSF23;;;ENSG00000216588;;;rs11083743-C;rs11083743;0;11083743;intron_variant;0;0.2682;0,000000001;90;;60971603;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;8p21.2;8;27465457;CHRNA2;CHRNA2;;;ENSG00000120903;;;rs34181358-A;rs34181358;0;34181358;intron_variant;0;0.1063;0,000000003;8,52E+15;;59258137;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44973854;CLPTM1;CLPTM1;;;ENSG00000104853;;;rs204480-T;rs204480;0;204480;intron_variant;0;0.2501;0,000000006;8,22E+15;;581275;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45154228;MARK4, NKPD1;MARK4, NKPD1;;;ENSG00000007047, ENSG00000179846;;;rs10421247-C;rs10421247;0;10421247;intron_variant;0;0.4994;0,000000007;8,15E+15;;5801472;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44865063;PVRL2;NECTIN2;;;ENSG00000130202;;;rs419010-C;rs419010;0;419010;intron_variant;0;0.4477;0,000000008;8,10E+15;;5773656;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45089217;CTB-179K24.3, GEMIN7, MARK4;MARK4, GEMIN7, GEMIN7-AS1;;;ENSG00000007047, ENSG00000142252, ENSG00000267348;;;rs9653111-T;rs9653111;0;9653111;intron_variant;0;0.1298;0,00000001;80;;56693845;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44907853;APOE;APOE;;;ENSG00000130203;;;rs769452-C;rs769452;0;769452;missense_variant;0;0.001629;0,00000002;7,70E+15;;55855217;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p21.1;6;41161469;TREM2;TREM2;;;ENSG00000095970;;;rs143332484-T;rs143332484;0;143332484;missense_variant;0;0.009954;0,00000003;7,52E+15;;55406914;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;7q22.1;7;100188127;STAG3;STAG3;;;ENSG00000066923;;;rs4727449-T;rs4727449;0;4727449;intron_variant;0;0.1607;0,00000003;7,52E+15;;55144157;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45327689;CKM;CKM - RPS16P9;ENSG00000104879;ENSG00000242675;;4712;5009;rs123187-A;rs123187;0;123187;intergenic_variant;1;0.3694;0,00000004;7,40E+16;;5504638;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;14q32.12;14;92460608;SLC24A4, RIN3;SLC24A4;;;ENSG00000140090;;;rs10498633-T;rs10498633;0;10498633;intron_variant;0;NR;0,0000002;6,70E+15;;517;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;11q14.2;11;86156833;PICALM;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;3499;35954;rs10792832-A;rs10792832;0;10792832;regulatory_region_variant;1;0.3702;7,00E-18;1,72E+16;;861;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p12.3;6;47520026;CD2AP;CD2AP;;;ENSG00000198087;;;rs10948363-G;rs10948363;0;10948363;intron_variant;0;0.2754;0,00000001;80;;572;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;11q24.1;11;121564878;SORL1;SORL1;;;ENSG00000137642;;;rs11218343-C;rs11218343;0;11218343;intron_variant;0;0.03743;1,00E-11;110;;679;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;7q35;7;143413669;EPHA1;EPHA1-AS1;;;ENSG00000229153;;;rs11771145-A;rs11771145;0;11771145;intron_variant;0;0.3085;0,000001;60;;488;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;7q22.1;7;100406823;ZCWPW1;ZCWPW1;;;ENSG00000078487;;;rs1476679-C;rs1476679;0;1476679;intron_variant;0;0.3085;6,00E-14;1,32E+16;;751;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;8p21.2;8;27337604;PTK2B;PTK2B;;;ENSG00000120899;;;rs28834970-C;rs28834970;0;28834970;intron_variant;0;0.3644;1,00E-11;110;;68;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;2q37.1;2;233159830;INPP5D;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs35349669-T;rs35349669;0;35349669;intron_variant;0;0.4983;0,000000005;8,30E+15;;585;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19p13.3;19;1063444;ABCA7;ABCA7;;;ENSG00000064687;;;rs4147929-A;rs4147929;0;4147929;intron_variant;0;NR;0,0000006;6,22E+15;;501;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;1q32.2;1;207518704;CR1;CR1;;;ENSG00000203710;;;rs6656401-A;rs6656401;0;6656401;intron_variant;0;0.1782;4,00E-18;1,74E+16;;867;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;2q14.3;2;127135234;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;27879;34777;rs6733839-T;rs6733839;0;6733839;intergenic_variant;1;0.3797;1,00E-29;290;;113;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;20q13.31;20;56443204;CASS4;CASS4;;;ENSG00000087589;;;rs7274581-C;rs7274581;0;7274581;intron_variant;0;0.084;0,00000003;7,52E+15;;553;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p21.32;6;32610753;HLA-DRB5, HLA-DRB1;HLA-DRB1 - HLA-DQA1;ENSG00000206240;ENSG00000196735;;20905;17426;rs9271192-C;rs9271192;0;9271192;intergenic_variant;1;0.2751;0,00000004;7,40E+16;;549;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;8p21.1;8;27610169;CLU;CLU;;;ENSG00000120885;;;rs9331896-C;rs9331896;0;9331896;intron_variant;0;0.4107;7,00E-17;1,62E+16;;835;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;11q12.2;11;60156035;MS4A6A;MS4A2 - AP001257.1;ENSG00000149534;ENSG00000254952;;57569;3652;rs983392-G;rs983392;0;983392;intergenic_variant;1;0.4083;2,00E-11;1,07E+16;;671;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;7q35;7;146252937;CNTNAP2;CNTNAP2;;;ENSG00000174469;;;rs114360492-T;rs114360492;0;114360492;intron_variant;0;2.59E-4;0,000000002;8,70E+15;;599;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;3p14.3;3;57192122;HESX1;IL17RD - HESX1;ENSG00000144730;ENSG00000163666;;21816;5716;rs184384746-T;rs184384746;0;184384746;intergenic_variant;1;0.002;0,00000001;80;;569;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p21.1;6;40974457;TREM2;AL583854.1 - UNC5CL;ENSG00000237947;ENSG00000124602;;259094;52454;rs187370608-A;rs187370608;0;187370608;intergenic_variant;1;0.002;1,00E-16;160;;826;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;18q21.31;18;58522227;ALPK2;ALPK2;;;ENSG00000198796;;;rs76726049-C;rs76726049;0;76726049;intron_variant;0;0.014;0,00000003;7,52E+15;;552;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;44848259;APOE;NECTIN2;;;ENSG00000130202;;;rs41289512-G;rs41289512;0;41289512;intron_variant;0;0.039;6,00E-276;2,75E+16;;355;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.32;19;45738583;AC074212.3;BHMG1;;;ENSG00000237452;;;rs76320948-T;rs76320948;0;76320948;intron_variant;0;0.046;0,00000005;7,30E+15;;546;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;20q13.31;20;56423488;CASS4;CASS4;;;ENSG00000087589;;;rs6014724-G;rs6014724;0;6014724;intron_variant;0;0.089;7,00E-10;9,15E+15;;618;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;17p13.2;17;5235685;SCIMP;AC087500.1;;;ENSG00000261879;;;rs113260531-A;rs113260531;0;113260531;intron_variant;0;0.12;9,00E-10;9,05E+15;;612;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;15q22.2;15;63277703;APH1B;APH1B;;;ENSG00000138613;;;rs117618017-T;rs117618017;0;117618017;missense_variant;0;0.132;0,00000003;7,52E+15;;552;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p21.32;6;32615580;HLA-DRB1;HLA-DRB1 - HLA-DQA1;ENSG00000206240;ENSG00000196735;;25732;12599;rs6931277-T;rs6931277;0;6931277;intergenic_variant;1;0.153;8,00E-11;1,01E+16;;649;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19p13.3;19;1039324;ABCA7;CNN2 - ABCA7;ENSG00000064666;ENSG00000064687;;256;777;rs111278892-G;rs111278892;0;111278892;intergenic_variant;1;0.161;8,00E-11;1,01E+16;;65;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;1q32.2;1;207613483;CR1;CR1;;;ENSG00000203710;;;rs2093760-A;rs2093760;0;2093760;intron_variant;0;0.205;1,00E-18;180;;882;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;2q37.1;2;233117202;INPPD5;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs10933431-G;rs10933431;0;10933431;intron_variant;0;0.235;9,00E-10;9,05E+15;;613;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;1q23.3;1;161185602;ADAMTS4;ADAMTS4;;;ENSG00000158859;;;rs4575098-A;rs4575098;0;4575098;3_prime_UTR_variant;0;0.24;2,00E-10;9,70E+15;;636;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;4p16.1;4;11024404;CLNK;LINC02498 - MIR572;ENSG00000283083;ENSG00000207716;;274818;344423;rs6448453-A;rs6448453;0;6448453;intergenic_variant;1;0.252;0,000000002;8,70E+15;;60;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;16p11.2;16;31121779;KAT8;KAT8;;;ENSG00000103510;;;rs59735493-A;rs59735493;0;59735493;intron_variant;0;0.3;0,00000004;7,40E+16;;549;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;7q22.1;7;100374211;ZCWPW1;PILRA;;;ENSG00000085514;;;rs1859788-A;rs1859788;0;1859788;missense_variant;0;0.31;2,00E-15;1,47E+16;;793;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;11q14.2;11;86065502;PICALM;PICALM;;;ENSG00000073921;;;rs867611-G;rs867611;0;867611;intron_variant;0;0.314;2,00E-18;1,77E+15;;875;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;19q13.41;19;51224706;CD33;SIGLEC22P - CD33;ENSG00000268849;ENSG00000105383;;12618;358;rs3865444-A;rs3865444;0;3865444;intergenic_variant;1;0.32;0,000000006;8,22E+15;;581;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;15q21.3;15;58730416;ADAM10;ADAM10;;;ENSG00000137845;;;rs442495-C;rs442495;0;442495;intron_variant;0;0.32;0,000000001;90;;607;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;14q32.12;14;92472511;SLC24A4;SLC24A4;;;ENSG00000140090;;;rs12590654-A;rs12590654;0;12590654;intron_variant;0;0.344;2,00E-10;9,70E+15;;639;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;6p12.3;6;47464901;CD2AP;B3GNTL1P2 - AL355353.1;ENSG00000271328;ENSG00000270761;;95671;12342;rs9381563-C;rs9381563;0;9381563;intergenic_variant;1;0.355;3,00E-10;9,52E+15;;633;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;10p14;10;11675398;ECHDC3;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;63171;4277;rs11257238-C;rs11257238;0;11257238;intergenic_variant;1;0.375;0,00000001;80;;569;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;11q12.2;11;60190907;MS4A6A;MS4A4A;;;ENSG00000110079;;;rs2081545-A;rs2081545;0;2081545;intron_variant;0;0.381;2,00E-15;1,47E+16;;797;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;8p21.1;8;27607412;CLU, PTK2B;CLU;;;ENSG00000120885;;;rs4236673-A;rs4236673;0;4236673;intron_variant;0;0.391;3,00E-19;1,85E+16;;898;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;2q14.3;2;127133851;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;26496;36160;rs4663105-C;rs4663105;0;4663105;intergenic_variant;1;0.415;3,00E-44;4,35E+15;;1394;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;17q22;17;58331728;BZRAP1-AS1;AC004687.1, TSPOAP1-AS1;;;ENSG00000265206, ENSG00000265148;;;rs2632516-C;rs2632516;0;2632516;non_coding_transcript_exon_variant;0;0.455;0,000001;60;;49;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;17q21.33;17;49373413;ABI3;AC091180.5;;;ENSG00000262039;;;rs28394864-A;rs28394864;0;28394864;intron_variant;0;0.473;0,00000002;7,70E+15;;562;NR z-unit increase;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-03-2019;30617256;Jansen IE;07-01-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30617256;Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.;Alzheimer's disease or family history of Alzheimer's disease;24,087 European ancestry late-onset Alzheimer's disease cases, 47,793 European ancestry individuals with family history of Alzheimer's disease, 383,378 European ancestry controls;NA;7q35;7;143411065;EPHA1;EPHA1-AS1;;;ENSG00000229153;;;rs7810606-T;rs7810606;0;7810606;intron_variant;0;0.5;4,00E-11;1,04E+16;;662;NR z-unit decrease;Affymetrix, Illumina [up to 10847151] (imputed);N;Alzheimer's disease, family history of Alzheimer’s disease;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0009268;GCST007320;Genome-wide genotyping array, Exome-wide sequencing
18-04-2012;22430674;Lambert JC;20-03-2012;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/22430674;Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease.;Alzheimer's disease;2,025 European ancestry cases, 5,328 European ancestry controls;7,913 European ancestry cases, 10,417 European ancestry controls;10p13;;;FRMD4A;"FRMD4A; FRMD4A; FRMD4A";;;;;;"rs7081208-A; rs17314229-C; rs2446581-A";"rs7081208; rs17314229; rs2446581";0;;"intron_variant; intron_variant; intron_variant";;0.028;1,00E-10;100;;168;[1.43-1.96];Illumina [287956];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001449;Genome-wide genotyping array
04-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease (APOE e4 interaction);10,352 APOE e4+ cases, 9,207 APOE e4+ controls, 7,184 APOE e4- cases, 26,968 APOE e4- controls;1,250 APOE e4+ European ancestry cases, 536 APOE e4+ European ancestry controls, 718 APOE e4- European ancestry cases, 1,699 APOE e4- European ancestry controls;1q32.2;1;209797265;IRF6;IRF6;;;ENSG00000117595;;;rs59043219-A;rs59043219;0;59043219;intron_variant;0;0.37;0,000009;5,05E+15;;119;[1.10-1.28];NR [NR];N;Alzheimer's disease, APOE carrier status;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0007659;GCST002814;Genome-wide genotyping array
04-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease (APOE e4 interaction);10,352 APOE e4+ cases, 9,207 APOE e4+ controls, 7,184 APOE e4- cases, 26,968 APOE e4- controls;1,250 APOE e4+ European ancestry cases, 536 APOE e4+ European ancestry controls, 718 APOE e4- European ancestry cases, 1,699 APOE e4- European ancestry controls;6p11.2;6;58045670;GAPDHP15, RBBP4P4;AL445250.1;;;ENSG00000225096;;;rs1936246-T;rs1936246;0;1936246;intron_variant;0;0.43;2,00E-13;1,27E+16;;104;[1.03-1.05];NR [NR];N;Alzheimer's disease, APOE carrier status;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0007659;GCST002814;Genome-wide genotyping array
04-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease (APOE e4 interaction);10,352 APOE e4+ cases, 9,207 APOE e4+ controls, 7,184 APOE e4- cases, 26,968 APOE e4- controls;1,250 APOE e4+ European ancestry cases, 536 APOE e4+ European ancestry controls, 718 APOE e4- European ancestry cases, 1,699 APOE e4- European ancestry controls;7p22.1;7;6732029;PMS2CL, ZNF12;PMS2CL;;;ENSG00000187953;;;rs116139393-C;rs116139393;1;7787147;intron_variant;0;0.84;0,00000003;7,52E+15;;1098901;[1.06-1.12];NR [NR];N;Alzheimer's disease, APOE carrier status;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0007659;GCST002814;Genome-wide genotyping array
04-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease (APOE e4 interaction);10,352 APOE e4+ cases, 9,207 APOE e4+ controls, 7,184 APOE e4- cases, 26,968 APOE e4- controls;1,250 APOE e4+ European ancestry cases, 536 APOE e4+ European ancestry controls, 718 APOE e4- European ancestry cases, 1,699 APOE e4- European ancestry controls;7p21.3;7;12148903;THSD7A, TMEM106B;THSD7A - TMEM106B;ENSG00000005108;ENSG00000106460;;316705;62338;rs1595014-T;rs1595014;0;1595014;intergenic_variant;1;0.72;0,000004;5,40E+16;;11904762;[1.11-1.28];NR [NR];N;Alzheimer's disease, APOE carrier status;http://www.ebi.ac.uk/efo/EFO_0000249, http://www.ebi.ac.uk/efo/EFO_0007659;GCST002814;Genome-wide genotyping array
29-09-2009;19734902;Harold D;06-09-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19734902;Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.;Alzheimer's disease;3,941 European ancestry cases, 7,848 European ancestry controls;2,023 European ancestry cases, 2,340 European ancestry controls;8p21.1;8;27607002;CLU;CLU;;;ENSG00000120885;;;rs11136000-?;rs11136000;0;11136000;intron_variant;0;0.60;9,00E-10;9,05E+15;;116;[1.11-1.22];Illumina [529205];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000479;Genome-wide genotyping array
29-09-2009;19734902;Harold D;06-09-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19734902;Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.;Alzheimer's disease;3,941 European ancestry cases, 7,848 European ancestry controls;2,023 European ancestry cases, 2,340 European ancestry controls;11q14.2;11;86157598;PICALM;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;4264;35189;rs3851179-?;rs3851179;0;3851179;regulatory_region_variant;1;0.63;0,000000001;90;;116;[1.11-1.22];Illumina [529205];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000479;Genome-wide genotyping array
29-09-2009;19734902;Harold D;06-09-2009;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/19734902;Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.;Alzheimer's disease;3,941 European ancestry cases, 7,848 European ancestry controls;2,023 European ancestry cases, 2,340 European ancestry controls;19q13.32;19;44892362;APOE, TOMM40;TOMM40;;;ENSG00000130204;;;rs2075650-?;rs2075650;0;2075650;intron_variant;0;0.15;2,00E-157;1,57E+16;;253;[2.37-2.71];Illumina [529205];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST000479;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;1q21.3;1;154713065;KCNN3;KCNN3;;;ENSG00000143603;;;rs16830122-A;rs16830122;0;16830122;intron_variant;0;0.13;0,000002;5,70E+15;;117;[1.10-1.25];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;2q14.3;2;127133851;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;26496;36160;rs4663105-C;rs4663105;0;4663105;intergenic_variant;1;0.43;2,00E-12;1,17E+16;;119;[1.13-1.24];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;3q22.3;3;137931894;SOX14, CLDN18;HSPA8P9 - CLDN18;ENSG00000241478;ENSG00000066405;;49657;66841;rs16847609-A;rs16847609;0;16847609;intergenic_variant;1;0.09;0,0000005;6,30E+15;;119;[1.11-1.28];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;4p13;4;43849075;PGBD3P4, KCTD8;RN7SL691P - RN7SL193P;ENSG00000239464;ENSG00000239679;;250231;14199;rs13146780-C;rs13146780;0;13146780;intergenic_variant;1;0.05;0,000003;5,52E+15;;123;[1.13-1.34];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;4q27;4;122647254;IL21, CETN4P;IL21-AS1;;;ENSG00000227145;;;rs78538083-C;rs78538083;0;78538083;intron_variant;0;0.06;0,000008;5,10E+15;;132;[1.17-1.48];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q14.1;5;80285949;SERINC5, KRT18P45;SERINC5 - KRT18P45;ENSG00000164300;ENSG00000249438;;29870;2500;rs71636213-G;rs71636213;0;71636213;intergenic_variant;1;0.1;0,000009;5,05E+15;;118;[1.10-1.27];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q31.1;5;131351444;CDC42SE2;CDC42SE2;;;ENSG00000158985;;;rs382216-C;rs382216;0;382216;intron_variant;0;0.64;0,0000002;6,70E+15;;11494253;[1.09-1.22];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q31.1;5;131552731;RAPGEF6;AC008695.1, RAPGEF6;;;ENSG00000273217, ENSG00000158987;;;rs6890695-G;rs6890695;0;6890695;intron_variant;0;0.79;0,0000006;6,22E+15;;11494253;[1.09-1.22];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q31.1;5;131773852;FNIP1;FNIP1, AC008695.1;;;ENSG00000217128, ENSG00000273217;;;rs758324-T;rs758324;0;758324;intron_variant;0;0.81;0,0000004;6,40E+16;;11627907;[1.1-1.22];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q31.1;5;131897266;FNIP1, ACSL6;MEIKIN, AC026398.1;;;ENSG00000239642, ENSG00000281938;;;rs142958719-G;rs142958719;0;142958719;intron_variant;0;0.82;0,0000003;6,52E+15;;11627907;[1.1-1.23];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q31.1;5;131965922;ACSL6;AC034228.3, ACSL6, AC026398.1;;;ENSG00000234758, ENSG00000164398, ENSG00000281938;;;rs476428-G;rs476428;0;476428;intron_variant;0;0.81;0,0000002;6,70E+15;;11627907;[1.1-1.23];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;5q31.3;5;140327854;PFDN1, HBEGF;PFDN1 - HBEGF;ENSG00000113068;ENSG00000113070;;24733;4989;rs11168036-T;rs11168036;0;11168036;intergenic_variant;1;0.5;0,0000003;6,52E+15;;112;[1.07-1.17];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;7p22.3;7;82377;FAM20C;AC093627.1;;;ENSG00000232325;;;rs11761441-G;rs11761441;0;11761441;intron_variant;0;0.46;0,000002;5,70E+15;;112;[1.07-1.17];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;7p15.2;7;25528235;NPVF, UBA52P1;AC005100.1 - AC091705.1;ENSG00000285960;ENSG00000227386;;27792;19527;rs10807828-C;rs10807828;0;10807828;intergenic_variant;1;0.51;0,000007;5,15E+15;;1098901;[1.05-1.15];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;7q35;7;143412115;EPHA1, TAS2R62P;EPHA1-AS1;;;ENSG00000229153;;;rs75045569-T;rs75045569;0;75045569;intron_variant;0;0.83;0,000008;5,10E+15;;11494253;[1.08-1.22];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;8p21.1;8;27598736;CLU;CLU;;;ENSG00000120885;;;rs2279590-C;rs2279590;0;2279590;non_coding_transcript_exon_variant;0;0.6;0,000002;5,70E+15;;11235955;[1.08-1.18];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;10p14;10;11678309;USP6NL, ECHDC3;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66082;1366;rs7920721-G;rs7920721;0;7920721;TF_binding_site_variant;1;0.38;0,000003;5,52E+15;;112;[1.07-1.17];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;10q23.1;10;80629227;SH2D4B;SH2D4B;;;ENSG00000178217;;;rs59616746-C;rs59616746;0;59616746;intron_variant;0;0.85;0,000001;60;;12987013;[1.18-1.45];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;10q26.2;10;128547890;MKI67, MGMT;AL390763.1 - AL355537.1;ENSG00000234640;ENSG00000224190;;227676;364989;rs61310603-T;rs61310603;0;61310603;intergenic_variant;1;0.84;0,000008;5,10E+15;;11904762;[1.11-1.3];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;11q12.2;11;60254475;MS4, MS4A6A, MS4A4A, MS4A6E;MS4A4A;;;ENSG00000110079;;;rs1582763-G;rs1582763;0;1582763;intron_variant;0;0.63;0,000000002;8,70E+15;;11494253;[1.1-1.2];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;11q14.2;11;86157598;PICALM;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;4264;35189;rs3851179-C;rs3851179;0;3851179;regulatory_region_variant;1;0.65;0,000002;5,70E+15;;11235955;[1.06-1.18];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;14q32.12;14;92460608;SLC24A4;SLC24A4;;;ENSG00000140090;;;rs10498633-G;rs10498633;0;10498633;intron_variant;0;0.78;0,0000004;6,40E+16;;11494253;[1.09-1.22];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;17q21.31;17;45746994;CRHR1;LINC02210-CRHR1, LINC02210-CRHR1;;;ENSG00000263715, ENSG00000282456;;;rs7207400-T;rs7207400;0;7207400;intron_variant;0;0.75;0,000005;5,30E+15;;11363636;[1.08-1.2];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;17q21.31;17;46275856;KANSL1, LRRC27A, MAPT;ARL17B;;;ENSG00000275748;;;rs2732703-T;rs2732703;0;2732703;intron_variant;0;0.87;0,000000006;8,22E+15;;1369863;[1.23-1.54];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;17q21.31;17;46788132;WNT3;WNT3, WNT3, WNT3;;;ENSG00000277626, ENSG00000108379, ENSG00000277641;;;rs199499-C;rs199499;0;199499;intron_variant;0;0.81;0,000006;5,22E+15;;11627907;[1.09-1.23];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;17q25.1;17;74979653;C17orf28, CDR2L;HID1-AS1 - CDR2L;ENSG00000263586;ENSG00000109089;;3925;7979;rs71380849-A;rs71380849;0;71380849;intergenic_variant;1;0.05;0,0000009;6,05E+15;;147;[1.26-1.71];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;20p12.1;20;16216865;MACROD2, PPIAP17;MACROD2 - PPIAP17;ENSG00000172264;ENSG00000225622;;163668;6885;rs6110969-T;rs6110969;0;6110969;regulatory_region_variant;1;0.08;0,000003;5,52E+15;;12;[1.11-1.29];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;1q32.2;1;207577223;CR1;AL137789.1, CR1;;;ENSG00000236911, ENSG00000203710;;;rs679515-T;rs679515;0;679515;intron_variant;0;0.21;0,000000004;8,40E+15;;122;[1.14-1.30];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;2q14.3;2;127135234;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;27879;34777;rs6733839-T;rs6733839;0;6733839;intergenic_variant;1;0.41;0,000000001;90;;12;[1.13-1.27];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;2q24.1;2;158844068;DAPL1, OR7E89P;DAPL1;;;ENSG00000163331;;;rs1125355-A;rs1125355;0;1125355;intron_variant;0;0.26;0,000004;5,40E+16;;116;[1.09-1.23];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;2q32.1;2;182154019;PDE1A;PDE1A;;;ENSG00000115252;;;rs17366218-A;rs17366218;0;17366218;intron_variant;0;0.95;0,000002;5,70E+15;;15384616;[1.28-1.85];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;2q34;2;211107743;CPS1, RPS27P10;AC012491.1 - AC013404.1;ENSG00000271074;ENSG00000231017;;2011;191198;rs178585-C;rs178585;0;178585;intergenic_variant;1;0.47;0,000004;5,40E+16;;113;[1.07-1.19];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;3p12.1;3;85855884;CADM2;CADM2;;;ENSG00000175161;;;rs71316816-C;rs71316816;0;71316816;intron_variant;0;0.92;0,000009;5,05E+15;;125;[1.14-1.37];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;3q13.33;3;121607829;FBXO40;FBXO40;;;ENSG00000163833;;;rs9869689-T;rs9869689;0;9869689;intron_variant;0;0.1;0,000003;5,52E+15;;121;[1.12-1.31];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;4q34.3;4;181180536;LINC00290, MGC45800;LINC00290 - AC019235.1;ENSG00000248197;ENSG00000248770;;21387;56822;rs10018288-G;rs10018288;0;10018288;regulatory_region_variant;1;0.19;0,000004;5,40E+16;;116;[1.09-1.24];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;6p24.3;6;10101984;OFCC1, RPL7AP36;OFCC1;;;ENSG00000181355;;;rs2876189-G;rs2876189;0;2876189;intron_variant;0;0.31;0,000006;5,22E+15;;114;[1.08-1.21];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;6p21.1;6;42964462;PEX6;PEX6;;;ENSG00000124587;;;rs1129187-T;rs1129187;0;1129187;missense_variant;0;0.45;0,000007;5,15E+15;;113;[1.07-1.19];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;7q31.1;7;110142514;RPL3P8, IMMP2L;RPL3P8 - AC073114.1;ENSG00000232199;ENSG00000278424;;142890;73377;rs59406683-A;rs59406683;0;59406683;intergenic_variant;1;0.89;0,000006;5,22E+15;;12048193;[1.11-1.3];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;8p21.1;8;27610169;CLU;CLU;;;ENSG00000120885;;;rs9331896-T;rs9331896;0;9331896;intron_variant;0;0.62;0,000000003;8,52E+15;;11904762;[1.12-1.25];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;11q14.2;11;85970540;PICALM;PICALM;;;ENSG00000073921;;;rs639012-G;rs639012;0;639012;intron_variant;0;0.7;0,0000001;70;;11627907;[1.1-1.22];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;11q14.2;11;86120499;PICALM;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;50617;32728;rs471470-A;rs471470;0;471470;intergenic_variant;1;0.68;0,00000003;7,52E+15;;11627907;[1.1-1.23];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;15q21.1;15;45065212;SORD;SORD;;;ENSG00000140263;;;rs2854437-G;rs2854437;0;2854437;intron_variant;0;0.87;0,000002;5,70E+15;;12345679;[1.14-1.35];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;21q21.2;21;24540925;VN2R20P, RPL13AP7;LINC01684;;;ENSG00000237484;;;rs721146-A;rs721146;0;721146;intron_variant;0;0.21;0,000004;5,40E+16;;117;[1.09-1.25];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;8p21.2;8;27458600;PTK2B;PTK2B;;;ENSG00000120899;;;rs2271920-A;rs2271920;0;2271920;3_prime_UTR_variant;0;0.39;0,000008;5,10E+15;;111;[1.06-1.16];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4+ carriers;10,352 cases, 9,207 controls;1,250 European ancestry cases, 536 European ancestry controls;11q14.2;11;86156833;PICALM;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;3499;35954;rs10792832-G;rs10792832;0;10792832;regulatory_region_variant;1;0.65;0,000004;5,40E+16;;114;[1.08-1.19];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002813;Genome-wide genotyping array
03-02-2016;25778476;Jun G;17-03-2015;Mol Psychiatry;www.ncbi.nlm.nih.gov/pubmed/25778476;A novel Alzheimer disease locus located near the gene encoding tau protein.;Alzheimer's disease in APOE e4- carriers;7,184 cases, 26,968 controls;718 European ancestry cases, 1,699 European ancestry controls;11q24.1;11;121564878;SORL1;SORL1;;;ENSG00000137642;;;rs11218343-T;rs11218343;0;11218343;intron_variant;0;0.96;0,000009;5,05E+15;;13;[1.16-1.45];NR [NR];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002817;Genome-wide genotyping array
02-05-2011;21460840;Hollingworth P;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460840;Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.;Alzheimer's disease;6,688 European ancestry cases, 13,685 European ancestry controls;13,182 European ancestry cases, 26,161 European ancestry controls;19p13.3;19;1046521;ABCA7;ABCA7;;;ENSG00000064687;;;rs3764650-?;rs3764650;0;3764650;intron_variant;0;0.10;5,00E-17;1,63E+15;;123;[1.18-1.30];Affymetrix, Illumina [496763];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001025;Genome-wide genotyping array
02-05-2011;21460840;Hollingworth P;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460840;Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.;Alzheimer's disease;6,688 European ancestry cases, 13,685 European ancestry controls;13,182 European ancestry cases, 26,161 European ancestry controls;11q12.2;11;60171834;MS4A4E, MS4A6A;AP001257.1 - MS4A6A;ENSG00000254952;ENSG00000110077;;11012;180;rs610932-?;rs610932;0;610932;regulatory_region_variant;1;0.58;2,00E-14;1,37E+16;;111;[1.09-1.15];Affymetrix, Illumina [496763];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001025;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;6p12.3;6;47485642;CD2AP;CD2AP;;;ENSG00000198087;;;rs9349407-C;rs9349407;0;9349407;intron_variant;0;0.27;0,000000009;8,05E+15;;111;[1.07-1.15];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;7q35;7;143412046;EPHA1;EPHA1-AS1;;;ENSG00000229153;;;rs11767557-?;rs11767557;0;11767557;intron_variant;0;0.81;6,00E-10;9,22E+15;;111;[1.08-1.16];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;11q12.2;11;60266956;MS4A4A;MS4A4A;;;ENSG00000110079;;;rs4938933-?;rs4938933;0;4938933;intron_variant;0;0.61;8,00E-12;1,11E+16;;112;[1.09-1.15];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;19q13.41;19;51224706;CD33;SIGLEC22P - CD33;ENSG00000268849;ENSG00000105383;;12618;358;rs3865444-?;rs3865444;0;3865444;intergenic_variant;1;0.70;0,000000002;8,70E+15;;11;[1.08-1.14];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
02-05-2011;21460840;Hollingworth P;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460840;Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.;Alzheimer's disease;6,688 European ancestry cases, 13,685 European ancestry controls;13,182 European ancestry cases, 26,161 European ancestry controls;1q32.2;1;207611623;CR1;CR1;;;ENSG00000203710;;;rs3818361-?;rs3818361;0;3818361;intron_variant;0;0.19;4,00E-14;1,34E+16;;118;[1.13-1.24];Affymetrix, Illumina [496763];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001025;Genome-wide genotyping array
02-05-2011;21460840;Hollingworth P;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460840;Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.;Alzheimer's disease;6,688 European ancestry cases, 13,685 European ancestry controls;13,182 European ancestry cases, 26,161 European ancestry controls;2q14.3;2;127137039;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;29684;32972;rs744373-?;rs744373;0;744373;intergenic_variant;1;0.29;3,00E-14;1,35E+16;;117;[1.12-1.21];Affymetrix, Illumina [496763];N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001025;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;1q32.2;1;207612944;CR1;CR1;;;ENSG00000203710;;;rs6701713-A;rs6701713;0;6701713;intron_variant;0;0.20;5,00E-10;9,30E+15;;116;[1.11-1.22];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;2q14.3;2;127132061;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;24706;37950;rs7561528-A;rs7561528;0;7561528;intergenic_variant;1;0.35;4,00E-14;1,34E+16;;117;[1.13-1.22];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;8p21.1;8;27608798;CLU;CLU;;;ENSG00000120885;;;rs1532278-?;rs1532278;0;1532278;non_coding_transcript_exon_variant;0;0.64;0,00000008;7,10E+15;;112;[1.08-1.18];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;11q14.2;11;86089237;PICALM;PICALM - RNU6-560P;ENSG00000073921;ENSG00000200877;;19355;63990;rs561655-?;rs561655;0;561655;intergenic_variant;1;0.66;7,00E-11;1,02E+16;;115;[1.10-1.19];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
24-05-2011;21460841;Naj AC;03-04-2011;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/21460841;Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.;Alzheimer's disease (late onset);8,309 European ancestry cases, 7,366 European ancestry controls;10,523 European ancestry cases, 28,231 European ancestry controls;19p13.3;19;1056493;ABCA7;ABCA7;;;ENSG00000064687;;;rs3752246-G;rs3752246;0;3752246;missense_variant;0;0.19;0,0000006;6,22E+15;;115;[1.09-1.21];Affymetrix, Illumina [2324889] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST001026;Genome-wide genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;2q14.3;2;127068957;BIN1;BIN1;;;ENSG00000136717;;;rs1060743-?;rs1060743;0;1060743;synonymous_variant;0;NR;0,00000005;7,30E+15;;11066935;;Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;8p21.1;8;27608798;CLU;CLU;;;ENSG00000120885;;;rs1532278-?;rs1532278;0;1532278;non_coding_transcript_exon_variant;0;NR;6,00E-10;9,22E+15;;11177499;;Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;19q13.41;19;51224706;CD33;SIGLEC22P - CD33;ENSG00000268849;ENSG00000105383;;12618;358;rs3865444-?;rs3865444;0;3865444;intergenic_variant;1;NR;0,000002;5,70E+15;;10942049;;Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;1q32.2;1;207518704;CR1;CR1;;;ENSG00000203710;;;rs6656401-?;rs6656401;0;6656401;intron_variant;0;NR;7,00E-11;1,02E+16;;11725225;;Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;11q12.2;11;60173126;MS4A6A;MS4A6A;;;ENSG00000110077;;;rs7232-?;rs7232;0;7232;missense_variant;0;NR;0,0000006;6,22E+15;;10942651;;Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;19q13.32;19;44908822;APOE;APOE;;;ENSG00000130203;;;rs7412-?;rs7412;0;7412;missense_variant;0;NR;3,00E-105;1,05E+16;;23065467;;Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;6p21.1;6;41161469;TREM2;TREM2;;;ENSG00000095970;;;rs143332484-T;rs143332484;0;143332484;missense_variant;0;NR;2,00E-14;1,37E+16;;16665556;[1.46-1.90];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;17q21.32;17;49219935;ABI3;ABI3;;;ENSG00000108798;;;rs616338-T;rs616338;0;616338;missense_variant;0;NR;5,00E-10;9,30E+15;;14296066;[1.3-1.6];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;16q23.3;16;81908423;PLCG2;PLCG2;;;ENSG00000197943;;;rs72824905-?;rs72824905;0;72824905;missense_variant;0;NR;5,00E-10;9,30E+15;;14756235;[1.25-1.67];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;6p21.1;6;41161514;TREM2;TREM2;;;ENSG00000095970;;;rs75932628-T;rs75932628;0;75932628;missense_variant;0;NR;5,00E-24;2,33E+15;;24557426;[2.06-2.92];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;16p13.3;16;63029;RHBDF1;RHBDF1;;;ENSG00000007384;;;rs78541046-?;rs78541046;0;78541046;missense_variant;0;NR;0,000002;5,70E+15;(adjusted);62228026;[2.94-12.5];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;11q12.3;11;62521506;AHNAK;AHNAK;;;ENSG00000124942;;;rs11828907-C;rs11828907;0;11828907;missense_variant;0;NR;0,0000002;6,70E+15;;44935546;[2.55-7.92];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;10p14;10;7799848;ATP5C1;ATP5F1C;;;ENSG00000165629;;;rs139967528-G;rs139967528;0;139967528;missense_variant;0;NR;6,00E-10;9,22E+15;;6119662;[3.45-10.9];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;19p13.3;19;572671;BSG;BSG;;;ENSG00000172270;;;rs201850688-G;rs201850688;0;201850688;missense_variant;0;NR;0,000009;5,05E+15;;1804889;[1.39-2.34];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;15q23;15;71746912;THSD4;THSD4;;;ENSG00000187720;;;rs201879533-?;rs201879533;0;201879533;missense_variant;0;NR;0,000004;5,40E+16;(adjusted);56306844;[2.7-12.5];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;11q22.3;11;108326169;ATM;C11orf65, ATM;;;ENSG00000166323, ENSG00000149311;;;rs56009889-?;rs56009889;0;56009889;missense_variant;0;NR;0,0000006;6,22E+15;;30578122;[1.96-4.76];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
30-04-2018;28714976;Sims R;01-09-2017;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/28714976;Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.;Alzheimer's disease (late onset);up to 16,097 European ancestry cases, up to 18,077 European ancestry controls;up to 20,693 European ancestry cases, up to 30,266 European ancestry controls;11q23.3;11;121146015;TECTA;TECTA;;;ENSG00000109927;;;rs148619105-?;rs148619105;0;148619105;missense_variant;0;NR;0,0000001;70;;18587084;[1.47-2.33];Illumina [241551];N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST005549;Exome genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;16p12.3;16;19796841;IQCK;IQCK;;;ENSG00000174628;;;rs7185636-T;rs7185636;0;7185636;intron_variant;0;0.8200000000000001;0,00000002;7,70E+15;;10869565;[1.05-1.12];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;15q21.3;15;58753575;ADAM10;ADAM10 - AC090515.3;ENSG00000137845;ENSG00000259173;;3597;2050;rs593742-A;rs593742;0;593742;intergenic_variant;1;0.7050000000000001;0,000000007;8,15E+15;;10752687;[1.05-1.1];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;21q21.3;21;26784537;ADAMTS1;CYYR1 - ADAMTS1;ENSG00000166265;ENSG00000154734;;211253;51210;rs2830500-C;rs2830500;0;2830500;regulatory_region_variant;1;0.692;0,00000003;7,52E+15;;10752687;[1.04-1.1];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;8q22.1;8;94964023;NDUFAF6;NDUFAF6;;;ENSG00000156170;;;rs4735340-T;rs4735340;0;4735340;intron_variant;0;0.524;0,00000009;7,05E+15;;10638298;[1.04-1.09];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;15q21.2;15;50716490;SPPL2A;SPPL2A;;;ENSG00000138600;;;rs10467994-T;rs10467994;0;10467994;intron_variant;0;0.667;0,0000004;6,40E+16;;10638298;[1.04-1.09];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;17q22;17;58331728;MIR142, TSPOAP1-AS1;AC004687.1, TSPOAP1-AS1;;;ENSG00000265206, ENSG00000265148;;;rs2632516-G;rs2632516;0;2632516;non_coding_transcript_exon_variant;0;0.56;0,00000005;7,30E+15;;10638298;[1.04-1.1];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;12q12;12;43573874;ADAMTS20;AC090525.2 - AC090525.3;ENSG00000257813;ENSG00000271508;;1836;59219;rs7295246-G;rs7295246;0;7295246;intergenic_variant;1;0.413;0,0000004;6,40E+16;;106;[1.04-1.08];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;10p14;10;11678309;ECHDC3;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66082;1366;rs7920721-G;rs7920721;0;7920721;TF_binding_site_variant;1;0.39;2,00E-11;1,07E+16;;108;[1.06-1.11];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;17q23.3;17;63460787;ACE;AC005828.5 - PPIAP55;ENSG00000265971;ENSG00000228979;;4970;10817;rs138190086-A;rs138190086;0;138190086;intergenic_variant;1;0.02;0,000000005;8,30E+15;;13;[1.19-1.42];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;6p21.1;6;41066261;OARD1;OARD1;;;ENSG00000124596;;;rs114812713-C;rs114812713;0;114812713;3_prime_UTR_variant;0;0.03;2,00E-13;1,27E+16;;132;[1.22-1.42];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;16q23.2;16;79321960;WWOX, MAF;RNA5SP431 - AC084064.1;ENSG00000222244;ENSG00000261472;;57387;183643;rs62039712-A;rs62039712;0;62039712;intergenic_variant;1;0.116;0,00000004;7,40E+16;;116;[1.10-1.23];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;5q11.2;5;53369400;LOC257396, FST;AC027329.1 - AC108114.1;ENSG00000285831;ENSG00000240052;;42835;44104;rs35868327-T;rs35868327;0;35868327;TF_binding_site_variant;1;0.987;0,0000003;6,52E+15;;14705882;[1.27-1.69];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;5p13.3;5;29005878;SUCLG2P4;SUCLG2P4 - RF00425;ENSG00000249226;ENSG00000252601;;2521;64618;rs71618613-A;rs71618613;0;71618613;intergenic_variant;1;0.99;0,0000003;6,52E+15;;14084507;[1.23-1.59];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;13q13.3;13;39050685;NHLRC3, PROSER1;NHLRC3 - AL354809.1;ENSG00000188811;ENSG00000273507;;576;2387;rs190094306-?;rs190094306;0;190094306;intergenic_variant;1;NR;0,000004;5,40E+16;;162;[1.32-1.99];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;7p22.1;7;6869229;CCZ1B;OR7E136P - OR7E59P;ENSG00000205897;ENSG00000250561;;1557;10398;rs187857322-?;rs187857322;0;187857322;intergenic_variant;1;NR;0,000002;5,70E+15;;163;[1.33-2.00];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;8q21.11;8;73378103;AK128216, STAU2;AC111149.1 - STAU2-AS1;ENSG00000253235;ENSG00000253302;;8808;41901;rs192326911-?;rs192326911;0;192326911;intergenic_variant;1;NR;0,000003;5,52E+15;;165;[1.34-2.04];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;15q13.3;15;31149558;TRPM1;TRPM1, TRPM1;;;ENSG00000134160, ENSG00000274965;;;rs192098867-?;rs192098867;0;192098867;intron_variant;0;NR;0,000007;5,15E+15;;12987013;[1.16-1.47];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;14q13.1;14;33974720;EGLN3;EGLN3;;;ENSG00000129521;;;rs35833468-?;rs35833468;0;35833468;intron_variant;0;NR;0,000003;5,52E+15;;10869565;[1.04-1.12];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;1p31.1;1;71755908;NEGR1, NEGR1-IT1;NEGR1;;;ENSG00000172260;;;rs190217640-?;rs190217640;0;190217640;intron_variant;0;NR;0,000007;5,15E+15;;14492754;[1.23-1.69];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;;;;UBE2D2;;;;;;;rs19213255-?;rs19213255;0;19213255;;1;NR;0,000004;5,40E+16;;13333333;[1.18-1.49];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;4p15.1;4;32832588;PCDH7;LINC02353 - AC017013.1;ENSG00000251329;ENSG00000250076;;479368;178360;rs182921547-?;rs182921547;0;182921547;intergenic_variant;1;NR;0,0000008;6,10E+15;;138;[1.21-1.56];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;19p13.11;19;18448066;ISYNA1, ELL, SSBP4;ELL;;;ENSG00000105656;;;rs8111708-?;rs8111708;0;8111708;intron_variant;0;NR;0,000002;5,70E+15;;106;[1.03-1.09];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;11p11.2;11;46783211;MIR5582, F2, CKAP5;CKAP5;;;ENSG00000175216;;;rs11038990-?;rs11038990;0;11038990;non_coding_transcript_exon_variant;0;NR;0,000006;5,22E+15;;109;[1.05-1.13];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
04-04-2019;30820047;Kunkle BW;28-02-2019;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/30820047;Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.;Alzheimer's disease (late onset);21,982 European ancestry cases, 41,944 European ancestry controls;up to 13,292 European ancestry cases, up to 17,219 European ancestry controls;3q12.3;3;101508591;FAM172BP, SENP7;SENP7;;;ENSG00000138468;;;rs6806784-?;rs6806784;0;6806784;intron_variant;0;NR;0,000004;5,40E+16;;153;[1.28-1.83];Affymetrix, Illumina [11480632] (imputed);N;late-onset Alzheimers disease;http://www.ebi.ac.uk/efo/EFO_1001870;GCST007511;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;1q31.2;1;193656103;intergenic;LINC01031 - AL357793.1;ENSG00000232077;ENSG00000226640;;290150;22791;rs6678275-C;rs6678275;0;6678275;intergenic_variant;1;0.169;0,0000003;6,52E+15;;109;[1.05-1.13];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;4p15.33;4;11628425;HS3ST1;AC005699.1;;;ENSG00000249631;;;rs6448799-T;rs6448799;0;6448799;intron_variant;0;0.3;0,00000007;7,15E+15;;108;[1.05-1.11];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;5q35.3;5;179811261;SQSTM1;SQSTM1;;;ENSG00000161011;;;rs72807343-T;rs72807343;0;72807343;intron_variant;0;0.016;0,0000007;6,15E+15;;135;[1.20-1.52];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;6p21.1;6;41186912;TREML2;TREM2 - TREML2;ENSG00000095970;ENSG00000112195;;23726;3365;rs9381040-C;rs9381040;0;9381040;intergenic_variant;1;0.703;0,0000006;6,22E+15;;10753;[1.04-1.1];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;8q22.1;8;95041772;NDUFAF6;NDUFAF6;;;ENSG00000156170;;;rs7818382-T;rs7818382;0;7818382;intron_variant;0;0.469;0,00000008;7,10E+15;;107;[1.04-1.10];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;10p14;10;11678309;ECHDC3;AL512631.2 - AL512631.1;ENSG00000271360;ENSG00000271046;;66082;1366;rs7920721-G;rs7920721;0;7920721;TF_binding_site_variant;1;0.387;0,0000003;6,52E+15;;107;[1.04-1.10];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;11p15.5;11;941941;AP2A2;AP2A2;;;ENSG00000183020;;;rs10751667-T;rs10751667;0;10751667;intron_variant;0;0.634;0,0000006;6,22E+15;;10753;[1.04-1.1];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;12q12;12;43573874;ADAMTS20;AC090525.2 - AC090525.3;ENSG00000257813;ENSG00000271508;;1836;59219;rs7295246-G;rs7295246;0;7295246;intergenic_variant;1;0.406;0,0000003;6,52E+15;;107;[1.04-1.10];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;14q32.33;14;106772332;IGH;IGHV2-70 - IGHV3-71;ENSG00000274576;ENSG00000254056;;1312;2825;rs2337406-C;rs2337406;0;2337406;intergenic_variant;1;0.897;0,0000003;6,52E+15;;11494;[1.09-1.2];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;15q21.2;15;50748601;SPPL2A;SPPL2A, AC012100.2;;;ENSG00000138600, ENSG00000259773;;;rs8035452-T;rs8035452;0;8035452;intron_variant;0;0.661;0,0000003;6,52E+15;;10753;[1.04-1.1];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;15q22.31;15;64433291;TRIP4;TRIP4;;;ENSG00000103671;;;rs74615166-C;rs74615166;0;74615166;intron_variant;0;0.02;0,0000004;6,40E+16;;129;[1.17-1.42];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;17p13.2;17;5233752;SCIMP;AC087500.1, SCIMP;;;ENSG00000261879, ENSG00000161929;;;rs7225151-A;rs7225151;0;7225151;intron_variant;0;0.121;0,0000004;6,40E+16;;11;[1.06-1.15];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;;;;ACE;;;;;;;chr17:61538148-A;chr17:61538148;0;;;1;0.018;0,0000003;6,52E+15;;134;[1.20-1.50];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;19q13.41;19;51224706;CD33;SIGLEC22P - CD33;ENSG00000268849;ENSG00000105383;;12618;358;rs3865444-C;rs3865444;0;3865444;intergenic_variant;1;0.693;0,000003;5,52E+15;;106;[1.04-1.1];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;1q32.2;1;207518704;CR1;CR1;;;ENSG00000203710;;;rs6656401-A;rs6656401;0;6656401;intron_variant;0;0.197;6,00E-24;2,32E+16;;118;[1.14-1.22];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;2q14.3;2;127135234;BIN1;BIN1 - NIFKP9;ENSG00000136717;ENSG00000237630;;27879;34777;rs6733839-T;rs6733839;0;6733839;intergenic_variant;1;0.409;7,00E-44;4,32E+15;;122;[1.18-1.25];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;6p12.3;6;47520026;CD2AP;CD2AP;;;ENSG00000198087;;;rs10948363-G;rs10948363;0;10948363;intron_variant;0;0.266;5,00E-11;1,03E+16;;11;[1.07-1.13];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;7q35;7;143413669;EPHA1;EPHA1-AS1;;;ENSG00000229153;;;rs11771145-G;rs11771145;0;11771145;intron_variant;0;0.662;1,00E-13;130;;11111;[1.08-1.14];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;8p21.1;8;27610169;CLU;CLU;;;ENSG00000120885;;;rs9331896-T;rs9331896;0;9331896;intron_variant;0;0.621;3,00E-25;2,45E+16;;11628;[1.12-1.19];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;11q12.2;11;60156035;MS4A6A;MS4A2 - AP001257.1;ENSG00000149534;ENSG00000254952;;57569;3652;rs983392-A;rs983392;0;983392;intergenic_variant;1;0.597;6,00E-16;1,52E+16;;11111;[1.09-1.15];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;11q14.2;11;86156833;PICALM;RNU6-560P - AP003097.2;ENSG00000200877;ENSG00000254699;;3499;35954;rs10792832-G;rs10792832;0;10792832;regulatory_region_variant;1;0.642;9,00E-26;2,50E+16;;11494;[1.12-1.18];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;19p13.3;19;1063444;ABCA7;ABCA7;;;ENSG00000064687;;;rs4147929-A;rs4147929;0;4147929;intron_variant;0;0.19;1,00E-15;150;;115;[1.11-1.19];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;2q37.1;2;233159830;INPP5D;INPP5D, INPP5D;;;ENSG00000281614, ENSG00000168918;;;rs35349669-T;rs35349669;0;35349669;intron_variant;0;0.488;0,00000003;7,52E+15;;108;[1.05-1.11];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;5q14.3;5;88927603;MEF2C;MEF2C-AS1;;;ENSG00000248309;;;rs190982-A;rs190982;0;190982;intron_variant;0;0.592;0,00000003;7,52E+15;;10753;[1.05-1.11];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;7p14.1;7;37801932;NME8;GPR141, EPDR1;;;ENSG00000187037, ENSG00000086289;;;rs2718058-A;rs2718058;0;2718058;intron_variant;0;0.627;0,000000005;8,30E+15;;10753;[1.05-1.11];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;7q22.1;7;100406823;ZCWPW1;ZCWPW1;;;ENSG00000078487;;;rs1476679-T;rs1476679;0;1476679;intron_variant;0;0.713;6,00E-10;9,22E+15;;10989;[1.06-1.12];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;11p11.2;11;47536319;CELF1;CELF1;;;ENSG00000149187;;;rs10838725-C;rs10838725;0;10838725;intron_variant;0;0.316;0,00000001;80;;108;[1.05-1.11];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;14q22.1;14;52933911;FERMT2;FERMT2;;;ENSG00000073712;;;rs17125944-C;rs17125944;0;17125944;intron_variant;0;0.092;0,000000008;8,10E+15;;114;[1.09-1.19];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;20q13.31;20;56443204;CASS4;CASS4;;;ENSG00000087589;;;rs7274581-T;rs7274581;0;7274581;intron_variant;0;0.917;0,00000003;7,52E+15;;11364;[1.09-1.19];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;6p21.32;6;32610753;HLA-DRB5, HLA-DRB1;HLA-DRB1 - HLA-DQA1;ENSG00000206240;ENSG00000196735;;20905;17426;rs9271192-C;rs9271192;0;9271192;intergenic_variant;1;0.276;3,00E-12;1,15E+16;;111;[1.08-1.18];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;8p21.2;8;27337604;PTK2B;PTK2B;;;ENSG00000120899;;;rs28834970-C;rs28834970;0;28834970;intron_variant;0;0.366;7,00E-14;1,32E+16;;11;[1.08-1.13];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;11q24.1;11;121564878;SORL1;SORL1;;;ENSG00000137642;;;rs11218343-T;rs11218343;0;11218343;intron_variant;0;0.961;1,00E-14;140;;12987;[1.22-1.39];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
16-04-2014;24162737;Lambert JC;27-10-2013;Nat Genet;www.ncbi.nlm.nih.gov/pubmed/24162737;Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.;Alzheimer's disease (late onset);17,008 European ancestry cases, 37,154 European ancestry controls;8,572 European ancestry cases, 11,312 European ancestry controls;14q32.12;14;92460608;SLC24A4, RIN3;SLC24A4;;;ENSG00000140090;;;rs10498633-G;rs10498633;0;10498633;intron_variant;0;0.783;0,000000006;8,22E+15;;10989;[1.06-1.14];Illumina [7055881] (imputed);N;Alzheimer's disease;http://www.ebi.ac.uk/efo/EFO_0000249;GCST002245;Genome-wide genotyping array
